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Preface
Every human being experiences cardiac arrhythmias during his or her life. The severity
may vary from innocent occasional ectopic beats to lire threatening arrhythmias.
Treatment of cardiac arrhythmias should preferably be based on knowledge about the
different responsible mechanisms. Several mechanisms arc known, of which reentry is
studied best, but there is also abnormal automaticiry and triggered activity. The
relevance of these different mechanisms for every clinically occurring arrhythmia is not
clear. The studies described in this thesis are focussing on the phenomenon of the
appearance of a new and different arrhythmia occurring after treatment with drugs aimed
to prevent and/or suppress heart rhythm disturbances. This is called a proarrhythmic
effect of antiarrhythmic drugs.
The name of the particular arrhythmia, which is the focus of this dissertation, is Torsade
de Pointes (TdP). In the past several other names have been used to describe this
arrhythmia because of its typical configuration. It is known for a long time that TdP
arrhythmias occur in the presence of prolonged ventricular repolarization which can be
recognized on the electrocardiogram as a prolonged QT interval. They are more
common during bradycardia and are characterized by a specific twisting of the QRS
complexes like a corkscrew around the baseline of ECG. The arrhythmia often ter-
minates spontaneously but may deteriorate in to ventricular fibrillation and thereby lead
to rhe death of the patient.
Although investigations have been performed to study the circumstances leading to this
arrhythmia and how to prevent it, no clinical relevant animal model existed in the early
nineties in which the mechanism of TdP could be reproducibly studied.
The aim of the research reported in this thesis was to evaluate the value of an animal
model of acquired TdP arrhythmias in which the mechanism of initiation, continuation
and termination of the arrhythmia could be studied. Moreover such a model could allow
the comparison of potential of different (new) antiarrhythmic drugs to induce TdP
under well controlled and reproducible circumstances.
This thesis consists of 8 chapters. In chapter 1 a review is given of the literature on
different models and the mechanism(s) of acquired Torsade de Pointes arrhythmias that
appeared until 1992 (the start of this PhD thesis). The dog model developed in
Maastricht to study acquired TdP is described in chapter 2. The role of early after-
depolari/.ations (EADs) and intcrventricular dispersion of repolarization (AAPD) in the
generation of TdP is discussed in chapters 3 and 4. Using a group comparison (inducible
versus non inducible dogs) the role of these parameters was determined. In chapter 3
the suppressive cfrcct of magnesium is also reported. In chapter 4, two drugs («/-sotalol
and almokalant) were administered in two separate experiments in the same dog to
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evaluate the relevance of EADs and interventricular AAPD for the induction of TdP.
The contribution of EADs to interventricular AAPD is the subject of chapter S. This
was done by studying the dynamic changes in between reproducible induced TdP
episodes. Chapter 6 relates to the treatment of TdP by two drugs that are known to
influence intracellular calcium, flunarizine and ryanodine. The influence of the
electrophysiologic changes induced by chronic complete AV block on Torsade de
Pointes incidence is discussed in chapter 7, by studying the dog at two different time
points (0 and 5 weeks) after AV block. Chapter 8 contains a general discussion using
the data presented in this thesis and the most recent literature. This is followed by a
summary in English and Dutch.
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Chapter 1
Review of the literature
1.1 Introduction
Torsade de Pointes arrhythmias (TdP) are defined as polymorphic tachycardias showing
a specific rotating pattern ot the QRS complexes around the baseline in the presence of
a prolonged repolarization (figure 1). TdP was first used by Desscrtenne to describe a
polymorphic tachycardia in a patient with acute third degree AV block (1). Since thai
time the name TdP has been used, although initially other names were also given like
cardiac ballet, aspecific polymorphous tachycardia, atypical tachycardia, and transient
or self terminating ventricular fibrillation (2,3).
TdP can be found in two different patient populations: 1) patients with a congenital
and therefore genetically determined cause of prolonged repolari/.ation and 2) patients
with an acquired form of prolonged repolarization (4).
The congenital long QT syndrome can be either familial or idiopathic (4). The familial
type consist of two subgroups: 1) the Jervell-1 jnge Nielsen syndrome which is associated
with deafness and 2) the Romano Ward syndrome with normal hearing (5). These
syndromes are found in a small part of the population. Recently there has been a marked
progress concerning their genetic basis (6-8).
Acquired or drug induced TdP is a less rare phenomenon. Its occurrence is higher when
synergistic circumstances as bradycardia, hypokalcmia and/or hypomagnesemia are
present (9). This in contrast to congenital TdP, in which bradycardia does not have to
be an essential component (4).
This review will deal with the acquired or drug induced form of TdP. First the clinical
circumstances and drugs leading to TdP will be discussed (§1.2). This is followed by a
description of several in vitro, in vivo and computer models of TdP (§1.3). which were
published before 1992 and formed the background for the development of our dog
model of acquired TdP. Thereafter, the importance of ventricular heterogeneity of
repolarization for the generation of TdP will be discussed (§1.4). Finally the different
possible treatments will be summarized (§1.5).
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1,2 Torsade de Pointes arrhythmias in patients
The itó€ of antiarrhythmic drugs can be associated with different proarrhythmic side
effects (13)- As pointed out by Wollens et al. (13) five different proarrhythmic responses
may occur after administration of a drug 1) Worsening of an arrhythmia which is already
present; 2) The- induction of sinoatrial or atrioventricular block or the suppression of
escape mechanisms; 3) Uncovering of a hidden arrhythmia mechanism; 4) Induction of
a new arrhythmia mechanism; 5) Combination of 1 to 4. The TdP arrhythmias fall in
the fourth Gitc-gory.
Depending upon the antiarrhythmic drug used, TdP arrhythmias may occur in about
I to 10% of patients ( I I ) . In those patienrs, episodes of TdP arc often repetitive till
preventive and/or supprevsivc measures are taken (4). These episodes often end spon-
taneously but can also deteriorate into ventricular fibrillation (4). In sudden arrhythmic
death documented by a Holter recording, a TdP arrhythmia was found in 12% of cases
as the initiation of the arrhyrhmia which led to the dearh or the patient (12).
Apart from the specific undulating pattern or the QRS complexes, TdP often shows a
fyjm.tl initiation sequence, the so-called short long short sequence (see figure 1) that is
present in more than 95% of patients (13-15). It has been suggested to put more
emphasis on this mode of initiation, when defining TdP arrhythmias (16).
Another feature which may be observed in the FdP patient is the change in the TU wave
morphology. Not only a prolongation or the Q I time is seen, but this is often associated
with the appearance of a prominent U wave (4, figure 1). On the electrocardiogram, the
U wave is the wave that directly follows the T wave, and has under normal circumstances
the same direction as the I wave. Abnormalities in repolarization may lead to U waves
which are directed opposite to the T wave or a fusion between the T and U wave. The
exact origin of the U wave is still not known.
Understanding the mechanism(s) involved in TdP can help to determine the risk of an
individual patient and to develop drugs which are devoid of this proarrhythmic effect.
The most frequent cause of TdP arrhythmias is the administration of class la and class
III antiarrhythmic drugs, but also other drugs which prolong repolarization may lead to
TdP (see table 1). The antiarrhythmic effect of class la and III drugs (table 2) is at least
partly based on the prolongation of repolarization. Because no alternative antiarrhyth-
mic drugs are presently available to replace these drugs, prevention of TdP induction by
removing these drugs from the market is not a realistic possibility.
In contrast to earlier suggestions (17) more specific K* channel antagonists do not seem
to have a lower incidence of TdP (11, table 2). Channel specificity can be defined as one
channel e.g. Na*, Ca-* or K* but there is also a subdivision of K* channels. However,
,i drug like amiodarone which blocks many channels, like K*, Ca-* and Na* channels,
has a very low incidence of TdP. Despite a similar lengthening in QT, there are even
reports in which amiodarone was safely and effectively administered to patients who
developed TdP after other antiarrhythmic drugs (18,19).
/ J | Chapter 1
. * * ? • • * - - - * • • * . *
« - - L ^ /
rn
V2
Figure 1. Episode of acquired TdP.
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Table 1. Drugs associated with the development of Torsade de Pointes (4,5)
drug group drug name
Amiarrhythmic drugs
Antihistamines
Neurolcptic cherapy/antideprcssam drugs
Antimicrobial agents
Vasodilatory agents
Apneu therapy
Antimalaria treatment
Organophosphate Insecticides
Cholesterol lowering drugs
I'rosugl.indinc
Diuretics
Antifungal agents
Scrotoninc antagonist
See table 2
Astemizole
Tcrfenadine
Haloperidol
Tricyclic antideprcssams
Tetracyclic antideprcssams
Erythromycin
Trimethoprimsuiphamethoxazole
Papavcrinc
Prenylaminc
Suxamethonium
Halofantine
Dimcthoatc
Mcthylparathion
Probucol
Furosemide
Kctoconazole
ltracona/olc
Tropisetron
Ketanserin
defined as a depolarizing potential that begins prior to the completion of repolarization
and causes interruption or retardation of repolarization (29). Some studies showed a
link between the U wave on the ECG and the EADs on the MAP (26). In one patient
with procainamide induced TdP there was a clear difference between the right and left
ventricular API"), so called interventricular dispersion (27). In most cases EADs were
only seen on the longest APD (responsible tor the ventricular dispersion) (27).
1.3 Models of TdP
The mechanism of TdP has been studied in several models. Those studies can be divided
in three subgroups: 1) QRS morphology studies using computer models and in vivo
data aimed at mimicking the specific TdP configuration, 2) EAD based models by
applying toxins and high dosages of drugs in vivo and in vitro, and 3) animal models
which try to reproduce the clinical circumstances such as bradycardia and the administra-
tion of TdP producing drugs in therapeutic dosages (pharmacological models).
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Table 2. Specificity of antiarrhythmic drugs in blocking potassium channels relative to development of
Torsade de Pointes arrhythmias (11,17,85)
Class Drug IK IK, 1,„ TdP
la
Ib
Ic
II
III
rv
Quinidine
Disopyramide
Lidocaine
Flecainide
Encainide
P blockcr
Sotalol
«Z-sotalol
Amiodaronc
Clofilium
Almokalant
E 4031
Dofetilide
Ibutilidc
Bcpridil
yes
yes
no
yes
yes
no
yes
yes
yes
yes
yes
yes
yes
>
yes
yes
no
no
no
no
yes
yes
yes
yes
no
no
no
>
yes
yes
no
no
no
no
yes
yes
no
no
no
no
no
>
2-8%
2-3%
0
*
*
0
1-5%
1-2%
<1%
10%
6%
•
•
8%
•
*: exact incidence not yet known.
In the early description of Dessertenne it was suggested that two competing foci were
responsible for the twisting morphology of TdP (1). This hypothesis has been tested in
a porcine Langendorff heart (30) and in a dog heart (31) in situ. In both cases pacing
from a left and right ventricular site at similar cycle length but slightly out ol phase
resulted in a TdP like configuration (30,31). In a dog with "normal" quinidine
concentrations and prolonged APD, application of acotinine on two sites of the heart,
leading to two triggering foci, also led to TdP (32). Other studies have stressed the
importance of alterations in ventricular activation site rather than two competing foci
(33). Thirdly, the TdP morphology can be explained by a reentrant mechanism caused
by dispersion caused by differences in duration of repolarization at different sites
(34-35). As far as the QRS morphology is concerned, all these theories (the two
competing foci, changing activation patterns of one focus or a reentrant circuit) can be
possible.
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The registration of EADs in patients with TdP by MAP catheters (24,25) led to
investigations as to the presence and causal mechanisms of these humps. In vitro models
using canine Purkinje fibers superfused with cesium (36,37), barium (38), quinidine
(13,37-40) or procainamidc (41) were the first tested models. These studies also allowed
evaluation of the frequency dependence of EADs, that demonstrating a clear bradycardia
dependence. Many studies are only capable of showing EADs at a cycle length exceeding
2000 ms (36,42). The APD of Purkinje fibers is longer than that of myocardial cells
(figure 2). Therefore Purkinje fibers seem to be more sensitive for the generation of
EADs and have been most extensively used in vitro.
In vitro studies provide the ideal circumstances to test the ionic background of the EAD.
It was demonstrated (table 3) that EADs can be generated under several circumstances,
ranging from drugs that block potassium channels, drugs that delay Na*-channel
inactivation (43) to drugs that open Ca~* channels (44). Each induced EAD seems to
have a rather specific way to be suppressed, although in all cases shortening of the APD
by acceleration of the rate is effective (table 3). A drug like isoprenaline can be used to
induce (45), facilitate (46) or inhibit EADs (46), depending whether its dominating
effect was an increase in repolarization or an increase in rate.
EADs have been suggested to occur at different membrane potentials: low membrane
potentials: phase 2, in the plateau phase with a take off potential about -30 mV and at
higher membrane potentials: phase 3 EADs (-60 mV). After cesium both kinds of EADs
(figure 3) have been observed in vitro (36) and in vivo (47). The phase 2 EADs can also
be evoked by the Ca~* agonist Bay K 6844 (44), and are logically suppressed by Ca^*
antagonists like nitrendipine (48). With ryanodine and the Ca-* chelator BAPTA the
phase 2 EAD seem not suppressible (48). These findings suggest that the Ca^* window
current is a likely mechanism for the phase 2 EADs (44).
Phase 3 EADs are not only induced by cesium but also occur after treatment with
isoprenaline (45). In contrast to phase 2 EADs the phase 3 EADs are responsive to
treatment with ryanodine (45). This observation indicates that different channel(s)
and/or mechanisms are involved as suggested by Szabo and co workers. They have put
emphasis on the Na*/Ca^* exchange (49).
Suppression of EADs is also accomplished with magnesium (37), and substances which
are not directly related to ion channels such as prostaglandines (50) and/ or a adrenergic
blockade (51). The effects of a adrenergic blockade could point to the involvement of
an altered intracellular Ca^* handling in the cell.
Most drugs which induce EADs in vitro were also used in the intact dog to investigate
whether their application would lead to TdP in vivo. Cesium has been the most often
/6 | Chapter 1
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Figure 2. Frequency dependent behavior of actionpotential from the different cells types.
The actionpotential duration (APD) of the four different cell types of the canine hc.iri is depicted at cycle
lengths ranging from 300 to 5000 ms. With an increase in cycle length the transnuir.il differente increases,
because the API) of the Purkinje and to a lesser extent of the M cell prolong relatively more in response to
a prolongation of the cycle length. Data modified from references 76 and 84.
used drug (47,50,52-58), but other drugs like anthopleurine A (59) or toxic dosages of
quinidine were also administered (33,60).
Because rate is an important factor in clinical TdP, several interventions were made to
slow heart rate, like vagal stimulation (58), crushing the sinus node, or the creation of
complete AV block (32,47,52). Some drugs like cesium have the advantage of not only
prolonging the cycle length but also to create long pauses because of induction of AV
block (55) which may act as a trigger for TdP. The limitations of cesium induced
polymorphic VT are described in the article of Nayebpour et al. (61).
/.3.3. A/odWf KJ/«g dVagj //w/ arc f «W
Originally, administration of clinically used drugs only lead to the appearance of IdP
like morphologies when toxic dosages were used or when they were combined with
ischemia (31), or after the application of aconitine (32, see table 4). 1 n the sixties, Roberts
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Table 3. In vitro studio reporting on the evoking of early arcerdcpolariuiions
drug/condition channel phase 2 phase 3
affected EADs EADs
cells
PF
PF
myocvtcs
PF
PF
PF
PF
PF
PF
antagonist
Ca^ blockade **.
fast pacing .
Na' blockade .
M g \ a blockade^'
M g , last pacing
ryaiodine
Na'blockade
Ca^" blocker
higl K. I T X . lidocaine
higl epinephrinc
pacng. lidocaine
not ahSrctrd
by
ryanodinc •**
Ca blockade ryanodinc
vrrapamil manganese
ryanodinc
enhanced
by
LongCL,
Bay K 8 6 4 4 ^
IOWKMOWCI'*
ischemia
low epinephrinclong C l
v|uinidinc.long CL
Iviprenaline
ryanodine Bay K 8644**
Acidosis"
Sotalol/Brctylium/Clofilium*^
Bcpridil/ljdoflazine*''
Ischemia"'
Na*. K*
Na*
CaL
K*
C J L. Na*
Abbreviations: PF: Purkinjc fibers. Cl.: cycle length
Table 4. Review of in vivo studies TdP using dog models
drug anesthesia diuretics heart rate stimulation MAP suppression
" * '
quinidinc
cesium *
tiuinidine"
47lesium
anihopleurinr^
cesium
Acotinine/quimdine ^
cesium
Co
cesium
SR decrease of rate by vjpj stim
S9
no
no
no
no
no
no
no
SR
SR/AV block
SR
AV block
SR (480-240Oms)
SR
SR/AV block
PF.S
1'KS. ischemia
stellate ganglion stim EADs
EADs endo/epi
EADs
M V T . PVT, TdP rare P blockade
quinidine
lidocaine
PVT
PVT
PVT
VT/PVT
ITX . rapid pacing
no
no SR vagal stim FADs/DADs
no 800 ms atrial pacing left and right ansca suKlavia stim FlADs I.V > EADs RV V T
yes/no AV block TdP
VT
QT-long-»TdP
Q'I'«shon-»PVT
PVI
VT
lidocaine. rapid pacing
magnesium
pacing
Abbreviations: SR; sinus rate. AV: complete atrioventricular. !'F_S: programmed electrical .limulaiion. MAP: monophasic action potential. EADs: early afterdepolari/ations;
M V I : monomorphic ventricular tachycardia, PVT: polymorphic ventricular tachycardia. '<T wnir/iudiu. •arJiiyi.uriin..«imi.vifniiliuinn..
B10
1 sac
Figure 3. Occurrence of early atterdepolariza-
tions after cesium administration in a dog.
On the left side a smooth monophasic action
potential signal is shown during the control
state. Alter cesium a high membrane potential
early afterdepolari/ation i.\ shown in panel A and
B and a low membrane potential early afterde-
polarization in panel C (47). Figure reproduced
with permission from the American Heart As-
sociation and the authors.
et al. reported that in awake dogs with complete AV block quinidine administration led
to ectopic activity, short runs of ventricular tachycardia, and to periods of syncope (62).
It took another 30 years before two models were published in which clinically used drugs
led to TdP. These models were developed independently from our own model, one is
an awake dog model while the other uses rabbits (63-65).
In hypokalemic awake dogs with chronic AV block, administration of quinidine only
leads to TdP after prolonged infusion or after a further deceleration in ventricular rate
using P blockade (63). Similarly it was also shown that administration of ^ /-sotalol leads
to spontaneous TdP (64).
Review of the literature |
In the other model, rabbits are pretreated with the a agonist methoxamine, followed by
the infusion of several class III agents (65). Spontaneous episodes of TdP evolve
following ectopic beats despite the fast heart rate of the rabbits. Omittance of the a
agonist requires a ten to hundred fold increase of the class III dose leading to TdP (65).
From all these model studies, consensus was reached about the necessity of EADs for
the occurrence of ectopic beats preceding TdP. The mechanism or continuation and
termination remained to be elucidated.
1.4 Ventricular heterogeneity in repolarization
The clinical observation of a difference in duration of repolarization between different
ventricular regions (27) in patients with TdP has been neglected in the experimental
studies during the period between 1980 and 1990. Dispersion in repolarization is a
common phenomena which has been shown to be present during baseline situation in
patients (24,66,67-69), see table 5. It is thought to represent a measure of non
homogeneous recovery of excitability which can include differences in API), differences
in refractory period, and/or differences in activation times. Finally it can be present as
tr.msmur.il, intervenrricular as well as intraventricular dispersion.
It was hypothesized that differences in repolarization duration could initiate reexcita-
tion, because cells with a prolonged API.) caused by local EADs were capable to reexcite
the neighboring cells (70). Other groups disapproved of this mechanism and suggested
that triggering F.ADs were also responsible for the continuation (29).
Surawicz (71) pointed to the pro's and con's of both EADs and dispersion of repolariza-
tion in the mechanism of the TdP. In the in situ experiments, most attention was
directed to the development and behavior of EADs. Although in some experimental
studies more than one MAP catheter was placed, no attention was given to differences
in duration, despite the observation of the preferential increase of LV EAD compared
with the RV EAD after stellate ganglion stimulation (54).
A study using M APs at four different endocardia! sites in dogs, did not find an increased
difference in repolarization after administration of a total of 18 mg quinidine (72).
Although none of the dogs developed EADs and/or TdP. these authors suggested that
other factors than the intrinsic APD prolongation after quinidine must be responsible
for TdP induction (72).
Dispersion as a mechanism for arrhythmias has been more extensively studied in other
fields, e.g. an increase in dispersion of APD by regional cooling and warming of the
ventricle facilitates tachycardia induction (73). No specific attention was ever placed to
interventricular dispersion. In vitro studies showed that the different antiarrhythmic
drugs increase or decrease the difference in APD between the Purkinje and ventricular
muscle cells in a cycle length dependent fashion (74). Besides the difference between
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Table 5. Data on imravcncricular dispersion in patients without QT prolongation
number of subjects/source registration site dispersion technique
Heart catheterization intra RV endocardial 0-38 ms suction MAP
rate dependent
n-40 '*
Heart catheterization intra RV endocardial 0-40 ms suction MAP
n=/
Heart catheterization intra l.V endocardia! 43 ± 18 (21-64) ms contact MAI'
5-11 sites RVAPD<LVAPD
n=3 *"
CABC;
n=10<>'
CABG
intra l.V cpicardial 59 ± 11 (45-73) ms epi APD < endo APD
5-10 sites inverse rel.ition AT .ind APD
intra L.V'epicardial 40 ± 19 (21-89) ms contact MAP inverse
10 sites relation AT ami API)
Electrophysiologic study intra L.V endocardial 0-40 ms
2-3 sites
contact MAP
Abbreviations: APD : action potential duration, AT: activation time. CAlUi: coronary artery bypass
grafting, LV: left ventricle, RV: right ventricle, MAP: monophasic action potential.
ventricular myocytes and Purkinje fibers, recent investigations also showed difference
between the different subpopulations of the mvooirdial cells: epicardial, endocardial and
M cells (75,76). In figure 2, the frequency dependent changes are .summarized, at slower
rates the APD prolongation is most pronounced in the Purkinje fibers, followed by the
M cell region, which creates an enlarged difference in intramural APD. The M cells
might also provide a possible explanation for the U wave formation (75). In addition,
administration of K* channel blocking drugs induces liADs more easily in M cells than
in endocardial and epicardial myocytes (75).
1.5 Treatment of TdP
Treatment of acquired TdP in patients consists of withdrawal of the offending drug.
For direct suppression, every measure that shortens the cycle length is capable of
suppressing episodes of TdP (4). This can be achieved by isoprcnaline infusion and
ventricular pacing. The most often used medicament is magnesium (20) which is a very
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effective suppressor of TdP. In addition, the calcium antagonist verapamil and lidocaine
have administered to prevent TdP (77). In vitro (see also table 3), all interactions that
shorten action potential duration are effective in prevention of the EADs. Most used is
the Na* channel blocker tetrodotoxin (TTX), but also several Ca^ + antagonists have
proven their efficacy (44,48,52,53).
In 1990 we started to develop our TdP model in dogs with chronic AV block. This AV
block dog was used because in Maastricht much experience had been obtained using
this model to study different mechanisms of ventricular arrhythmias under awake and
anesthetized circumstances (78-81).
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ABSTRACT
/: It has been well established that (antiarrhythmic) drugs can also have
proarrhythmic effects such as Torsade de Pointes arrhythmias (TdP). It was the purpose
of this study to create an animal model with a high incidence of reproducible TdP that
occur under clinically relevant circumstances.
A/rt/wdi: Experiments were performed in anesthetized dogs that had been in chronic
atriovcntricular (AV) block for 9 ± 6 weeks. Inducibiliry of TdP was attempted using
different pacing modes before and after the administration of 2 mg/kg */-sotalol (dS).
In some experiments, endocardial monophasic action potentials (MAP) were recorded.
#»»//;: dS increased the cycle length of the idioventricular rhythm (CL-IVR: 1475 ±
460 to 1730 ± 570 ms, P<0.01) and the QT time (390 ± 65 to 480 ± 85 ms, P<0.01).
In 10%) of the experiments "spontaneous" TdP occurred after dS. The incidence of
"pacing dependent" TdP was 52% (P<0.01). In the inducible group CL-IVR and QT
time were significantly longer despite equal percentual increases in these parameters after
dS in both groups. The pacing modes consisting of more than one frequency change
had a higher induction rate of TdP (P<0.()5). Reproducibility of induction of TdP (> 3
times using the same pacing train) remained present for about 60 minutes after dS and
was >90% within the same animal over weeks. Induction of TdP was related to the
presence of early afterdepolarizations (HADs) on the MAP recordings: 5/6 in the
inducible group vs. 2/6 in the non responders. Inducibiliry could be further increased
to 89% when a second bolus of dS was administered to non inducible dogs. On the
other hand, decreasing QT time by faster basic pacing, isoprenaline or MgSC>4 prevented
induction of TdP. This eftect of MgSO.j coincided with disappearance of EADs.
Cö«r/wjf/V/;M: Our animal model shows a high incidence of reproducible acquired TdP
arrhythmias allowing study of mechanism and treatment of TdP. Induction of 1 dP was
related to the combination of 1) a slow ventricular rate, 2) prolongation of QT time, 3)
a sudden induced rate change which often requires > 2 cycle length changes, and 4) the
presence of EALXs.
INTRODUCTION
Torsade de Pointes arrhythmias (TdP) can be congenital or acquired (1). The latter often
occur in the presence of drugs which prolong ventricular repolarization, such as class la
and HI drugs. By definition, one of the characteristics of the drug induced TdP is the
prolongation of the QT(U) duration. Prolongation of the refractory period of cardiac
muscle is at the same time the desired antiarrhythmic goal to prevent reentrant
tachycardias.
Several canine models exist (2-10). which enable the study of the morphological or
mechanistic characteristics of TdP arrhythmias. Initiation of TdP is often associated
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with early atterdepolarizations (EADs) (2-5). Still, we had the impression that the
addition or a model that mimicks the clinical circumstances ot TdP is ot importance tor
a) the comparison of the proarrhythmic potential or drugs to initiate TdP, and b) to
study mechanisms and treatment of TdP. The clinical conditions known to favor
acquired TdP are 1) bradycardia. 2) therapeutic dosages ot drugs that prolong Q T
duration, 3) sequences of short long short intervals and 4) hypokalemia and/or hypomag-
nesemia (1).
In the dog we developed a highly reproducible TdP model by mimicking the first three
circumstances by 1) chronic AV block, 2) administration of 2 mg/kg </-sotalol, and 3)
specific pacing modes. To investigate the model further, we increased basic heart rate
by pacing, we administered MgSC»4 and isoprenaline and we recorded monophasic
action potentials (MAP) to demonstrate involvement of ILADs. Finally, different pacing
modes were used to clarity the relevance of the number of cycle length changes (e.g. the
short long short sequence) needed to initiate IdP.
METHODS
The study protocol was approved by the Committee for Experiments on Animals of the
University ofLimburg, Maastricht, The Netherlands and conducted in accordance with
the guidelines of the American Physiological Society.
The experiments were performed on 18 adult mongrel dogs of either sex having a body
weight between 20-35 kg (26 ± 5). In a preliminary surgery, a righr thoracotomy was
performed to induce a permanent complete AV block by injecting 37% formaldehyde
into the AV junction (11). During the same session, pacing electrodes (Bakken Research
Center, Medtronic, Maastricht, The Netherlands) were inserred epicardially into the
basal portion of the right ventricle and the apex ot the left ventricle. 1 he wires were
exteriorized through the back of the neck.
Six surface electrocardiographic leads and one local electrocardiogram were continuously
registered and stored on optical disk. All drugs were administered through a canula in
a cephalic vein.
Anaesthesia was induced by 1) premedication i.m. (1 ml/5 kg: 10 mgoxycodon, 1 mg
acepromazine, and 0.5 mg atropine) and 2) sodium pentobarbital (20 mg/kg i.v.). The
dogs were artificially ventilated through a cuffed endotrachcal tube using a mixture of
oxygen, nitrous oxide and halothane (vapor concentration 0.5%) by a respirator.
Ventilation was controlled by continuous reading of the carbon dioxide concentration
in the expired air. A thermal mattress was used to maintain adequate body temperature.
Proper care was taken postoperatively, including antibiotics (1000 mg ampicilin) and
analgetics (0.3 mg i.m. buprenorfine).
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Stimulation was done preferably from the right ventricular lead with a programmable
stimulator having a synchronizing circuit (12). Unipolar stimuli were given using a pulse
width of 2 ms and a stimulus strength of twice the diastolic threshold. As indifferent
electrode, we used a needle placed through the skin.
Pacing consisted of /ó«r <//^/r«r ƒ></<•/«£ WO^IM, which represent respectively one, two
and three cycle length changes. The pacing modes for the one cycle length change
consisted of 1) 3 stimuli (NVS=3), and 2) continuous pacing for 30 seconds (CP). Both
were performed with equal intcrstimulus intervals and shortened from 1200 to 400 ms
in steps of 100 ms for NVS=3, while CP was started just below the cycle length of the
idiovcntricular rhythm (CL-IVR) and reduced to 1200, 900, 600 and 400 ms. The
pacing modes with more than one frequency change were: 3) a basic train of 8 stimuli
followed by an extrastinuilus (8+1), and 4) a short long short sequence (SLS). The
extrastimulus was shortened from 350 ms down in steps of 10 ms until the effective
refractory period (VERP) was reached. VERP was defined as the longest stimulus interval
which was not followed by a ventricular complex. VERP was determined during IVR
and at paced rates similar to the CP protocol. SLS consisted of a) 4-8 paced beats with
an interval of 600 ms followed by a beat with an interval of 1200 ms and finally an
extrastimulus (4-8x600/1200/extra), b) 400/800/extra, and/or c) 2x300/900/extra. The
pacing protocol needed 30-40 minutes for completion, while the different pacing modes
were applied in a random manner.
Incidence of TdP was related to a specific pacing train and mode. Moreover, because
'I'dP frequently started before the pacing train was completed, induction was also
classified to the specific change in cycle length that seemed to be responsible for the
initiation ot TdP. When TdP was induced during the first 8 paced beats of either CP
or 8+1, it was classified as being induced after one frequency change. A dog was
considered inducible when a TdP arrhythmia could be reproducibly induced by the
same pacing train tor at least 3 times.
A Torsade de Pointes arrhythmia was defined as a polymorphic ventricular tachycardia
(VT) consisting ot > 5 beats twisting around the baseline having a rate of more than 200
beats/min which occur in the setting of a prolonged QT(U) duration (1). These VTs
either stop spontaneously or degenerate into ventricular fibrillation. The VT was
terminated using cardioversion (60-70 Joule) when it lasted longer than 10 sec. Defibril-
lation was performed maximally 6 times per experiment. TdP was differentiated from
VF using the following characteristics: 1) twisting QRS behaviour using all 6 ECG-leads,
2) the (change in) amplitude of the QRS complex in a single ECG lead, and 3) the
frequency of the arrhythmia.
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/4f ivirf fwo uw& after the creation of complete AV block, the dogs were anaesthetized
(see above). A blood sample was taken 1) to measure plasma levels of the electrolytes:
calcium, sodium, potassium and magnesium, and 2) to establish their kidney function
by measuring ureum and kreatinine. Two defibrillation patches, which were connected
to a defibrillator, were attached at both sides or the chest. Most dogs were tested at
different weeks to investigate reproducibility of their response.
After the baseline pacing prorocol, a bolus «-/-sotalol (2 mg/kg/5 min) was administered.
Thereafter, 5 minutes elapsed before pacing was resumed. The experiments were divided
in two groups: inducible (1) and non inducible (Nl). In group 1, we distinguished
between TdP which occurred spontaneously after </-sotalol ("spontaneous" TdP) and
TdP which was pacing dependent ("pacing dependent" TdP). Because the number of
cardioversions per experiment was limited, it was often not possible to repeat the
complete pacing protocol in group I.
In the majority of the experiments belonging to the group NI, we added another bolus
^-sotalol (2 mg/kg/5 min) and repeated the pacing protocol.
When TdP was inducible, we performed three procedures. First, the inducibility and
reproducibiliry of TdP arrhythmias was tested further using different pacing modes. Also
the length of the period (min) was determined during which a single bolus of e/-sotalol
in combination with pacing was able to induce TdP. Second, the basic ventricular rate
was accelerated by: 1) pacing, or 2) administration of isoprenaline i.v. (10 Mg/5 min).
Thereafter, the specific pacing train responsible for TdP induction was repeated. Third,
MgSC>4 (100 mg/kg/2 min) was administered to assess its suppressivc effect against
"spontaneous" TdP and to study its preventive effect against "pacing dependent" TdP.
A single endocardial MAP recording was made before and after «/-sotalol to detect F.ADs
in 12 experiments. Either through the jugularis vein (n= 1 1) or the carotid artery (n= 1),
the MAP catheters (Franz combination catheter, EPT # 1650) were placed randomly
under fluoroscopy (13). The MAP was amplified by a DC-coupled differential amplifier,
which is provided with a 20 mV calibration pulse. The MAP signals were sampled at a
rate of 1 KHz. The recording sites were chosen based on stability, quality of the signal
and an amplitude which had to exceed 15 mV (13). The presence of an EAD on the
MAP recording was defined as a retardation in repolarization (2-5).
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The following parameters were measured in each experiment by two independent
observers: CL-IVR, QRS duration, and QT(LJ) duration. QT(U),- duration was calcu-
lated according to Ba/xtt's formula (14).
Por determination of statistical difference (P<0.05), we used analysis of variance
(ANC)VA) for comparisons between more than two groups, followed by Bonferroni's
/-test when the P-value permitted. Paired Student's r-test was applied to compare data
between two groups and X' testing was used when the data were presented as percentages.
All data are presented as mean ± standard deviation (SD), or when indicated as mean ±
standard error of the mean (SF.M).
RESULTS
111 IK dogs, we performed 42 experiments (2.5 ± 1.2). The mean time interval between
the first experiment and AV block was 9 ± 6 weeks, whereas the time in between
experiments was 14 ± 9 days. All dogs had normal electrolytes except for a slightly
decreased potassium level or 3.4 mmol/1 in one dog receiving diuretics because of heart
failure.
We were not able to induce TdP by pacing under baseline conditions. However in 3
dogs, we noticed transient episodes of repolarization abnormalities (occurrence of
U-waves) in the first spontaneous beats directly following pacing.
Administration of//-sotalol resulted in a marked increase in the CL-IVR from 1475 ±
460 to P30 ± 570 ms (P<0.01) and QT duration from 390 ± 65 to 480 ± 85 ms
(P<0.01), often occurring in the presence of U waves.
In a subset of dogs (n=8), we investigated the duration of these electrophysiologic
changes (figure 1). The increases in Cl.-IVR and QT duration diminished in time, but
remained present during the invcstigational period of 50 min. Also, QT,- showed a
similar behaviour. No changes were observed in QRS duration.
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Figure I. Time dependent electrophysiologic effects of one bolus of «/-sotalol (2 mg/kg).
The time dependent elcctrophysiological effects of </-sotalol are described for C.L-IVR, Q F, Q I ^ and QRS
duration (panels 1-4 respectively). The time after d'-sotalol is presented on the x-axis for 0-50 minutes.
Cl.-IVR, QT duration and QTjime were all maximally increased 10 minutes after c/-sotalol (p.inels 1-3).
From that period on, the effect diminished, but remained statistically significant for 40 minutes, i.e. 50
minutes after che start of «/-sotalol. Reproducible induction of TdP arrhythmias was possible for a similar
time period. Finally, QRS duration did not change after </-sotalol (panel 4).
VERP during spontaneous IVR increased from 265 ± 60 to 325 ± 65 ms (P<0.05). The
effect of </-sotalol on VERP was reverse-use dependent: the relative increase of VERP
was greater at slower heart rates (+23%) than at faster ones (+2%, P< 0.01).
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Figure 2. "Spontaneous" TdP arrhythmia after «/-sotalol.
Six surface elcctrocardiographic leads and a local elcctrogram from the left ventricular (LV) apex arc
recorded simultaneously in an anaesthetized dog with chronic AV block. Paper speed is 25 mm/sec. Panel
1: spontaneous idioventricul.tr rhythm. Panel 2: 10 minutes after </-sotalol CL-IVR and QT time arc-
increased and cctopic beats with different QRS configurations occur at the end of the TU wave. Panel 3:
spontaneous induction of a TdP arrhythmia. Note the "typical" short long short sequence which precedes
the polymorphic VT. . . •, . •
Following </-sotalol administration, we noticed four "spontaneous" appearances of a
TdP arrhythmia: 4/42= 10% (figure 2, panel 3). These episodes were repetitive and often
needed interventions, such as cardioversion and back-up pacing at faster rates to suppress
the arrhythmia. More frequently (50%). ectopic beats with different configurations
often arising from the end of the TU wave were observed (figure 2, panel 2).
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After the first bolus of */-sotalol, pacing resulted in reproducible TdP in 22/42 experi-
ments (52%, P<0.01 vs "spontaneous"), which appeared in 12 of the 18 dogs. An
example is presented in figure 3. In all dogs with "spontaneous" TdP, pacing also resulted
in the induction of TdP. Inducibility remained present using similar pacing modes tor
at least 60 minutes in the 3 dogs, in which this was tested.
Inducibility was related to CL-IVR and QT(U) duration (table 1). In (he NI group
(n=20), CL-IVR and Q T time were significantly shorter, although the relative increase
induced by </-sotalol was comparable for both parameters in both groups. Correction
for QRS duration (JT interval) revealed no differences in the quantification of the
parameter of repolarization.
Only in two dogs, the (in)abiliry to induce TdP was not reproducible in subsequent
experiments: one inducible and one non inducible dog that reversed their response.
Therefore, the reproducibiliry is quite high (38/42=90%).
EADs were registered in 7/12 experiments (figures 4-6). In half of the MAP experiments,
TdP could be induced. The occurrence of ectopic beats was related to the presence of
EADs in 4/5 experiments (figure 4). EADs were seen in 5/6 inducible and in 2/6 non
inducible experiments. In figure 5, an example is presented of a TdP induction by
"pacing" which is initiated by EAD-dependent triggered beats. Often, pronunciation of
EAD amplitude was seen during the pacing train.
In a subgroup of subsequent, inducible experiments (n=l 1), we analyzed the induction
of 55 episodes of TdP in relation to the pacing mode. Defibrillation was performed in
21 cases, while spontaneous termination occurred in 34 TdP. Induction either occurred
during the pacing train or directly thereafter (figures 3 and 5). In case of CP, induction
was always seen in the beginning of the pacing train. The incidence of TdP in relation
to pacing mode is presented in the left part of table 2. It is shown that the modes 8+1
and SLS are equally effective and possess a greater ability to induce TdP than the other
two modes (P<0.05), while NVS=3 is more successful than CP (P < 0.05).
Induction was related to the number of cycle length changes: Half of the inductions
occurred after one change in cycle length, i.e. starting during or directly after protocols
1 or 2, or during the first frequency change of protocols 3 and 4 (right part of table 2,
presented as first change). However, inducibility was only possible in the other half of
the experiments by at least 2 frequency changes, as illustrated in figures 3 and 5.
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Table 1. EJcctrophysiologic changes of «/-sotalol (2mg/kg)
lnduciblc experiments (N«22) Control D-SOT (10)
CL-IVR (ms)
QT(U)
1745 ± 465
420 ± 60
325 ± 45
2055 ± 580
535 ± 80"
380 ± 60'
+ 18
+27
+ 17
Non induciblc experiments (N»20) Control D-SOT (10)
( I ! \ U
QKU)
1175 ± 190' 1370 ± 255' ' +17
350 ± 45' 425 ± 50*' +21
325 ± 45 365 ± 40" +12
" P'0.001 vs lonirol; * IMI.001 vs induciblc, mean ± SD
d-SOTALQL
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Figure 3. Induction ofa TdP arrhythmia directly after pacing in the presence ot </-.sotalol.
Six Niinuli.ino.UNly recorded ICC-leads are shown at a paper speed of 10 mm/sec. After </-sotalol. the
idiovcntricular rhythm is interrupted by a short long short sequence (400/800/extra). Directly following
this pacing pmtocol. a self terminating TdP iKciirs. We have classified this sequence as a TdP induced by
three cycle length changes.
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Figure 4. Registration of EADs on MAP recordings during spontaneous cctopic activity alter </-soialol.
Three surface ECX-lcads and an endocardial MAI ' regisiration from the apex of the lelt ventricle arc
simultaneously seen at a paper speed of 10 mm/sec. After ^-sotalol (middle and riglu panel), spontaneous
ectopic beats from different origin occur during the idioventricular rhythm. In the enlarged MAI ' recording
of the middle panel, phase 2 subthreshold EADs (1) can be clearly seen. Also pha.se 3 EADs (T) can be seen
which trigger and induce (an) ectopic beat(s).
Arter administration of a second bolus of */-sotalol in 14 of the 20 non induciblc
experiments, inducibiliry increased to a total of 32/36 (89%, P<0.01 vs first bolus
</-sotalol). This was accompanied by increases in CL-IVR from 1340 ± 190 to 1690 ±
500 ms, p < 0.05 and QT(U) duration from 450 ± 60 to 490 ± 55 ms, p < 0.05.
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Figure 5. Registration of RADs on MAP recordings during "pacing dependent" TdP in the presence of
«/-MIUIOI.
In (he same experiment as in figure 4, a pacing protocol which consisted of 8x600/1200/cxtra was
performed. Paced beats arc indicated by S. Eciopic beats interfered with the paced complexes. Resulting
in a self terminating TdP. When we look at the MAP signal, again we sec subthrcshold phase 2 EADs
(second "paced" beat) and triggering phase 3 KADs (last part ot the pacing train) that are responsible for
the initiation of ectopic beats and eventually TdP. This induction of TdP was classified to have started after
two cycle length changes.
Table 2. The relevance of the pacing mode for the inducibiliry of TdP arrhythmias in a subgroup of
induciblc animals
incidence 1st change 2nd change 3rd change total
25
17
10
3
SLS
8+1
NVS-3
CP
90%
100%'
63%'
20%
9
6
10
3
7
11
-
_
total (%) 50% 30% 20% 55
CP: continuous pacing for 30 seconds. 8+1:8 stimuli • 1 extra, NVS=3: three stimuli, SLS: short long
short. 'p<O.()S vs CP; 'p<0.()5 vs NVSO and CP
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Figure 6. Administration of g ^
This is the same experiment as in figures 4-5. At the time of MgSC^ administration, ectopic beau arc still
present (panel 1). Also, subthreshold and triggered EADs can be seen on the MAP registration. Following
MgSCX», the QT duration shonens to 470 ms, while the cycle length increases. The ectopic beats completely
disappear and the repolarization phase of the action potential becomes smooth (panels 2-3). Pacing is no
longer able to induce ectopic beats, EADs, or a TdP arrhythmia (panel 4). Note the rcpolarization
abnormality (negative T wave) in the first spontaneous beat postpacing.
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TaWe3.
CL-IVR
QT(U)
QTc
Elcctrophysiologic
Control
1710 1390
405 ± 75
310 ±35
results of magnesium
D-SOT (10')
2025 ± 490'
490 ± 110'
345 ±60'
(100mg/kg, n=6))
D-SOT (40')
1910 ±540
485 ± 95
355 ±65
-
Mg (3')
2730 ± 1475
420 ± 80*
270 ± 65*
Mg (5')
2030 ± 655
435 ±110*
300 ± 60**
' P < 0.05 vs Control; ' P<0.05 vs D-SOT 40'; *P< 0.05 vs Mg 3'. mean ± SD
/Vrw»//0»
rarr rw/<v The basic heart rate was increased by continuous pacing to ± 65%
of spontaneous CL-IVR (n=3). Inducibility was completely prevented but returned
when continuous pacing was stopped. Administration of isoprenaline (n=2) decreased
CL-IVR to ± 70% and resulted in complete prevention of inducibility. Thirty minutes
after isoprenaline, CL-IVR and QT duration returned to their original value and TdP
arrhythmias became inducible again.
o/ A/f.S'Oj. MgSC>4 was administered to 6 "pacing dependent" TdP
experiments. Two of these dogs also showed "spontaneous" TdP. In 2 experiments, a
MAP signal was registered. At the time of MgSO^ administration, spontaneous ectopic
beats were seen in two experiments (figure 6, panel 1). MgSC>4 suppressed the ectopic
beats (panels 2-3) and prevented the induction of TdP in all dogs tested (panel 4). This
was accompanied by disappearance of the (subthreshold) EADs on the MAP recordings.
Also, the pacing proton)! was completed without the occurrence of ectopic beats.
Elcctrophysiologically, MgSC>4 shortened the Q T time (table 3). The QT,- duration
decreased even more due to the fact that MgSO4 increased the CL-IVR.
In two experiments, reinduction of TdP was seen after the effect of MgSO^ had
disappeared.
DISCUSSION
When we summarize the results in this animal model, it becomes obvious that to
reproducibly induce TdP arrhythmias, the CL-IVR and the Q T time have to be
sufficiently long at the start of the experiment. Shortening of the QT duration by either
an increase in the heart rate by pacing, administration of isoprenaline or MgSC>4 will
prevent induction, whereas a second bolus of </-sotalol. which further lengthens Q T
time and CL-IVR. will tend to make the non susceptible animals inducible. Both the
"spontaneous" I dP as the "pacing dependent" FdP rely for their induction on the
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presence of EADs. Finally, a sudden rate change often consisting of è 2 cycle length
changes is needed to induce TdP under the above conditions.
In recent years, the interest for (animal models of) Torsade de Poinres-arrhythmias has
increased considerably (1-10). Attention was focussed on 1) the (ionic) mechanism(s)
underlying the induction and perpetuation of TdP arrhythmias, 2) screening for
parameters and/or circumstances which could predict possible proarrhythmic effects of
antiarrhythmic drugs, especially new class III drugs, and 3) prevention of I'd I' by specific
interventions, including changes of the activity of the autonomie nervous system,
specific antiarrhythmic drugs, including new drugs like ^-activators (2-10.IS-19).
The intervention most widely used to induce TdP arrhythmias in animals is cesium
administration (3,5,7,9,18). In anaesthetized dogs with chronic AV block, we developed
a TdP model that shows a high incidence of TdP inducibility together with a high
reproducibility. Depending on the number of doses of //-sotalol the incidence of TdP
is 52% or 89% respectively. Reproducibility of I'dP induction was present during a
experiment for about 60 minutes and in repeated experiments over weeks in 90% of the
attempts. In the majority of experiments, inducibility was dependent on (abrupt)
changes in the cycle length, applied by pacing.
During the course of our experiments, an article was published which reported a similar
approach (10), although important differences exist between the two methodologies.
W«ds.siaibur^ir. t^.:d.^t.0\srjuiiwl^w//7/;/?/7/«inilii/;fJ/}i}.of. f.'<iJ? ir.r.b,y»J>mi.i.s in.<:o».M.ioii.s
dogs with chronic AV block. To achieve that, they needed higher dosages of the
antiarrhythmic drugs, in the presence of either hypokalemia, p" blockade or both.
The electrophysiologic effects of cZ-sotalol are in agreement with a therapeutic dose of
this drug and they do represent clinically achieved values (20). The observed reverse
use-dependency of VERP has also been described as a property of (^)-sotalol (21,22).
Next to the increases in Q T time and VERP, ^/-sotalol slowed the heart rate (increase
in CL-IVR). Similar findings for (^-sotalol but also other class III agents have recently
been reported for dogs in sinus rhythm (23-24). This negative chronotropic effect of
class IH-agents has been attributed almost entirely to prolonged repolarization.
«ttw£<T o
Spontaneous, drug induced TdP arrhythmias often show a specific initiating sequence
that is related to the occurrence of spontaneous ectopic beats: short long short intervals
which represent 3 abrupt cycle length changes in a short period of time (1,6,10,15,19).
Using a similar pacing mode, we tried to imitate this sequence. Because there is
controversy in the literature about the specificity of this sequence (1,25-27), we also
used other pacing modes to study their (possible) relevance. Two pacing modes were
clearly superior in initiating TdP arrhythmias in our model: SLS and 8+1. Especially,
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the equal incidence of the 8+1 pacing mode is of interest, because this is worldwide the
most often used pacing mode during elcctrophysiologic studies.
Using the MAP catheter, we saw the occurrence of (triggered) EADs directly after the
start of pacing (figure 5) when the rate was relatively fast and the APD relatively short
in comparison to the idioventricular rhythm. This observation indicates that (inade-
quate) adaptation of the duration of the action potential to abrupt changes in cycle
length are of importance for the induction of TdP. This has also been suggested by others
(28). Support for this line of thinking comes from the results of the two pacing modes
with fixed intersrimulus intervals but differences in duration (NVS=3 vs CP). The higher
inducibility of NVS=3 underscores the importance of (an) abrupt frequency change(s)
rather than the duration of pacing. Additional confirmation comes from 1) the obser-
vation that, in case of CP, TdP always started within the first 10 beats, and 2) that one
cycle length change already induced TdP in half of the experiments. When however a
second or a third interval change is added, inducibility is doubled.
The fact that prolonged pacing is often used to prevent induction of spontaneous drug
induced TdP is another argument to stress the importance of the abruptness of the cycle
length change.
Interpretation of these data should however be done with some caution. Because we
allowed ourselves only a small number of cardioversions per experiment, we could not
always study all pacing modes in the same experiment. We tried to correct this by using
the other pacing modes in a subsequent experiment of the same animal. Still, we cannot
answer questions concerning cycle length dependence (interstimulus interval) and/or
possible interference of different pacing modes on inducibility of TdP.
The most effective treatment for clinical acquired TdP are rapid ventricular pacing,
isoproterenol or magnesium administration (1). They were all tested and considered
effective in preventing TdP arrhythmias.
Several studies have addressed the involvement of triggered activity resulting from EADs
in the initiation of I'dP (2-5,15.18,19). And although the contribution of EADs is still
not completely resolved, evidence is becoming more convincing that EADs play an
important role in the induction of acquired TdP. As seen in this study, the presence of
EADs seems to be related to as well "spontaneous" as "pacing dependent" TdP. It is
however difficult to demonstrate the causal relation between the presence of EADs,
triggered beats elicited by EADs, and the actual TdP. The continuous shift in site of
origin of EADs and the elicited beats together with the speed of the arrhythmias
complicate the MAP registrations. This technique itself has also some technical difficul-
ties, like stability and the possibility of registering artefacts. We relied on some good
fortune to be at the site of origin of the EAD (figures 4-6). Still, we are convinced that
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these recordings in a few experiments are representative for the model. We also believe
that the experiments with MgSO^ demonstrate that the EADs are no artefacts. There-
fore, we think that initiation of TdP is EAD dependent. Whether the same mechanism
is also responsible tor the perpetuation of the arrhythmia lu.s to be established.
A relatively low incidence of "spontaneous" TdP arrhythmias occurring after d'-sotalol
administration was observed in these experiments. We defined TdP as S 5 beats. More
frequently ( ± 50%), ectopic beats occurred arising trom the TU-wave that seem to be
dependent on EADs. These beats occurred as singles, doubles or triplets. Reproducible
initiation of TdP arrhythmias required cycle length changes which were induced by
pacing. Still, we believe that this "pacing dependent" TdP can be used to study
mechanism and treatment ot "spontaneous" acquired TdP because 1) in dogs showing
"spontaneous" TdP, pacing was also able to induce TdP rcproducibly, 2) both forms ol
TdP seem to be dependent tor their initiation on the presence ot EADs (figures 4 and
5), 3) "pacing dependent" TdP showed the same specific ECCi characteristics as
"spontaneous" TdP and often terminated spontaneously, and 4) both torms ol I dP
could be suppressed by MgSÜ4 (figure 6), levcromakalim (17), tlunari/.inc (2')) and by
increasing the heart rate.
In this model, we have tested the dogs at a relatively long period after application ol AV
block (9 ± 6 weeks). The bradycardia related volume overload and subsequent
biventricular hypertrophy (personal observations) could be of importance for the
inducibility of TdP. Currently, we are documenting these changes over time, both
echocardiographically and electrophysiologically and we are testing the relevance of these
changes for the inducibility of TdP. The observation by Strauss et al. (21) that
application of acute AV block together with a similar dose of </-sotalnl did not result in
TdP arrhythmias, indicates that additional changes have to be present.
At this moment, we are also testing other drugs that prolong action potential duration.
Our results indicate that this animal model can be used to compare the proarrhythmic
potential of different drugs. Whether this model is suitable to predict the occurrence of
TdP in patients treated with these drugs has to be determined.
In conclusion, this animal model shows a high incidence of reproducible, acquired
Torsadede Pointes arrhythmias, that allows study of mechanism and trcatmeni of these
triggered tachycardias.
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ABSTRACT
£ / • The mechanism of acquired Torsade de Pointes arrhythmias (TdP) is not
clear. To study the importance of 1) triggered activity by early afterdepolarizations
(EADs) and 2) intcrventricular dispersion in duration of repolarization (AAPD) for the
initiation of TdP, both parameters were recorded in our recently described animal model
of acquired TdP. In half of the anesthetized dogs with chronic complete AV block, the
combination ofV-sotalnl and pacing leads to reproducible induction of TdP (> 3 times
TdP using the same pacing mode).
A W W r Eleven inducible (I) and nine non inducible dogs (NI) after </-sotalol were
compared. Trom at least two sites, endocardia! monophasic action potentials (MAPs)
were registered to record EADs and to measure regional differences in action potential
duration (APD). The rate dependent behavior of the interventricular AAPD (APD of
left minus right ventricle) was studied in seven dogs in which no EADs were visible.
MgS(),j (100 mg/kg) was administered to 7 ri'-sotalol treated dogs (4 I and 3 NI dogs).
/f««//j; In ilie absence of EADs, we demonstrated that interventricular AAPD is
bradycardia dependent (greater at longer paced cycle lengths (PCL)). ^-Sotalol
prolonged the spontaneous cycle length of the idioventricular rhythm (Cl.-IVR). Q T
time and the API) of both ventricles, but did not increase interventricular AAPD when
the PCI. was kept constant. After r/sotalol the I dogs demonstrated a longer CL-IVR:
2115 ± 320 vs 1615 ± 265 ms, (P<0.05), increased Q T time (540 ± 80 vs 450 ± 70 ms,
P<().05), ,i higher incidence of EADs (14/22 MAPs vs 5/18 MAPs, P<0.05), an equal
number of triggered ectopic beats induced by EADs (8/11 vs 4/9) and an increased
interventricular AAPD (135 ± 55 vs 60 ± 40 ms, p<0.05). Interventricular AAPD was
always larger than the simultaneously recorded APD differences within one ventricle.
Although ( I I\'K increased after MgSO., (1885 ± 320 to 2400 ± 755 ms, P<0.05), this
drug prevented induction of TdP (4/4) by suppressing EADs, decreasing APD and the
interventricular AAPD from 110 ± 45 to 55 ± 60 ms (P<0.05).
C.»wf/j«/'»Mj: 1) In the absence of EADs, AAPD demonstrates frequency dependence 2)
Increased interventricular AAPD in the presence of local EADs is an important factor
in the initiation of TdP and 3) MgSO^ diminishes both interventricular AAPD and
presence of EADs.
INTRODUCTION
Prolongation of QT duration with (antiarrhythmic) drugs has been associated with
cardiac arrhythmias, like Torsade de Pointes (1.2). Because repolarization parameters
will lengthen when heart rate slows, the incidence of acquired TdP will increase under
bradycardic circumstances. In recent years, evidence has accumulated that early after-
dcpolari/ations (EADs) play a decisive role in the genesis of ectopic beats and the U
Chapter.*
wave changes that often precede the spontaneous occurring TdP (3-8). It has been
demonstrated in vitro and in vivo that EADs are bradycardia dependent and originate
preferably in cells with prolonged action potential duration (APD) (8-12). No evidence
was provided that the EAD dependent triggered activity also led to TdP (13).
In patients with congenital TdP. intraventricular dispersion or" APD has been observed
(14,15). Also, these studies provided evidence that EADs occurred site specifically,
thereby explaining (in part) the observed intraventricular dispersion (14-16). More
recently, intcrventricular dispersion was seen in combination with EADs in a patient
with acquired TdP (17).
In our animal model or pacing induced TdP (18), our main objective was to investigate
the contribution of two parameters i.e. EADs and intcrventricular dispersion of APD
for the initiation of TdP. For this purpose, we compared induciblc vs non induciblc
experiments after //-sotalol and we administered MgSO^ because of its antiarrhythmic
effect on TdP (18-21). Our additional goals were to determine the frequency depend-
ence of the intcrventricular dispersion in the absence of EADs and, secondly to
differentiate between inter- and intraventricular dispersion in APD. For the latter goal,
multiple (simultaneous) endocardial MAP recordings were made in some dogs.
METHODS
All experiments were performed according to the principles of the American Physiologi-
cal Society and approved by the Committee for Experiments on Animals of the
University of Limburg, Maastricht, the Netherlands.
The experiments were performed on 20 anesthetized adult dogs with chronic AV block
(5 ± 3 weeks) of either sex with a body weight between 18 and 34 kg. Each dog had one
epicardial electrode (Bakken Research Center, Medtronic, Maastricht, The Nether-
lands) implanted at the apex of the left ventricle, when a right sided thoracotomy was
performed to produce a complete AV block by injection of formaldehyde (0.37%) in
the AV groove (18). Between AV block and the experiment a minimum of two weeks
elapsed.
Pacing was done with a programmable stimulator capable of pacing synchronously to
the QRS complexes. Unipolar stimuli were given using a pulse width of 2 ms and a
stimulus strength of twice the diastolic threshold. As indifferent electrode a needle was
placed through the skin. Six surface electrocardiographic leads and > 2 endocardial MAP
signals were simultaneously registered and stored on hard disc. All drugs were ad-
ministered through a canula in the cephalic vein.
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Anaesthesia was induced by 1) premedication i.m. (1 ml/5 kg: 10 mgoxycodon, 1 mg
acepromazinc and 0.5 mg atropine) and 2) sodium pentobarbital (20 mg/kg i.v.). The
dogs were artificially ventilated through a cuffed endotracheal tube using a mixture of
oxygen, nitrous oxide and halothane (vapor concentration 0.5%-1%) by a respirator.
Ventilation was controlled by continuous reading of the carbon dioxide concentration
in the expired air. A thermal mattress was used to maintain adequate body temperature.
Proper care was taken after the experiments, including administration of antibiotics
(1000 mg ampicillin) and analgesics (0.3 mg i.m. buprenorfine). A temporary pacemaker
(with a maximum of 24 hours) was given after the AV block operation and also after
the experiments, because the animals are tested repeatedly.
A detailed description of the Torsade de Pointes protocol is described elsewhere (18).
In short, anesthetized animals received two defibrillation patches that were attached to
both sides of the chest and connected with a defibrillator. Half an hour after the onset
of anaesthesia, pacing was done from the epicardial electrode and consisted of two
different pacing modes: 1) short long short sequence and 2) 8 basic stimuli followed by
an extra stimulus. Theintcrstimulus interval was 400,600 or 1200 ms, theextrastimulus
was shortened from 500 ms with steps of 50 ms till 300 ms. After completing the pacing
protocol, a bolus of */-sotalol (2 mg/kg/5 min) was administered. Pacing was resumed
10 minutes after the start of the bolus. A Torsade de Pointes arrhythmia was defined as
a polymorphic ventricular tachycardia consisting of > 5 beats, which twisted around its
baseline in the presence of a prolonged QT(U) duration. When TdP did not stop
spontaneously in 10 seconds or when it deteriorated into ventricular fibrillation,
cardioversion (60-70 |) was performed.
This animal model of "pacing induced" TdP results in reproducible TdP arrhythmias
in half of the animals (18). In 20 consecutive experiments in which stable MAP
recordings could be made, we induced TdP in eleven animals (inducible group).
1 nducibility was defined as the initiation of TdP for at least 3 times using the same pacing
mode.
MgSC>4 (100 mg/kg/2 min) was administered within 45 minutes after ^-sotalol to 7/20
animals, 4 inducible and 3 non inducible dogs. We have demonstrated that one bolus
ofV-sotalol is capable of reproducible induction of TdP for at least 60 minutes (18). At
5 minutes after the start or the injection of MgSCj, the pacing modes which led to TdP
induction were repeated.
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Endocardia! monophasic action potentials were recorded simultaneously to observe the
occurrence of EADs and to measure the (differences in) the duration of the action
potential (APD). A quadripolar contact electrode (FranE combination catheter, KPT #
1650), that provides both pacing and MAP recording (22) capabilities was placed
cndocardialiy in the left and in the right ventricle. Placement was based on quality of
the signal. Therefore a carotid and/or femoral artery and an external jugular vein were
dissected free and the 7 French MAP catheter was introduced under fluoroscopv. After
the experiment the carotid artery and the external jugular vein were sewed-up. The MAP
signals were amplified with an isolated DC coupled differential amplifier with calibrated
gains of 10, 20, 50, 100, 200 and 500 (custom made. University of Limburg). The offset
of the amplifier is variable and can be adjusted to the recorded signal. All amplifiers arc
provided with a 20 mV calibration pulse. Data acquisition of the MAP signals is achieved
by an 8 bits Analog to Digital Converter resulting in a 0.39% resolution of full stale.
The MAP signals are sampled at a rate of 1 kHz per signal. MAP phases were defined
according to the definitions used for transmembrane potentials (9). Amplitude was
defined between phase 4 and 2 of the signal. Besides a minimal amplitude ol 15 mV,
the MAP had to have a constant configuration and a smooth shape during control
circumstances. After placement of the MAP catheter, 5 paced beats were given using the
MAP electrode to register the ECC- (QRS morphology). This morphology was used to
determine the site at which the MAP catheter was placed and also used for correct
repositioning, when amplitude decreased and adjustment was necessary. EADs were
defined as an interruption of the smooth contour of phase 2 or 3 of the action potential
(4,9). The presence of EADs was examined in all MAPs.
In all experiments, two MAP catheters were placed randomly to measure the API) in
the left and in the right ventricle. After the first 10 minutes of </-sotalol, we replaced
these catheters to several sites (23) to measure intraventricular differences in APD in
seven experiments. To more carefully asses LV intraventricular differences especially in
regard to EADs. We placed an additional LV MAP catheter, while the first MAP catheter
remained at a stable site in 4 experiments.
In 7 experiments a paced ventricular rhythm (on the epicardial electrode) with a paced
cycle length (PCL) of 1000 and 500 ms was used to investigate the rate related changes
of the APD and the interventricular AAPD. At steady state (> 2 minutes pacing) the
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APD was determined as the average of 5 beats. After administration of < -^sota]ol the APD
measurements were repeated, and we could include a PCL of 1500 ms.
All data were analyzed using a custom made computer program with a resolution of 2
ms and adjustable gain and time scale. Using lead II, electrophysiological measurements
of cycle length of the idioventricular rhythm (CL-IVR) and QT(LJ) time were performed
before and after the administration of ^-sotaJol and MgSC^. The QT,. time was
calculated using the formula of Bazett (QT\=QT/CL-IVR, 24), to correct for rate
differences. The action potential duration was measured after total repolarization
(•API)|oo) and was determined for both ventricles at the same time points as the other
parameters. Interventricular dispersion was calculated as the difference between the APD
of the left and right ventricle (AAPD). Each value represents the mean of 5 consecutive
beats. Additionally the incidence of spontaneous beats was scored which occurred during
the first 10 minutes of ^-sotalol.
Paired Student's Mest was applied to compare data under the different conditions
(drugs). To compare differences between inducible and non inducible dogs an unpaired
Mest was used. P values <0.05 were considered significant. All data are presented as
mean ± standard deviation (SD).
RESULTS
In the twenty dogs tested, ri'-sotalol significantly prolonged QT time from 405 ± 75 to
500 ± 90 ms and the CL-IVR from 1585 ± 335 to 1890 ± 385 ms (both P<0.001),
while the QRS duration was not affected. All these measurements were performed at
the start of c/-sotalol (control) and at the end of the observation period of 10 minutes.
The API) of the LV (390 ± 65 to 495 ± 90 ms, P<0.01) prolonged more (both absolutely
and relatively) than the RV (330 ± 40 to 395 ± 55 ms) leading to a larger interventricular
AAPD after ^-sotalol (from 60 ± 30 to 100 ± 65 ms, P<0.01).
Only once we saw F.ADs under control conditions (1/20. see further). Within the 10
minutes observation period after ^-soialol spontaneous ectopic beats occurred in 12/20
dogs. The responsible EADs occurred in 14/20 dogs, and were present more
predominantly in the LV (12/20) than in the RV (7/20).
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Under baseline conditions, the LV APD of these 20 dogs showed a linear relation with
QT time (r = 0.81. P<0.01) and with CL-1VR (r=0.8. P<().01).
The APD of both ventricles increased when the PCL was lengthened from 500 to 1000
ms (figure 1). In addition, a clear frequency dependence was seen for the intcrventricular
AAPD (P<0.05), because the LV APD prolonged more than the RV APD when the
PCL increased. In the absence of EADs, similar observations were obtained after
//-sotalol. The more pronounced increase or the LV APD at the different PCI resulted
again in bradycardic lengthening or the intervcntricular AAPD. However, </-sotalol did
not increase the interventricular AAPD at these specific paced frequencies (figure 1).
In the 7 dogs presented in table 1 (4 I and 3 Nl), the APD was measured at several
intraventricular sites after d'-sotalol. The mean interventricular AAPD at randomly
chosen sites was 105 ± 65 ms. The mean intraventricular difference in APD of the left
and right ventricle only amounted to maximal 30 ± 25 ms and 20 ± 20 ms respectively.
Furthermore the intraventricular differences did not differ between inducible and non
inducible dogs.
Table 1. Inter and intraventricular differences in action potential duration after «/-«otalol
dog
I*
2
3*
4*
5*
6
7
MEAN
±SD
CL-IVR
2215
1335
2295
1830
2600
1350
1660
1900
±490
LVAPD
425
460
590
540
590
395
455
495
±80
RVAPD
390
375
505
305
445
320
385
390
±70
AAPD
35
85
85
235
145
75
70
105
±65
LV APD*
435
460
640
485
555-590
355-425
485
RV APD*
385
390
480
320
495
325
385
LV-LV
10
0
50
55
0-35
30-70
30
30
±25
RV-RV*
5
15
25
15
50
5
0
20
±20
AAl'D RANGE
35-50
70-85
85-160
165-235
60-145
30-105
70-100
100
±55
All values are expressed in milliseconds, CL-IVR: cycle length of the idiovcntricular rhythm, IV APD:
action potential duration of the left ventricle, RV APD: action potential duration of the right ventricle,
AAPD: LV APD - RV APD (interventricular difference as found when only 2 MAPs would have been
placed). LV APD', RV APD', APD of the left and right ventricle at other sites. LV-I.V, RV-RV': range
of intraventricular differences found, AAPD RANGE, the range of interventricular differences, " induci-
ble animals.
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Figure 1. l-rci|ucncy dependent behavior of action potential duration (APD) and intcrvcntricular difference
in APD (AAPD) before and after «/-soialol.
In this graph the frequency dependent behavior of the APD and the interventricular AAPD is shown. On
the y axis the APD is depicted of the left (LV) and the right ventricle (RV). The dogs (n=7) are paced at
steady state through the left epicardial electrode. The x axis represents the paced cycle length (PCL). At
500 ms the interventricular AAPD amounts 35 ms during baseline. With an increase in cycle length to
1000 ms the AI'D of both ventricles prolong significantly. The LV APD increases relatively more, leading
to a significantly higher interventricular AAPD at the longer cycle length (P<0.05). </-Sotalol (dS) increases
the absolute value of both APDs. Interventricular AAPD displays bradycardia dependence although the
amount of inicrvcntricular AAPD is not increased at a specific PCL in the absence of EADs.
When we divided the dogs in two groups (inducible and non inducible), we found that
under baseline conditions the electrophysiological values (CL-IVR and QT) of the
susceptible dogs were longer than those of the non inducible dogs (reference 18 and
table 2). This was also the case for the LV, RV APD and interventricular AAPD (75 ±
30 vs 40 ± 30 ms, p<0.01), while the Q'I\. was similar.
</-Sotalol further enhanced the length ot the repolarization, as illustrated in figure 2.
With the exception of intcrvcntricular AAPD in the non inducible group, all parameters
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Table 2. Elcctrophysiologtcal changes after W-sotalol(2mg/kg)
Inducibledogs(N>ll) Control D-SOT(IO)
CL-IVR (ms)
QT(U)
QT<
LV APD
RV APD
AAPD
EADs
1810 ±
440 ±
325 ±
425 ±
345 ±
75 ±
1/22
245
75
45
60
35
30
2U5±
540 ±
370 ±
5S0±
410 ±
135 ±
14/22*
320*
80*
50*
80*
60'
55'
• 17
• 22
• 14
• 29
• 1')
• 80
Non induciblc dogs (NU9) Control D-SOT(IO')
CL-IVR (ms)
QT(U)
QT.
LVAPD
RVAPD
AAPD
EADs
1310 ±
360 ±
320 ±
345 ±
305 ±
40 ±
0/18
210'
40'
45
30-
35'
30'
161S±
450 ±
355 ±
430 ±
375 ±
60±
5/18
265'*
70'*
65'
50'*
45'
40'
•23
•25
• 11
• 25
• 23
•38
* P<0.05 vs induciblc. * P<0.05 vs control, D - S O T ( 1 0 ) : 10 minute» « / - s o u U , Cl IVR; iv i l e length
idiovcntricular rhythm, QT^: corrected Q T time according to Bazcti, LV AI'D: action poirmi.il iltiMiion
of the left ventricle, RV A P D : action potential duration of the right ventricle, AAPD: LV AIM) - RV AIM),
EADs: early afterdepolarizations observed on the MAP in both the right and left ventricle i.e. in total
20*2=40 MAP recordings.
demonstrated a significant increase (table 2), resulting in a large difference in inter-
ventricular AAPD (135 ± 55 ms v s 6 0 ± 4 0 ms, p<0.01) between the inducibleand non
inducible group.
The development of EADs after «/-sotalol was noticed in almost all inducible (10/1 1,
figure 2) as well as in half of the non inducible dogs (4/9). The ectopic beats did not
differ in both groups (8/11 vs 4/9).
With the exception of one dog (see below) pacing under control conditions did not lead
to TdP (figure 2, panel 1). Following d'-sotalol, induction of TdP occurred often during
the pacing train, because pacing exaggerated the occurrence of EADs and spontaneous
beats (figure 2, panel 2).
One of the susceptible dogs showed already prominent U waves when the dog was tested
consciously prior to the experiment. When anesthetized, this dog possessed EADs and
a large interventricular dispersion under baseline conditions (figure 3, panel 1) and
pacing led to TdP. After treatment with MgSO4 the ECG normalized and the induction
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Figure 2. Initiation of a "pacing induced" Torsade de Pointes arrhythmia
after e/-sol.ilol.
A three lead l.CXi and two monophasic action potential (MAP) signals
recorded cndocardully in the right (RV) and left ventricle (LV) arc shown
at a paper speed of 10 mm/s. A pacing train of 8'600 ms followed by an
extrastimulus during control conditions does not induce any arrhythmic
event (panel 1). Stimulation is shown by a S. Interventricular AAPD
amounts to SO ms. In panel 2, administration ot ^-sotalol leads to an
increase in cycle length of the idiovcntricular rhythm, the QT time, and
both the RV MAP (3M) to 460 ms) and the LV MAP (400 to 600 ms).
Because the increase in LV APD is more pronounced, the interventricular
AAPD is increased to 140 ms. Note the occurrence of EADs on both
MAPs (see arrows). Repetition of the pacing train results in a TdP. The
arrhythmia starts already during the pacing train by beats that arc trigge-
red by LADs (marked by an asterisk). Also subthreshold EADs can be
clearly seen, especially in LV MAP (arrows).
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Figure 3. Spontaneous TdP after «Z-sotalol.
In this figure a six lead ECG is shown together with MAP recordings in the right (RV MAP) and in the
left ventricle (LV MAP) recorded at a paper speed ot 10 mm/s. Already under control conditions this dog
had a pronounced interventricular dispersion of API) (AAPD) of 1 1 5 ms and I.AOscan lie seen on the I.V
MAP (arrow, panel 1). Administration ofV-sotalol (panel 2) increases the C'l.-IVR, Q T time, RV AIM) to
460 ms and LV APD to 640 ms resulting in a dispersion of 180 ms. Also negative T waves develop and
the EADs became more pronounced (see arrows), leading to ectopic beats (asterisk) and spontaneous TdP.
This self terminating TdP starts in the classical way of a short long short sequence triggered by the EADs
occurring on the LV MAP.
of TdP by pacing was prevented. Thirtyfive minutes after MgSO.4, */-sotalol induced
spontaneously triggered beats resulting several times in episodes of spontaneous TdP
(figure 3, panel 2). For a second time MgSC>4 was administered to this dog, to abolish
the effect of */-sotalol (figure 4).
MgSO4 was administered at 35 ± 8 minutes after ^/-sotalol to 7 animals (4 I and 3 NI).
Because the electrophysiological effects of <^-sotalol decrease in time (18), the value
"d-sotalol 35' " was introduced representing the electrophysiologic measurements at the
start of MgSC>4 administration. No significant differences were found between ^-sotalol
10' and "d-sotalol 35 ". In 6/7 animals EADs (both inducible and non inducible for
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Figure 4. Effect of MgSO.,.
Same dog and composition a.\ figure .V At the start of MgSC^ (20 minutes after d'-sotalol) a bigcmic rhythm
exist. The l.V MAI' is markedly prolonged compared with the RV APD and has very pronounced EADs,
that trigger «.'topic beats (panel 1). Three minutes after start of MgSO,, the repolarization process has
changed (disappearance of the negative U waves), the «.'topic beats are suppressed and the QT time, RV
APD and the l.V APD markedly shortened resulting in less dispersion. All this takes place while the CI-IVR
increases (!) to 4180 ms. The EADs of LV MAP have disappeared completely, while the EADs in RV MAP
remained present but appear with less amplitude.
TdP) and in 2/7 animals ectopic beats were present at the moment of MgSC>4
adminstration. The effect of MgSC>4 was most pronounced at 3 minutes after the start
of the injection. Although the CL-IVR increased, MgSC>4 1) diminished QT time (table
3), 2) suppressed ectopic beats (2/2) (figure 4, panels 1-2), and 3) either suppressed (3/6)
or diminished the amplitude of EADs (3/6, eg figure 4, panel 2), and 4) shortened RV
and LV APD. Because of the more overt decrease of the LV APD, the interventricular
AAPD (55 ± 60 ms) was significantly decreased to values comparable with baseline (60
± 35 ms. table 3). MgSC>4 prevented TdP induction (4/4). The magnitude of the
electrophysiological effects of MgSC>4 was more pronounced for the CL-IVR, LV APD
and RV APD in the inducible dogs, while interventricular AAPD was halved in both
groups.
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Table 3. Electrophysiologic effects of MgSO^ (100mg/kg) in ~ dogs (4 induciblc and 3 nun induciblc)
CL-IVR (ms)
QT(U)
QTc
LV APD
RVAPD
AAPD
CONTROL
1625 + 320
410150
325 ± 50
390170
330140
60135
D-SOT (35')
18851320'
530 1 85*
390 1 70"
5101 100"
400 1 60'
110145'
MgSO< (3)
2400 1 ->55'*
470 1 65*
310160'*
435 1 85"'
380 1 40'
55 1 60*
MEAN 1SD; ' P< 0.05 vs control. * P< 0.05 vs D-SOT (35"); D-SOT (35): 35 minutes 4soulnl. MgSO<
(3'): 3 minutes MgSO.,, CL-IVR: cycle length idioventricular rhythm. Q/T\ corrected QT time. IV APD:
action potential duration ot the lelt ventricle. RV APD: action potential duration ot the right ventricle.
AAPD: interventricular dispersion otAPD calculated as LV APD - RV APD.
DISCUSSION
In our opinion, this study presents new information regarding the relevance of iiucr-
ventricular AAPD tor the initiation of acquired 'I'dI' arrhythmias in our animal model.
Although this has been suggested by others (13.17) we have made the following
important observations: 1) In the absence of EADs, interventricular AAPD demonstrates
bradycardia dependence: there is an increase in interventricular AAPD when the heart
rate slows; 2) After ^-sotalol, interventricular AAPD is increased because of slowing of
the IVR and site specific occurrence of EADs; 3) endocardially measured interventricular
AAPD is always greater than intraventricular differences in APD; 4) Both the presence
of EADs and interventricular AAPD are greater in the inducible dogs, while the
incidence of ectopic beats does not differ; and 5) suppression or prevention ot I dP by
MgSC>4 is related to disappearance of EADs and diminishment of interventricular
AAPD.
Since the description of TdP arrhythmias more than 25 years ago (25), several
mechanisms have been proposed to explain its occurrence, like EAD dependent triggered
activity (ectopic beats) and reentry based on dispersion. In the intact heart, both
parameters can be measured by the use of MAP catheters, which provide information
on regional repolarization (22,26). In patient studies, both intra- and interventricular
differences in APD have been indicated to be related to TdP (14-17). When EADs
originate at specific sites, APD will prolong regionally and by definition dispersion will
increase. Recent studies have also indicated an increased dispersion of repolarization in
acquired TdP by measuring Q T intervals in multiple ECG leads (27-29).
Dispersion and TdP | 55>
Rate dependent behavior of repolarization parameters and EADs is widely acknowledged
(see e.g. 1,4,9,10). Data concerning the frequency dependence of APD dispersion are
scarce. Still, there is some evidence that differences in APD are smaller at faster rates
(30,31). In the present study >2 MAPs were recorded simultaneously. For the first time,
we present evidence that the sensitivity of the APD to prolong when the heart frequency
decreases is different for the LV than the RV, resulting in an increase in interventricular
AAPD (bradycardia dependence). These observations are obtained in the absence of
EADs on the registered MAPs so that the increase cannot be explained by the contribu-
tion of EADs to interventricular AAPD. Similar information can be obtained from table
2, but now in the presence of EADs. Comparing the different cycle lengths in the groups
with and without */-sotalol, a clear lengthening of the interventricular AAPD is seen as
the CL-IVR between groups increases. To what extent EADs exactly contribute to this
interventricular AAPD is not known, but a contribution will exist when EADs are
induced at selected sites as is the case with ^-sotalol for the LV.
A possible explanation for the higher sensitivity of the LV to prolong after a frequency
change might be the presence of M cells (32). The canine myocardium is said to exist
of circa 40% of M cells. Under baseline conditions the M cells of the LV show more
prolongation at slower cycle lengths than the RV M cells, leading to an interventricular
AAPD of approximately 100 msec at 2000 msec (figure 4 of reference 12). Regional
development of EADs by class HI drugs will attribute to the dispersion and it is known
that M cells are also more sensitive than endo- and epicardial cells to develop EADs after
drugs such as quinidine, <//-sotalol, and Bay K 8644 (12).
Although cV-sotalol will not increase interventricular AAPD at steady state CL in the
absence of EADs (figure 1), administration of the drug will influence interventricular
AAPD in several ways: 1) increase in CL-IVR, and 2) occurrence of (site-specific) EADs.
A second indication that EADs and interventricular AAPD are two independent
phenomena is indicated by the effects of MgSC^. The induced increase in CL-IVR
would normally be associated with an increase in APD and interventricular AAPD.
When extrapolation of the APD to a CL of 2400 ms is allowed (using table 2, baseline
values, no EADs), the calculated LV APD would be approximately 510 ms, while the
RV has a length around 380 ms. The mean values that were observed after MgSC»4 are
however much less: LV APD of 435 ms and RV APD of 380 ms, resulting in a
interventricular AAPD of 55 ms similar to baseline (table 3). The shorter LV APD is
partially caused by the disappearance of the EAD but to a larger extent to homogeniza-
tion of repolarization by a more pronounced shortening of the LV APD.
Whether the pronounced interventricular AAPD is related to the presence of chronic
complete AV block seems indicated by the results of a recent study (33).
To determine the exact contribution of EADs to interventricular AAPD further studies
need to be performed.
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Based on our data, we cannot assess the exact contribution of EADs for intcrvcntricular
AAPD. But we do believe that we provide evidence that both EADs and intcrvemricular
AAPD, as suggested by others (1,13.17), have to be present in a certain magnitude to
induce TdP. Inducible dogs have a higher incidence ot EADs. a similar incidence of
cctopic beats as non inducible dogs but possess a more pronounced interventricular
AAPD. Because EADs and ectopic beats arc also present in the non inducible group,
their appearance alone seems not sufficient to induce TdP. The fact that the presence
of ectopic beats does not lead to spontaneous TdP nor seems related to pacing induced
TdP could be explained by 1) the differences in coupling interval, 2) ihc number of
beats in the pacing train, 3) to the lack of interventricular AAPD, or 4) combination of
these factors.
Secondly, prevention of TdP by MgSO4 is achieved through a more pronounced
reduction of repolarization leading to less interventricular AAPD. Similar data that we
obtained in a different study confirm this observation: in the same dog the higher
occurrence of (spontaneous) TdP after almok.ilant was associated with more EADs and
a higher interventricular AAPD compared with cAsotalol (34).
This study again emphasizes the role for bradycardia in the genesis of TdP. EADs, APD
and interventricular AAPD all show bradycardia dependence. Acceleration of the rate
cither by isoprenaline or ventricular pacing prevents the occurrence of TdP (18). And a
further slowing of the rate by a second bolus of «/-sotalol in the non inducible dogs,
increases inducibility to 70-80% (18).
Next to interventricular AAPD, intraventricular differences in APD could also con-
tribute to dispersion of repolarization. Although only in part of the dogs the APD was
measured at multiple sites in the same ventricle, these data show that in our animals
(table 1) the observed intraventricular differences are much less than interventricular
AAPD. So it seems that the ventricles themselves behave more uniformly, although
potentially large intraventricular differences can never be excluded, because of the
regional information provided by the MAP catheter which was placed randomly.
A non uniform repolarization of the heart (dispersion) has already for a long time been
acknowledged as a substrate for lethal ventricular arrhythmias (35). Differences in
repolarization will favor reentry which could perpetuate the ectopic impulse formation
after the first triggered beat(s) and so initiate TdP. One of the possibilities is spiral wave
reentry which causes polymorphic patterns in epicardial sheets. The spiral wave reentry
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is due to a gradient in dispersion or conduction velocity (36). Another possibility is
intramural reentry caused by transmural dispersion due to the M cells (12).
However a role of reentry in the mechanism of continuation of TdP has never been
proven. Recent research using three dimensional mapping suggested the presence of
different foci (37,38), originating from the endocardium as the perpetuation substrate
of the arrhythmia. The present study is not able to discriminate between triggered
activity or reentry for the mechanism of continuation of TdP.
Our data point to the involvement of interventricular AAPD and EADs in the initiation
of TdP. However neither the presence of EADs nor an absolute amount of inter-
ventricular AAPD can predict the occurrence of TdP, because a small overlap in the
values of the interventricular AAPD between inducible and non inducible dogs is
present.
It may be important to note that all rate dependent effects of the differences in APD are
reported during steady state paced cycle lengths or during a relatively stable CL-IVR
(30,31). A sudden rate change after </-sotalol i.e. by programmed electrical stimulation
or by triggered beats may increase interventricular AAPD, due to a (temporal) accen-
tuation in HADs (sec e.g. figure 2). This can provide the trigger for the initiation of TdP,
either chic to the triggering of the accentuated EADs or due to the prolonged inter-
ventricular AAPD. The dynamic behavior of EADs and interventricular AAPD in
relation to frequency needs therefore further investigation.
During spontaneous IVR the activation times will differ depending on the origin of the
focus. This may influence differences in APD when we consider a relation between the
time of activation and AP duration (39,40). There are numerical places for impulse
formation in our dogs. Therefore, we do not believe that specific activation site will
markedly influence dispersion in APD.
Like EADs, interventricular AAPD independently demonstrates frequency dependence
during steady state rhythms. An increased interventricular AAPD with or without the
contribution of local EADs is an important factor in the initiation of TdP.
We th.mk the Bakken Research Institute (Medtronic) Maastricht, the Netherlands for
providing the epicardial electrodes. This study was supported by a grant from the
Netherlands Heart Foundation (#91.104).
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Relevant factors for the initiation of Tdl'
ABSTRACT
. Further investigation of the initiating mechanism of acquired Torsade de
Pointes (TdP) arrhythmias.
/fcKvfrjjrawW.- Administration of class III agents can be associated with TdP. We have
developed a dog model in which after </-sotaiol TdP can be reproducibly induced by
pacing. This model shows reproducible results over weeks.
A/<7/WJ: Fn 14 anesthetized dogs with chronic complete AV block, two separate
experiments were performed in which </-sotaJol (2 mg/kg) or almokalant (0.12 mg/kg)
were administered. Monophasic action potentials were simultaneously recorded from
the endocardium of the right and the left ventricle to register early afterdepolarizations
(MAI)s) and to measure the action potential duration (APD). Interventricular dispersion
of rcpolarization (AAPD) was defined as the APD of the left ventricle (LV) minus that
of the right ventricle (RV). /?««//*: Baseline conditions were identical in the serial
performed experiments (cycle length of the idioventricular rhythm (CL-IVR): 1645 ±
325 ms. Q I lime: 400 ± 55 ms. LV APD: 375 ± 45 ms, RV APD: 330 ± 35 ms, and
intcrventricular AAPD: 45 ± 25 ms (mean ± SD). The CL-IVR and Q T time increased
with 16% and 26% after </-sotalol and with 15% and 3 1 % after almokalant. Similar to
l'.ADs (18/22 vs 1 1/24, P<().05), single or multiple ectopic beats were more frequently
observed after almokalant than after «-/-sotalol. After both drugs the LV APD prolonged
more than tli.it of tin- right ventricle, thereby increasing intcrventricular AAPD. This
was more pronounced after almokalant (110 ± 60 ms) than for d'-sotalol (80 ± 45 ms,
I'<().()5). Spontaneous TdP was observed in 10/14 dogs after aimokalant, and the
incidence could be increased to 12/14 after programmed electrical stimulation (PES).
After </-sotalol. TdP could only be induced by PES (5/14, P<0.05).
(.«//<•//<.«/'»//.«.• In the same dog, almokalant induced more delay in repolarization, more
l\ADs, and more ventricular inhomogeneity in APD than </-sotalol. These changes were
related to a higher incidence of TdP, and thereby confirm the importance of EADs and
interventricular AAPD in the genesis of TdP. The findings also show the possible value
of our model to evaluate proarrhythmic potential of different drugs.
INTRODUCTION
Antiarrhythniic drugs which prolong repolarization without affecting conduction have
attracted interest, because of their possible value in prevention and suppression of
reentrant tachycardias (1-3). However class III drugs do produce Torsade de Pointes
(TdP) arrhythmias in about 1-5% of patients (1,2,4-9).
Many articles have pointed to the relevance of early afterdepolarizations (EADs) and
HAD dependent ectopic beats (EBs) for the initiation of TdP arrhythmias (9-12).
Whether they can be solely responsible for the initiation and/or whether other factors
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like ventricular dispersion of repolarization (AAPD) do contribute is still a matter of
discussion (13-15). Regional differences in the duration of the action potential (APD)
can be present within the ventricular wall (transmural). within one ventricle (in-
traventricular) and/or between ventricles (interventricular).
Comparing inducible vs non inducible animals in our canine model of TdP, we have
demonstrated that the number or EADs is higher and the amount of interventricular
AAPD larger, using endocardially placed monophasic action potential (MAP) catheters
(16). In anesthetized dogs with chronic complete AV block, TdP can be reproducibly
initiated using the combination or d-sotalol and pacing in hair or the experiments (17).
Because the response is maintained over weeks (17), we compared the effect of two
antiarrhythmic drugs, d-sotalol and almokalant in their ability to induce TdP arrhyth-
mias in the same dog. In this way we could assess whether differences in the occurrence
of EADs, EAD dependent EBs and/or interventricular AAPD could explain initiation
ofTdP.
METHODS
The study protocol was approved by the Committee for Hxperiments on Animals of the
University of Limburg, Maastricht, the Netherlands and conducted in accordance with
the guidelines of the American Physiological Society.
The experiments were performed on anesthetized adult mongrel dogs of either sex with
a body weight between 20 and 31 kg. In preliminary surgery, a right thoracotomy was
performed to induce a permanent complete AV block by injection of 37% formaldehyde
into the AV junction (18). During the same session, a pacing electrode (Bakken Research
Center, Medtronic) was inserted at the apex of the left ventricle. The wire was
exteriorized through the back of the neck of the dog. Six surface elcctrocardiographic
leads and 2 endocardial MAP were simultaneously registered and stored on optical disc.
All drugs were administered through a canula in the cephalic vein.
Anaesthesia was induced by 1) premedication i.m. (1 ml/5 kg: 10 mgoxycodon, 1 mg
acepromazine and 0.5 mg atropine) and 2) sodium pentobarbital (20 mg/kg i.v.). The
dogs were artificially ventilated through a cuffed endotracheal tube using a mixture of
oxygen, nitrous oxide and halothane (vapor concentration 0.5%-l%) by a respirator.
Ventilation was controlled by continuous reading of the carbon dioxide concentration
in the expired air. A thermal mattress was used to maintain adequate body temperature.
Proper care was taken before and after the experiments, including antibiotics (1000 mg
ampicillin) and analgesics (0.03 mg/7 kg i.m. buprenorfine). A temporary ventricular
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pacemaker (VV1) was sometimes given after the AV block operation and after the
experiments. Pacing was switched off after a maximum of 24 hours.
In sinus rhythm dogs, other investigators have shown that the effect of 0.35 rng/kg
almokalant on clectrophysiological parameters as APD was about two times as strong as
3 mg/kg </-sotalol (19). Therefore we chose a dose of 0.12 mg/kg almokalant, to create
similar effects as 2 mg/kg </-sotalol. This is the dose that we have used in the past (16-18)
to induce TdP.
In preliminary experiments two dogs were tested with this dose of almokalant. These
dogs showed repetitive episodes of spontaneous TdP. This is in contrast with the low
incidence (± 8%) of spontaneous TdP with */-sotalol in our model (17). Administration
of almokalant also resulted in the death of an animal during the infusion of almokalant
(0.06 mg/kg): an episode of TdP deteriorated into ventricular fibrillation which could
not be cardioverted. Therefore, we started to administer almokalant (0.12 mg/kg/5 min)
first to selected dogs (n=3) in whom no TdP could be induced by */-sotalol. In these
experiments the arrhythmogenic potential of almokalant was well controlled so that we
than administered almokalant to eleven successive dogs. In the 14 dogs tested, «/-sotalol
was given first (4 ± 2.2 weeks after creation of complete AV block) in eleven dogs,
followed by almokalant 3 ± 2.1 weeks later. In three dogs the order was reversed;
almokalant at 5 ± 2.6 weeks and c/-sotalol at 9 ± 3.1 weeks of chronic complete AV
block. I he time of administration of almokalant was doubled from 5 to 10 minutes in
the last 10 animals following a publication on the possible relation between (high)
infusion rate and the initiation of TdP by almokalant (11).
A detailed description of the TdP protocol is described elsewhere (17). In short, at least
2 weeks after creation of AV block anesthetized animals received two defibrillation
patches that were attached to both sides of the chest and connected with a defibrillator.
At least halt an hour after the onset of anaesthesia programmed electrical stimulation
(PES) was performed from the epicardial electrode. Stimulation was done with a
programmable stimulator capable of pacing synchronously to the QRS complexes.
Unipolar stimuli were given using a pulse of 2 ms and a stimulus strength of twice
diastolic threshold. As indifferent electrode a needle was placed through the skin. PES
consisted of two different pacing protocols: 1) A short long short sequence (400 800 +
extrastimulus, or 4*600 1200 + extrastimulus) and 2) 8 basic stimuli followed by an
extrastimulus. The interstimulus intervals were 600 or 1200 ms. The extrastimulus
interval in both pacing protocols was shortened from 500 ms using steps of 50 ms till
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300 ms. After completing the basic pacing protocol, //-sotalol (2 mg/kg/5 min) or
almokalant (0.12 mg/kg/5 or 10 min) were administered.
Pacing was resumed 10 minutes after the start of the infusion unless spontaneous TdP
had occurred during the observation period. When TdP occurred, we tried to perform
the pacing protocol at 15 minutes. Pacing was always performed in .» random order. A
TdP arrhythmia was defined as a polymorphic ventricular tachycardia consisting of 5
beats or more misting around the baseline in the setting of a prolonged QT(U) duration.
TdP was terminated using cardioversion (60-70 J) when it lasted longer than 10 seconds.
A dog was called induciblewhen TdP was induced 3 times or more using the same pacing
mode and/or when spontaneous initiation of TdP occurred (^ 3 times). In one
experiment problems with cardioversion urged us to stop prematurely, so that
reproducibiliry could not be assessed.
MAPs were recorded to observe the occurrence of EADs and to measure the API) the
of the left (LV) and right ventricle (RV). Quadripolar contact electrodes (Fran/
combination catheter, EPT # 1650), that provide both pacing and MAP recording
capabilities were placed endocardially in the right and in the left ventricle via the external
jugular vein and the carotid artery under fluoroscopie guidance. MAP phases were
defined according to the definitions used for transmembranc potentials (20). Amplitude
was defined between phase 4 and 2 of the signal. Besides a minimal amplitude of 15 mV
the MAP had to have a constant configuration and a smooth shape during control
circumstances.
The MAP catheters were randomly placed in the ventricle and accepted for analysis if
all these conditions were fulfilled. Good quality MAPs in both ventricles were present
in 11/14 experiments with almokalant and in 12/14 experiments with «/-sotalol. EADs
were defined as an interruption of the smooth contour of phase 2 and/or 3 of the action
potential (10). The presence of EADs was examined in both MAPs.
With the use of a custom made computer program with a resolution of 2 ms and
adjustable gain and time scale, the following parameters were measured: cycle length of
the idioventricular rhythm (CL-IVR), QT time and APD. All elcctrophysiological data
reported are the mean of 5 consecutive (single) beats, and were checked by an inde-
pendent blinded observer.
Interventricular AAPD was defined as the difference between the LV APD and RV APD
measured after total repolarization (=APDKJO).
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Multiple measurements ANOVA, followed by a Bonferroni t-tcst was used to compare
the data between the two treatments and a X" test was used when the data were presented
as percentages. P values ^ 0.05 were considered significant. All data are presented as mean
± standard deviation (SD), unless otherwise specified.
RESULTS
&jr m/Su/on
The change in infusion rate (5 vs 1Ü minutes) of almokalant did not alter the
elcctrophysiological effects nor the (time of) occurrence of EBs and/or incidence of TdP.
Therefore, we will present the data as a whole.
Baseline conditions were similar in each of the 14 serially tested animals. Values for
CL-IVR, Q T time, API) of both ventricles and the interventricular AAPD are sum-
marized in table 1. At 10 minutes, </-sotalol had significantly prolonged the CL-IVR
with 10%, and the t.,) I time with 26%. It also significantly increased the LV APD and
RV APD. Because prolongation of the LV APD was more pronounced (27% vs 21%),
interventricular AAPD increased significantly (table 1).
Also almokalant significantly increased the CL-IVR and all the repolarization
parameters. Again interventricular AAPD increased (p<().05) due to a more pronounced
increase in the LV APD compared to the RV APD (45% vs 29%, table 1).
Table I. Hlcctrophysiologic effects of *</-soialol and almokalant
(/-sotalol almokalant
C1.-1VR
QT
RVAPD
LVAPD
AAPD
0'
1620 ±300
390 ± 50
320 ± 30
370 ± 45
50 ±25
10'
1880 ±.V0'
495 ± 80"
390 ±45"
470 ± 60"
80 ± 45"
%
+ 16
+ 26
• 21
•27
•75
0'
16701360
415 ± 55
335 ± 35
375 ± 45
40 ±20
10'
1910 ±425"
545 ± 115"
440 ± 60"*
535 ± 110"*
110±60#
%
• 15
+31
•29*
•45*
+330
* P<0.05 t» 10 vs 1*0, * P<0.05 almokalant vs </-sotalol. CL.-IVR: cycle length of the idioventricular rhythm,
APD: action potential duration. IV: left ventricle. RV: right ventricle. AAPD:LV APD - RV APD. Dau
are in milliseconds (mean ± SD) measured at the start and after 10 minutes of drug administration.
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Figure 1. Occurrence of EADs, triggered beats and spontaneous TdP-arrhythmia after almokalant in the
canine heart.
Three simultaneously recorded surface electrocardiographic leads and two endocardia! monophasic action
potentials {one from the left: L.V MAP and one from the right ventricle: RV MAP) are presented. Paper
speed is iO mm/sec. Panel 1: Baseline conditions with a spontaneous idiovcntricular rhythm having a cycle
length of 1670 ms (IVR), and a QT time of 390 ms. The difference between the left and the right action
potential duration (AAPD) is 65 ms. Panel 2: 7 minutes after almokalant CL-1VR (2170 ms) and QT-timc
(625 ms) have increased ami the positive T wave (lead 11 and 111) has changed into a negative TU wave.
Dispersion in repolarization (AAPD) has increased to 200 ms. In both MAPs, early aflerdepolarizaiions
(EADs) are present (arrows). Spontaneous ectopic beats occur in the repolarization phase. Some <>( (hem
clearly seemed to be triggered by an EAD that has reached threshold (asterisk). This is followed by a short
period of TdP.
When comparing */-sotalol with almokalant, no differences were found in the amount
of lengthening of the CL-IVR. However the effect on the parameters of repolarization
was greater after almokalant (table 1).
In the first 10 minutes, administration of the drugs resulted in the occurrence of EADs
(figure 1, panel 2} in 18/22 MAPs with almokalant and in 11/24 MAPs after «/-sotalnl
(table 2). With ^/-sotaloi EADs tended to appear more frequent in the left ventricle
(P<0.1, table 2), whereas no difference was seen after almokalant. Single EBs developed
Relevant factors for the initiation of TdP I 73
Table 2. Incidence of early afterdcpolarizations and Torsade de Pointes arrhythmias (TdP) after </-sotalol
(dS) and almokalant (A)
doe LV/RV EADdS EAD A INDU TdP dS INDU TdP A
1
2
3
4
5
6
7
8
9
10
11
12
13
14
LV
RV
LV
RV
LV
RV
LV
RV
LV
RV
LV
RV
LV
RV
LV
RV
LV
RV
I.V
RV
IV
RV
I.V
RV
ND
ND
+
•
•
-
•
-
-
+
ND
ND
ND
no
PES
no
PES
no
PES
PES
no
PES
no
no
no
no
no
no
Spon*
Spon
• PES
PES
Spon*
Spon
+ PES
Spon'
Spon
• PES
PES
Spon
• PES
PES
Spon*
Spon
no
loi.il 11/24 18/22" 5/14 12/14'
LV: left ventricle, RV: right ventricle, EADs: early after depolarizations present in RV or LV, ND: not
determined, INDU: inducibility: no: no TdP, PES: induction by programmed electrical stimulation. Spon:
spontaneous initiation of TdP. P<0.05 vs dS. * Due to spontaneous activity no PES could be pcformed.
in almost all dogs with almokalant (13/14) and in less than half of the dogs after </-sotalol
(5/14). Moreover, multiple EBs were observed after almokalant. In some experiments
those spontaneous beats could be associated with triggering of EADs recorded with the
MAP catheter (figure 1, panel 2).
Despite the occurrence of EBs after </-sotalol, none of these dogs developed spontaneous
TdP. Almokalant induced spontaneous TdP in 9 dogs (figures 1 and 2), which was
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Figure 2. Continuous ectopic activity and TdP after almokalant.
Recordings are shown at a paper speed of 10 mm/s. Before the administration of almokalant (CONTROL)
a stable cycle length of the idioventricular rhythm (CL-IVR) (1510 ms) with a QT time of 430 ms is
present. Administration of almokalant (0.12 mg/kg/10 min) led to the occurrence of ectopic beats at 3
minutes. From that time on to 30 minutes after the start of the infusion, episodes of ectopic beats and TdP
alternated with the IVR. In this figure a continuous recording of 225 sec starting 5 minutes after start of
almokalant is shown. Almokalant has increased the CL-IVR to 1745 ms and the QT time to 680 ms.
Furthermore the T wave has become more negative. At the end of this T wave an ectopic beat starts a period
of TdP. After cessation another period of TdP evolves. After a change in the site of origin of the IVR
(different QRS configurations) a new episode of TdP starts now after a short long short sequence.
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Figure 3. Incidence ot spontaneous Iorsadc de Pointes related to interventricular
dispersion.
This graph shows the mean values (± SF.M) of interventricular dispersion in APD
(AAPD) in the animals with MAPs at both experiments. Dispersion has been
dividend in three groups I) baseline. 2) after class III without spontaneous TdP
(class III. d-.sotalol and almokalant: n=lS), and 3) after class III drugs in those
experiments with spontaneous occurrence or TdP (sp TdP, almokalant; n=7).
The last group has the largest interventricular AAPD (P<0.0S) compared with
baseline (*) and class III (*). Intcrvcntricular AAPD of 9S nis has a specificity of
7 3 % and a sensitivity of 8V\i to predict TdP
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Figure 4. Induction of TdP by almokalant.
Same layout, abbreviations, and animal as in figure 1. At 43 minutes after the start of the almokalant
administration, all values still are shorter as compared with figure 1, but still longer than after «/-soialol
(figure 5). Also negative T waves are present and the MAP recording clearly demonstrates the presence of
EADs (arrows). The AAPD is 125 ms. A pacing train of 400/800+ 1 cxtrastimulus initiates a self terminating
Tdl'. Note the shortening of the APD and suppression of EADs after termination of the TdP with a
diminution of AAPD to 60 ms. Thereafter the EADs reoccur and APD starts to increase.
associated with a significantly larger interventricular dipsersion (figure 3) and a higher
incidence and number of the EBs.
After </-sotalol, PES resulted in the induction of TdP in 5 dogs.
PES could not be performed in 4/9 spontaneously inducible dogs because ectopic
activity and periods of TdP prohibited this (see example in figure 2). In the other 5 dogs
pacing induced TdP in 4 animals (table 2). In the dogs without spontaneous arrhythmias
(n=5), pacing resulted in 3 dogs in TdP. Therefore the total incidence of TdP after
almokalant was 12/14 dogs.
An representative illustration of the difference in response to ^-sotalol and almokalant
in the same animal is shown in figures 4 and 5- Comparing d-sotalol with almokalant
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Figure 5. No TdP with pacing after «/-soialol.
Same animal as in figures 1 and 4. After </-sotalol a slow CL-IVR (1645 ms) is seen accompanied by a
prolonged QT time (4')() ms). In both ventricles no EADs arc present, and the intervcntricular AAPD
measures ')0 ms. Performance of the same pacing train as used with almokalant did not initiate a TdP after
c/-sotalol, although pacing seemed to evoke an EAD in the RV (arrow).
showed: 1) a higher incidence of TdP by almokalant independent of the order of the
experiments, and 2) all inducible dogs with r/-sotalol were also inducible with almokalant
(table 2).
In two dogs, //-sotalol was administered in a third experiment. The response was similar
to the first experiment thereby confirming reproducibility.
DISCUSSION
The exact contribution of the different factors leading to initiation of TdP is still a matter
of discussion. Besides the accepted parameters: bradycardia and (class III induced)
prolonged Q T time, tADs and AAPD have been indicated in the genesis of TdP. By
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using MAP catheters, the in vivo appearance of EADs have been associated with EAD
triggered EBs, negative T or TU waves. Similarly, an increased iiuraventricular AAPD
has been round in patients with congenital or acquired TdP (13). However, only one
case report has shown a causal relation between the occurrence ot EAD triggered EBs,
interventricular AAPD and initiation ot spontaneous acquired TdP (15). In this study
we have tried to confirm the importance of both parameters in the genesis of acquired
spontaneous and pacing induced TdP by comparing the proarrhythmic effects of
almokaiant with </-sotalol.
Interventricular AAPD in relation to spontaneous and pacing induced Torsade de
Pointes
Spontaneous occurrence of TdP after almokaiant was preceded by 1) an increase in the
LV APD and RV APD, 2) occurrence of subthreshold EADs, 3) an increase in
interventricular AAPD (figure 3). and 4) spontaneous EBs. In comparison with the other
almokaiant and </-sotalol experiments not showing spontaneous TdP, we tound that all
the above mentioned parameters were significantly increased. This confirms and extends
the importance ot EADs (and their triggered responses) and interventricular AAPD in
the genesis of spontaneous TdP. In a previous study we have shown that these parameters
also discriminate between pacing inducible and non inducibledogs after//-sot.ilol in this
model (16). Prevention and/or suppression of TdP by MgSCXj resulted trom disap-
pearance of EADs (13,17) and diminishment of interventricular AAPD (16).
Using PES, we demonstrated that the incidence of TdP could be increased markedly.
Also in this study pacing inducible dogs showed a larger interventricular AAPD, than
the non susceptible ones.
In dogs with chronic complete AV block, we have shown that interventricular AAPD is
present under baseline conditions and is bradycardia dependent, with a decrease in heart
rate an increase in interventricular AAPD is seen (16). In vitro studies using isolated
canine myocytes showed that under baseline conditions the APD of the left endocardial
(and epicardial) cells is longer than that of the right ventricle (21). This difference has
been described to be even more pronounced for the M cell, located within the
myocardium.
Like the Purkinje fiber, the M cell is much more sensitive for class III agents in its ability
to prolong the APD and to develop EADs (21). The increase in interventricular AAPD
in our experiments after class III drugs, is primarily due to a larger decrease of the LV
APD compared to the RV APD. By decreasing heart rate, class III agents will increase
the interventricular differences in APD. Therefore the effect of almokaiant (or */-sotalol)
could be different for the various tissues involved in the heart explaining interventricular
AAPD. The M cells are not only described in dogs (21), but recent studies also showed
the existence of these M cells in normal human myocardium (22). It is not known to
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what extent the M cell contribute to the APD as recorded by the endocardially placed
MAP catheter.
Regional appearances of EADs can also explain the increase in interventricular AAPD.
</-Sotalol predominantly induced EADs in the left ventricle, while almokalant produced
them in both ventricles. Because administration of almokalant led to a more pronounced
increase in interventricular AAPD, the relative contribution of the amplitude of the
EADs might be important.
When spontaneous episodes of TdP occur, pacing will normally also lead to the
reproducible induction of these arrhythmias (see e.g. figures 1 and 4 and reference 17).
Dogs with spontaneous TdP have more EBs (both single and multiple EBs) than dogs
without, lor the induction of pacing induced TdP, the presence or single EBs during
idioventricular rhythm docs not seem to be essential (23), indicating that either the
number of EBs and/or their respective coupling interval is not sufficient to start
spontaneous TdP. Our pacing modes do consist of several beats with multiple frequency
changes (17) and can lead to the occurrence of EADs and triggered EBs within the pacing
train. Therefore, application of PES can lead to TdP in those dogs that do not show
spontaneous TdP. When considering that the respective contributions of the different
parameters is equal, p.icinn can onlv lead to TdP when interventricular AAPD is or
becomes present. Until now we have not been able to determine the dynamic changes
within the pacing train.
The proarrhythmic potential of class HI agents is well known (1-9). Prolongation of
repolari/.ation is the mechanism of the antiarrhythmic effect of class 111 drugs, but
prolongation is also associated with the risk of TdP development. Measurement of the
absolute QT interval does not predict proarrhythmic potential both in clinical condi-
tions (5) as in our animal model (24). Currently Q T dispersion (as a parameter of non
homogenous rcpolari/ation) is frequently mentioned as a possible tool to predict
proarrhythmic risk as well as antiarrhythmic efficacy (25). The Q T dispersion measured
in multiple ECXJ leads correlates with the dispersion in regional repolarization measured
by epicardial M APs (26). Because QT dispersion shows a large variation, due to different
methodologies and different patient characteristics, the question to its use as a general
arrhythmic marker has still not been resolved (27).
This makes it important to screen for the proarrhythmic potential of a new class III
agents using an animal model. Most animal TdP models have used non clinically relevant
drugs like cesium (10.13,28) or Bay K8644 (29). The only exceptions are an awake AV
block dog model with hypokalemia and (J blockade followed by antiarrhythmic drugs
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(30) and a rabbit model (31). In the awake dog it is not possible to measure MAPs and
thereby correlate proarrhythmic findings to EADs and API). In the rabbit, TdP develops
at relatively fast heart rates after administration of class III agents and concomitant a
adrenergic stimulation. Comparison between different agents in the same animal
concomitant with MAP recordings have not been described until this study (30-32).
Because the response of the dog is maintained over weeks, serial comparison for screening
of proarrhythmic effects or (antiarrhythmic) drugs is feasible. Although this information
cannot be translated into the exact incidence of TdP in the patient population, it allows
an estimation of the relative risk of drugs and their risk/benefit ratio.
Almokalant and </-sotalol both prolong the APD by blockade of K* currents (33-35).
While almokalant is a selective blocker of 1 ^ (33,35), the data from the literature are
not consistent for */-sotalol. It might also aftect other K* channels like l ^ j , 1^, and 1,,,
(35-37). In addition, </-sotalol has some P blocking effects, (less than 5% of «//-sotalol
(6)) whereas almokalant is devoid of P blocking activity (34).
The difference in prolongation of the APD and occurrence of tADs after d'-sotalol
compared to almokalant may be explained by 1) differences in dose and/or kinetics, or
2) administration time. In the preparation of this study we calculated that a dose of 0.12
mg/kg almokalant should give approximately the same effect on rcpolari/ation as 2
mg/kg </-sotalol (13). The former is comparable with the dose given to patients to treat
ventricular tachycardias (38). The effect on CL-1VR and Q T was about equal for both
drugs (table 1), although it should be mentioned that in the experiments with al-
mokalant, the electrophysiological measurements were often hampered due to recurrent
presence of EBs and episodes of TdP. This could have led to an underestimation of the
electrophysiological effects of almokalant. The kinetics between the two drugs could
also be different, in vitro data show that the effect of «/-sotalol has a slower onset than
almokalant (35).
Doubling the time of administration of almokalant did not alter the response, which is
in contrast to the reported effects in patients (38) and rabbits (11).
In this study two MAP catheters were randomly placed, one in the left and the other in
the right ventricle. This provides information about the differences in rcpolari/ation
between the two ventricles (interventricular AAPD). Possible rransmural or in-
traventricular differences in APD have not been assessed in this study. Placement of
multiple MAP catheters with d-sotalol revealed that the intraventricular difference
amounted only to 20-30% of the interventricular AAPD (16). We do not know the type
and the amount of cells contributing to the MAP. Similarly, whether the presence of
EAD on the MAP is real or based on differences in transmural repolarization is not
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known. However, interventions specifically directed to EAD formation like pacing and
drugs leads to disappearance of these EADs.
Transmural differences have been implicated in the mechanism of TdP (21). Besides
their relevance for the occurrence of EADs, differences in APD have been shown to
create the substrate for a reentrant tachycardia (39). Whether reentry plays a role in the
initiation and continuation of TdP is still unclear. It is conceivable that reentry succeeds
triggered activity (40,41), this is certainly the case when TdP progresses into ventricular
fibrillation.
Interventricular AAPD is not likely to play a role in reentrant arrhythmias, because
spatial dispersion is located to far apart. Still the polymorphic appearance of TdP can
be explained by interventricular AAPD. Appearance of EBs from single foci can lead to
TdP when this "monomorphic tachycardia" encounters continuously shifting areas of
repolari/ation. Things become more complicated when triggered EBs arise from multi-
ple sites in the ventricles.
Our study confirms the relevance of interventricular AAPD and EADs for the initiation
of (spontaneous) acquired TdP.
These findings also show that this canine model of TdP can be used to screen for the
proarrhythmic potential of drugs.
We are grateful to Mr 11. Wiering and C Ketelaars, ASTRA Nederland who provided
us with almokalant and to Mr) . Verschuuren, Bristol Meyers Squibb forrf'-sotalol. The
Bakken Research Institute (Medtronic) Maastricht, the Netherlands gave us theepicar-
dial electrodes. The study was financially supported by a grant from the Netherlands
Heart foundation (#91.104).
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ABSTRACT
Spontaneous termination of pacing induced acquired Torsade de Pointes arrhythmias
(TdP) and their reinduction was examined in anesthetized dogs with chronic AV block.
Therefore early afterdepolarizations (EADs), action potential duration (APD) and
interventricular dispersion (AAPD), before (B), of the last beat (L) and after TdP, were
analyzed in 20 episodes of spontaneous terminating TdP (15 ± 9 beats, cycle length
(CL): 240 ± 20 ms). TdP termination was associated with a shortening of the APD, a
decrease in EADs (L: 0/40 vs B: 20/40) and interventricular AAPD (L: 10 ± 15 vs B: 80
± 55 ms). The first beat after termination again showed EADs and an interventricular
AAPD of (>0 ms. Thereafter, with no change in CL, EADs diminished significantly from
23/40 (beat 1) to 9/40 (beat 5), while AAPD decreased to control values. TdP could
only be reinduced by pacing when EADs and AAPD had completely returned. When
measuring interventricular AAPD in the presence and absence of EADs, the contribu-
tion of EADs to interventricular AAPD was calculated to be around 35%. Therefore an
essential contribution of the EAD to the changes in interventricular AAPD and
induction TdP is indicated.
INTRODUCTION
Torsade de Pointes arrhythmias (TdP) are an intriguing polymorphic ventricular
tachycardia which can either be congenital or acquired following the administration of
certain drugs or electrolyte abnormalities (1). In the presence of a prolonged QT(U)
interval, TdP is often initiated by a short long short sequence (SLS, 1,2). The occurrence
of these premature ectopic beats has been associated with the development of early
afterdepolarizations (EADs, 3-7). However the presence of induced EADs leading to
ectopic beats docs not always result in the initiation of TdP (6), suggesting that at least
one additional parameter is required to initiate TdP. The spontaneously occurring SLS
sequence and its consequences can be mimicked by frequency changes induced by
programmed electrical stimulation (PES) of the heart. In our animal model of acquired
TdP. PES is able to reproducibly induce TdP after administration of a therapeutic dose
of the class 111 drug c/-sotalol (7). We have recently shown, using endocardial
monoph.iMc action potential (MAP) recordings, that induction of TdP in this model is
associated with bradycardia, prolonged QT duration, EADs, and interventricular dis-
persion in the duration of ventricular repolarization (AAPD,7,8). The presence of EADs,
and the length of the action potential duration (APD) are positively correlated to the
cycle length (9-14). Interventricular AAPD is also frequency dependent: in the absence
of EADs the interventricular dispersion increases when the cycle length prolongs (8,15).
It seems plausible that EADs and interventricular AAPD are related, but it is unknown
to what extent EADs contribute to interventricular AAPD. It is also not clear whether
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EADs and interventricular AAPD play a role in the mechanism of continuation ofl 'dP.
Because part of the TdP episodes terminate spontaneously (1,2.7), we used these
episodes to gain more insight the possible contribution of EADs to interventricular
AAPD and their role in the mechanism of TdP.
METHODS
All experiments were performed according to "Guiding principles in the care and use of
animals" or the American Physiological Society and approved by the Committee for
Experiments on Animals of the University of Limburg, Maastricht, the Netherlands.
The experiments were performed on 20 anesthetized adult dogs with chronic AV block
(6 ± 3.5, range 2-11 weeks) of either sex with a body weight between 20 and 30 kg. Math
dog had one epicardial electrode (Bakken Research Center, Medtronic, Maastricht, The
Netherlands) implanted at the apex of the left ventricle, after a right sided thoracotomy
was performed to produce chronic complete AV block (for details see reference #16).
Pacing was done with a programmable stimulator capable of pacing synchronously to
the QRS complexes. Unipolar stimuli were given using a pulse width of 2 ms and a
stimulus strength of twice the diastolic threshold. As indifferent electrode a needle was
placed through the skin. Six surface electrocardiographic leads and 2 MAP signals were
simultaneously registered, digitized, visualized on a monitor and stored on hard disc.
All drugs were administered through a canula in the cephalic vein.
Anaesthesia was induced by 1) premedication i.m. (1 ml/5 kg consisting of 10 nig
oxycodon, 1 mg acepromazine and 0.5 mg atropine) and 2) sodium pentobarbital (20
mg/kg i.v.). The dogs were artificially ventilated through a cuffed endotracheal tube
using a mixture of oxygen, nitrous oxide and halothane (vapor concentration 0.5%-1%)
by a respirator. Ventilation was adjusted on the basis of continuous reading of the carbon
dioxide concentration in the expired air. A thermal mattress was used to maintain
adequate body temperature.
Proper care was taken after the experiments, including antibiotics (1000 mg ampicillin)
and analgetics (0.1 mg i.m. buprenorfine). Temporary ventricular pacing (for a maxi-
mum of 24 hours) was performed after the AV block operation and after the experiments.
A detailed description of the Torsade de Pointes protocol is given elsewhere (7). In short,
anesthetized animals received two defibrillation patches that were attached to both sides
of the chest and connected with a defibrillator. Half an hour after the onset of
Relation of EADs and AAPD I #7
anaesthesia, pacing was done from the epicardial electrode using two different pacing
modes: 1) short long short sequence, with intervals of 400 and 800 ms followed by an
extrastimulus or intervals of 600, and 1200 ms followed by an extra stimulus and 2)
Eight basic stimuli with an interstimulus interval of 600 ms followed by an extra
stimulus. During both pacing modes the interval of the extrastimulus was shortened
from 500 ms in steps of 50 ms until 300 ms. After completing the pacing protocol, one
of the following class III agents was administered intravenously; </-sotalol (2 mg/kg/5
min) or almokalant (0.12 mg/kg/10 min). Pacing was resumed 10 to 15 minutes after
the start of the injection of the drug. A Torsade de Pointes arrhythmia was defined as a
polymorphic ventricular tachycardia consisting of > 5 beats, which twisted around the
baseline and occurring in the presence of a prolonged QT(U) duration. A second dose
of'</-sotalol (2 mg/kg) was given when no TdP could be induced after the first dose.
This was followed by repetition of the pacing protocol.
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Monophasic action potentials were recorded to observe the occurrence of EADs and to
measure the APD in the left and right ventricle before initiation, at the time of and after
the termination of the TdP. The method used to record MAPs has been described in
detail in an earlier report (8). Briefly, endocardial quadripolar contact electrodes (Franz
combination catheter, EPT # 1650), with pacing and MAP recording capabilities were
placed .ii random in the right and the left ventricle via the external jugular vein and the
carotid artery.
MAP phases were defined according to the definitions used for transmembrane action
potentials (17). Amplitude was defined as the distance berween phase 4 and 2 of the
signal. Under control circumstances the MAP was required to have a minimal amplitude
of 1 5 mV, an identical configuration in successive beats and a smooth shape.
EADs were defined as an interruption of the smooth contour of phase 2 or 3 of the
action potential (5). The presence of EADs was examined in the LV as well as in the RV
MAP.
We looked at 27 consecutive experiments in which either </-sotalol (n=22) or almokalant
(n=5) were administered in combination with two simultaneous recorded MAP's in both
ventricles. All spontaneously terminating TdP that were induced by the pacing protocol
showing stable MAP recordings were included. Spontaneous initiation of TdP or TdP
lasting longer than 10 seconds requiring cardioversion were excluded.
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Both the development of EADs and interventricular AAPD is bradycardia dependent.
It is known that */-sotalol will increase the development or EADs by increasing APD.
Because ^-sotalol also lengthens CL-IVR, contribution of EADs to interventricular
AAPD can only be assessed at the moment EADs appear and/or disappear when CL is
kept constant. In 6 additional experiments, we therefore continuously paced the
ventricle during administration of ^-sotalol leading to development ot EADs. Paced CL
was chosen just beneath IVR at baseline.
Secondly we performed a further subgroup analysis in the TdP group in which the
disappearance and reappearance of EADs after termination was related to changes in
interventricular AAPD.
All data were analyzed by two independent observers using a custom made computer
program with a resolution of 2 ms and adjustable gain and time scale.
Electrophysiological measurements of cycle length of the idioventricular rhythm (CL-
IVR) and APD were performed before, at the last beat of the TdP and after the
spontaneous termination of the TdP. From each episode of TdP, the number of TdP
beats was counted and the mean cycle length of the whole arrhythmia was determined.
The first 5 beats after the TdP were individually measured. Thereafter every fifth beat
was measured until the pacing train was repeated.
Interventricular dispersion of repolarization (AAPD) was calculated as the difference
between the left and right APD using the total repolarization duration ( = APD|oo) in
each ventricle.
Comparisons were made using a paired or unpaired Student f-test when appropriate. P
values <0.05 were considered significant. All data are presented as mean ± standard
deviation (SD).
RESULTS
In 15/27 experiments, episodes of TdP could be reproducibly (>3) induced by PES. In
the other experiments no TdP could be induced (n= 10), or the occurrence of numerous
spontaneous TdP episodes prevented the performance of a pacing protocol (n=2). In
10/15 experiments spontaneous terminating TdP occurred. In these 10 experiments (10
dogs) a total of 39 (mean 3.9 + 1.5) pacing induced episodes were seen: 12 had to be
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hgurc I. Kepolariiaiion parameters during baseline conditions and after administration of two dosages of
(/-SOI.llol.
Three IX X i leads are recorded simultaneously with two monopha.sk- action potential recordings in the right
(RV) and in the left ventricle (LV) at a paper speed of 10 mm/s. Before pacing, a stable idiovcntricular
rhythm (IVR) is seen with a cycle length (Cl.) of I 1 SO ms and a QT time of 340 ms (panel I). Both action
pi.temi.ils .ire smooth with .1 duration (APO) of 340 ms for the l.V and 320 ms for the RV. leading to a
dispersion m duration of repolari/alion (A/MM)) of 20 ms. The pacing train consisting of two stimuli of
400 and 800 ms followed by an extra after 400 ms is not able to induce a TdP under baseline conditions.
In the second panel the effect of the first dose otV-sotalol is seen. The CL-IVR and QT time prolong to
1 S~0 ms and 4~S ms. while both AIMVs increase to 420 and 440 ms respectively. No TdP could be induced
by the pacing protocol. Therefore a second dose of r/-sotalol (panel 3) was given resulting in a further
increase in Cl.-IVR to 1800 ms. Also the duration of all rcpolarization parameters prolonged further. Now
the development of early aftcrdcpolari/ations (EADs. arrows) can clearly be seen in both MAIY The AAIM)
has increased to 100 ms, due to a more pronounced increase in the LV APD compared to the RV APD.
cardioverted and 27 ended spontaneously. Of the spontaneously terminating TdP, 20
episodes fulfilled the criteria in regard to the MAP signal. These 20 episodes occurred
in 6 dogs after the first injection of </-sotalol. in 2 dogs after the second dose, and in 2
dogs after almnkalant.
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Table 1. Electrophysiological parameters (mcan±SD) before drug administration, before Torsade dc
Pointes (TdP), the last beat of TdP and after a spontaneously ending episode of TdP (TdP)
CL-IVR (ms)
LV APD (ms)
RV APD (ms)
AAPD (ms)
EAD
control
1645 ± 295
365 ±45
325 ± 30
40 ±25
0
before TdP
1870 ±255
460 ±80
380 ± 50
80 ±55
20/40
last beat of TdP
250 ± 30
250 ±25 '
235 ± 15'
10± 15"
0/40'
1" beat after TdP
1920 ±420
430 ± 55'
370 ± 50"
60 ±50"
23/40
5* beat after TdP
19351315
390 ± 5 5 '
345 ±40*
45 ± 30
9/40'
' P<0.05 vs before TdP.' P<0.05 vs 1 " beat after TdP. CL-IVR: cycle length of the idiovcntricular rhythm.
LV: left ventricle. RV: right ventricle. APD: action potential duration. AAPD: difference between IV .uul
RV action potential duration, EAD: early aftcrdepolahzation.
In the control situation, programmed electrical stimulation did not result in TdP, nor
were any EADs registered (figure 1, panel 1). Ten minutes after the administration of
the class III agents, */-sotalol or almokalant, the CL-IVR increased significantly from
1645 ± 295 to 1995 ± 270 ms, the LV APD from 365 ± 45 to 500 ±110 ms, the RV
APD from 325 ± 30 to 400 ± 70 ms and interventricular AAPD from 40 ± 25 to 100
± 75 ms (all P<0.01). In addition, development of EADs after administration of the
drugs (figure 1, panel 3) was observed in 8/10 experiments prior to TdP induction.
rt/'tt »ƒ r/tt"
The 20 analyzed periods of TdP lasted 15 ± 9 beats (range 5-35) with a mean cycle-
length of 240 ± 20 ms and occurred 22 ± 9 minutes after the start of the drug injection.
The electrophysiological parameters are summarized in table 1. All parameters were
somewhat decreased compared with 10 minutes after the start of the injection. Prior to
TdP induction the mean LV APD amounted to 460 ± 80 ms and the RV APD 380 ±
50 ms. Therefore the interventricular AAPD prepacing was 80 ± 55 ms. EADs were
present in 20/40 MAP recordings. These EADs were more frequently seen in the LV
MAP (n=l4) than in the RV MAP (n=6, P<0.05). A representative example of a
spontaneously terminating TdP can be seen in figure 2.
The high rate of the TdP resulted in a significantly shorter APD and almost no dispersion
in the last beat of the TdP before spontaneous termination. Furthermore no (sub-
threshold) EADs were seen in any of the terminations (table 1, third column and figure
2, panel 2).
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Figure 2. Initiation .nul spontaneous termination of a Torsadc de I'ointes arrhythmia ( FdP) following
d'-soulol administration.
This is the same experiment as in figure 1. Prior to TdP induction by pacing the CI.-IVR amounts to 1855
ni.s with a QT time of 5 SO ms. The IV' API) measures 615 ms and the RV APD 515 ms resulting in a
AAPl) of 100 ms. In both the IV APD and the RV APD a clear EAD (arrow) is seen. The same pacing
train (400/800/400 ms, indicated by S) is now interrupted by an ectopic beat and after the extrastimulus
the TdP starts. In panel 2 the MAP recordings during initiation and spontaneous termination have been
enlarged. The last beat of the TdP has a AAPD of 25 ms and the EADs have disappeared, although a small
deviation of the MAP is still present. This was not considered to be an EAD. In the first beat after the TdP
the EAD is back in both MAPs (panel 2). In subsequent beats the EAD gradually decreases. In the 5th beat
the I 'J \D from the RV has disappeared and the EAD in the LV has clearly diminished. In the 10th beat
post U'Miiin.uion the KAl) on the IV has also disappeared (shown enlarged in panel 3). In line with the
disappearance of the EADs the AAPD decreases (')() ms in the 5th to 45 ms in the 10th beat).
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The first ventricular beat after the termination of the TdP occurred after 1920 ± 550
ms, and had a shorter APD compared with the preparing beat. However EADs were
again present (figure 2. panel 2) and interventricular AAPD was 60 ± 50 ms. In
subsequent beats the APD shortened with a concomitant decrease in interventricular
AAPD (figures 2-3). This decrease took place without a change in CL-IVR, and seemed
to be related to a decrease in EADs (23/40 at the first beat to 9/40 at the 5th beat.
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Figure 3. Return of EADs and dispersion leading to rcinduction of TdP.
This figure is a continuous registration after figure 2 and has (he same composition. It starts 17 beats after
spontaneous termination ot the TdP. An EAD is only minimally present in the left MAP and becomes
more pronounced in the following beats (see the enlargement in panel 2). With the increase in height of
the EAD in the LV MAP, the AAPD also gradually starts to increase from 60 (beat 17) to 1 10 ms (beat
30. see enlargement in panel 3). just before the repetition of the pacing train (panel 1). The EAD in the
right MAP returns around the 25th beat (panel 3). The same pacing train performed after 32 beats again
induces a TdP.
P<0.05). At the fifth beat, interventricular AAPD (45 ± 30 ms) is comparable to the
control value (40 ± 25 ms) for this CL-IVR (table 1).
After a short stable level of the APD between the 5th and the 1 Oth beat post termination,
the APD of both ventricles started again to increase (figures 2-4). This was accompanied
by the reappearance of EADs and augmentation of interventricular AAPD (figure 3).
The behavior of the LV and RV APD was not always synchronously, for example in
figures 2 and 3, the RV EAD disappears around beat 5 whereas the LV APD only
disappears around beat 10. Also in the reappearance there are differences, the LV EAD
is the first to return followed by the RV EAD. This incongruent behavior of the LV and
RV EAD influences APD and interventricular AAPD. The smallest interventricular
AAPD is found when EADs are absent in both ventricles (figure 2, panel 3), and the
reappearance of LV EADs increases the interventricular AAPD again to 120 ms at beat
25 (see further, figure 3).
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Figure 4. Time murw i>f API") adaptation after spontaneous trrmination of TdP.
In ilws tigure the linu- murw ot (lic API) of the right (•) and left ventricle (o) is shown as the mcan±SD
before .nul jlier I 2 episodes ol TdP. The Ic-npih of the APDs arc shown on ihc vertical axis, and the number
of heats before and after the TdP on the vertical axis. The first value is the APD of the last beat before (B)
the start of the pacing train leading to induction of TdP. Beat I. is the last beat of the TdP. Due to the fast
rate of the TdP the API) of the List be.it is decreased. The first he.» (1) after termination of the TdP has
an API) significantly shorter than heat B. The API") decreases further till a minimum value is reached after
S beats. Thereafter the API") increases slowly. At 30 beats after TdP the APD is still shorter than before the
start of the TdP. The AAPD is shown between the lines of the RV and L.V APD. The same pattern of
shortening and subsequent increase can be observed.
The course of the APD could be followed in 12 episodes for 30 beats after termination
(figure 4). At the end of these 30 beats the APD had not yet completely returned to its
prepacing value (see below). Again the difference in APD behavior can be observed, the
curve of the IV APD seem to differ from the RV APD. In this subgroup of TdP, the
Cl.-IVR ranged from 1 825 ± 235 ms at the prepacing beat to 1860 ± 665, 1935 ± 300
and 1815 ± 235 ms at the first, fifth and 30th beat after termination.
Repetition of the pacing train after 32 ± 9 beats was performed in 15/20 TdP. A positive
response i.e. reinitiation of TdP was evoked in 8/15 of the attempts (figure 3). In 5 other
attempts a maximum of 4 ectopic beats were evoked, which did not meet our definition
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Table 2. Electrophysiologic parameters in relation to either successful rcinduction or failure to a induce
TdP
CL-IVR(ms) LVAPD(ms) RV APD (ms) AAPD (ms) EADs
First episode n=8 1810 ±295 455190 380 ± 70 70 ± 30 8/16
Rcinducible 1790 ±290 455 ± 75 385 ± 60 70 ± 35 7/16
First episode n=7 1965 ±220 445 + 85 370 ± 40 75 ± 65 5/14
Not rcinduciblc 1995 ± 150 420 ± 70* 370 ± 45 50 ± 40* 2/14
P<0.05 vs TdP first episode, same abbreviations as table 1.
of TdP. In table 2, the electrophysiological findings arc separated in two groups: 1)
Those showing reinduction of TdP and 2) those without rcinduction of TdP. Reinduc-
tion or TdP was characterized by values of LV APD. RV' APD, iniervenrriiular AAPD
and presence of EADs similar to those of the first episode of TdP. The non rcinduciblc
group had a shorter LV APD (445 ± 85 vs 420 ± 70 ms. P<0.05), similar RV APD. a
lower incidence of EADs and a significantly smaller interventricular AAPD than when
the TdP could be induced.
The influence of the duration of the TdP was studied with a comparison between short
episodes (< 10 beats) and long episodes (> 10 beats). The CL-IVR, LV API) and
interventricular AAPD before TdP were similar. Termination of TdP occurred when
the LV APD was ± 250 ms irrespective of duration. Also the reoccurrence of EADs in
the first beats after termination and their subsequent disappearance were similar in both
groups.
AAPD
O/*£/1.DJ." In general after spontaneous termination all EADs disappeared.
However the temporal behavior for their disappearance in the dogs was different.
Moreover within dogs the response of the LV and RV is different in time (see e.g figure
2-3). The EAD of the left ventricle disappeared after a mean of 5 beats (range 2-9) and
that of the right ventricle after 3 beats (range 2-5).
The presence of EADs was diminished from 23/40 (LV:12, RV:11) in beat 1 to 9/40
(6 LV, 3 RV) in beat 5. In table 3, four different situations are compared between beat
1 and beat 5: 1) Total absence of EADs in the first and 5th beat (n=3), 2) Total
disappearance of the EAD in the left and/or right ventricle (n=10). Irrespective of the
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Table 3. Relation between the presence and or disappearance of EADs with the amount of AAPD in beat
1 to 5 after spontaneous TdP termination
AAPD beat 1 AAPD beat 5 difference (ms)
1) Absence of EADs (n-3) 30 ± 50 ms 30 ± 25 ms 0 (0%)
2) local disappearance of all EADs (n«IO) 50 ± 50 ms 35 ± 15 ms 15(30%)
3) Disappearance ofLV EADs (n-7) 80 ± 45 ms 40 ± 10 ms 40(50%)
4) Continued presence of LV EADs (n=6) 80145 ms 80 ± 45 ms 0(0%)
lor abbreviations see table 1.
behavior of the FAD in the right ventricle we scored 3) Disappearance of the EAD in
the left ventricle (n=7), or 4) Persistence of LV EADs (n=6).
When the EADs disappeared (group 2 and 3) we calculated that EADs contribute 30
to 50% to the interventricular AAPD (table 3). In both other instances no change in
iniervent rkular AAPD was observed. In the 1 5 episodes of table 2, EADs reappeared in
9 MAIN. Ilic reappearance of the LV EAD increased the interventricular AAPD from
75 ± 55 to 120 ± 55 ms (45/120= 35%).
l9lr«r/rmr ry/f/f/'Af: Paced CL was I 750 ± 390 ms. During the administration of
</-sotalol the APD of both ventricles significantly increased from 420 ± 45 to 495 ± 65
ms (LV) and 355 ± 30 to 420 ± 35 ms (RV). In 4/6 experiments EADs developed (LV
EADs: 4 and RV EADs: 1). In the experiments with appearance of EADs, the inter-
ventricular AAPD increased significantly with approximately 40% from 65 ± 40 to 90
± 40 ms, whereas in the 2 experiments without appearance of EADs no change in
interventricular AAPD occurred.
DISCUSSION
In this study self terminating TdP was analyzed to 1) obtain further knowledge about
the mechanism of termination and thereby also of the mechanism of continuation of
TdP. And 2) to address the relationship between EADs and interventricular AAPD.
Termination of acquired TdP is associated with a decreased incidence of EADs and a
decreased interventricular AAPD, while (re)induction is associated with the presence of
EADs and an increased interventricular AAPD. Although EADs and interventricular
AAPD are bradycardia dependent, EADs contribute significantly (35%) to inter-
ventricular AAPD.
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Triggered activity based on EADs is generally considered to be the initiating mechanism
of TdP (4,5.7-10,14,17). In our animal model of TdP the occurrence of EADs or
triggered ectopic beats after </-sotalol administration occur also in non inducible
experiments and seems therefore not to be sufficient to initiate TdP (6). We and others
suggested that besides EADs, TdP induction requires the presence of a critical amount
of interventricular AAPD (8,18,19), caused by regional differences in repolari/ation,
which are possibly accentuated by abrupt frequency changes.
At baseline, EADs are absent, while interventricular AAPD is relatively small. Abrupt
frequency changes (by using PES) do not result in TdP. Class III agents induce EADs,
increase interventricular AAPD and TdP can now be induced by sudden frequency
changes, which may either occur spontaneously (SLS sequence) or can be induced by
the use of PES. Occurrence of (spontaneous) TdP is associated with a large inter-
ventricular AAPD and presence of EADs and ectopic beats (8,20).
In this study, confirmation of the involvement of both parameters came in the attempts
to reinduce TdP. Reinduction was only possible when EADs and interventricular AAPD
had returned to their original values. In addition, suppression of EADs and diminish-
ment of interventricular AAPD by drugs (i.e. MgSO4 or flunari/ine) prevents spon-
taneous and/or_pacing induced TdP (8.21).
By definition a decrease in cycle length (e.g. by a tachycardia), will decrease EADs, APD
(5,7-10,12,13) and the interventricular AAPD (8). The disappearance of EADs and the
marked shortening of the (A)APD at spontaneous termination are therefore in line with
the effect of the increased rate. In this animal model around 60% of the total shortening
of the APD takes place in the first 20 beats after an increase in rate (22).
Spontaneous termination indicates the impossibility to continue the arrhythmia. The
mechanism of termination might give more insight about the electrophysiological
changes responsible for continuation. The last beat of the TdP is devoid of EADs and
the interventricular AAPD is small. The time of disappearance is not known because the
MAP recording does not allow analysis during the TdP. Because the duration of TdP
episodes varies (in clinical circumstances TdP can last over 1 minute (23,24), other
factors than EADs and AAPD can be involved in the continuation and eventual
termination of TdP. Also the time point at which TdP deteriorated into ventricular
fibrillation is different. Because VF is based on a reentrant mechanism (25) there is a
strong indication that other mechanisms can be responsible for continuation.
This is also suggested by in vitro and computer models proofing the existence of a
reentrant mechanism (e.g. 26,27). However mapping data obtained in vivo demonstrate
focal activity (28,29) as possible mechanism of continuation. This point is not yet settled
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and additional experiments should be performed e.g. using multiple transmuraJ MAP
electrodes. This would enable to investigate transmural, inter- and intraventricular
differences in repolarization and the formation (and triggering) of local EADs.
EADs and AAPD arc both present in the first beat post termination. The (re)appearance
of EAD might be caused by the sudden deceleration of the rate. As we and other have
shown sudden rate changes can lead to pronunciation of (the amplitude of) EADs (7,30).
In the following beats the EAD disappears concomitantly with the AAPD. The APD
(independent of EADs) shortens, which might be a delayed compensation for the fast
rate of the TdP. Thereafter APD starts to increase to pre TdP levels. A similar APD
behavior has been described in humans after an abrupt deceleration in rate (11).
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Discrimination between FADs and AAPD in the genesis of TdP is difficult because both
are bradycardia dependent (8,13,17,31). Already at baseline without EADs, at a CL-IVR
of 1650 ms, there is a difference berween I.V and RV APD of approximately 40 ms. At
longer ( '1. this AAPD increases (8,15). This frequency dependence of intervcntricular
dispersion is also observed in vitro: left ventricular cells demonstrate a longer APD than
the right ventricle .u slow heart rates. I his not only the case for endocardial (and
cpicardial) cells but also and even more pronounced for the recently described M cells
(32). At 2000 ms this leads to a AAPD of about 100 ms (figure 4 of reference 32) without
the presence of action potential prolonging drugs. The presence of EADs can further
increase AAPD. The M cell behaves like a Purkinje fiber in the aspects of rate dependent
APD behavior and their sensitivity to develop EADs (14). However Purkinje fibers do
not contribute much to the MAP signal due to their small mass (30-33). Because M
cells are found throughout the left, right and in the ventricle septum (34), their mass
could be sufficient to be registered by the M APs. In the intact canine heart, EADs arising
from the M cells have been also described (35). The combination of EADs and increase
in Cl. contribute both to the observed increase in AAPD after class III agents.
In the literature several arguments are in favor of a contribution of the EAD to the
AAPD. 1) The longest APD is often the one with the most pronounced EAD (18,19).
Site specific EADs could therefore contribute to inter- but also to intraventricular
AAPD. 2) Magnesium suppresses the EADs and decreases AAPD despite an increase in
CL-IVR(8). *
In this study the disappearance of EADs after spontaneous termination is associated with
a decrease in AAPD while (reappearance of EADs corresponds to an increase of AAPD
(figures 2,3,4). An estimation of the contribution of EADs to AAPD is only possible
without changes in cycle length. We calculated the contribution of the EAD to the
AAPD to be between 25 to 50%.
There are some limitations to this estimate: 1) random placement of the MAPs might
fail to detect all EADs, 2) the LV and RV' do not seem to behave synchronously (figure
Chapters
2-4). This dynamicity alters AAPD from beat to beat, and 3) the role of the RV EAD
in AAPD is not clear. Presence of EADs in both ventricles is not associated with a smaller
AAPD (see e.g. figure 2-3). A possible explanation for this apparent contradiction could
be the difference in baseline values. It is likely that EADs will develop earlier in longer
APDs. The RV EAD development will therefore lag behind the LV EAD. If the LV
EAD still grows when the RV EAD occurs the value of the AAPD will be maintained,
only when the LV EAD has reached its maximum value the contribution of the RV
EAD to APD will alter AAPD.
A fourth point are the small variations in CL-1VR and QRS complexes after termination,
which might have influenced the behavior of EADs and AAPD by different activation
times and rate. However the contribution of EADs to AAPD was confirmed in the steady
state pacing experiments with ^/-sotalol, where both activation time and rate are constant.
Another important fact is that the experiments are performed in dogs with chronic AV
block. Chronic AV block leads to biventricular hypertrophy due to volume overload
(15) and may play a role in the occurrence of EADs and the magnitude of AAPD. It has
been described that ventricular hypertrophy facilitates the induction of EADs (9). The
effect of hypertrophy on EADs and AAPD requires further investigation.
In conclusion the fast rate of the TdP reduces EADs and interventricular AAPD,
concomitant with termination of the TdP. Besides their role in the initiation this
indicates an important role for as well EADs as AAPD in the mechanism of continuation
of TdP. EADs provide an essential contribution (25-50%) to the changes in inter-
ventricular AAPD, as evidenced by the behavior of EADs and AAPD after spontaneous
termination and after administration of class 111 agents at paced cycle lengths.
The Bakken Research Center (Medtronic), Maastricht, the Netherlands provided the
epicardial electrodes. ASTRA, Gotenburg, Sweden, (dr L. Carlsson) supplied us with
almokalant and Bristol Meyers Squibb, Brussels, Belgium with ^-sotalol.
This study was supported by a grant of the Netherlands Heart Foundation (#91.104
and #94.010).
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ABSTRACT
Ryanodine, a specific blocker of the Ca^* release channel of the sarcoplasmic reticulum,
and flunari/.inc, a [Ca^*)j overload blocker, possess antiarrhythmic effects against
delayed afterdepolarizations (DADs) and DAD dependent arrhythmias. In vitro con-
troversy exists about their effect against early afterdepolarizations (EADs): no effect was
reported against cesium induced EADs, while ryanodine did prevent EADs induced by
isoproterenol.
C%«7/p«; To study the possible role of intracellular Ca^* overload in acquired EAD
dependent Torsadc de Pointes arrhythmias (TdP), we tested the effects of flunarizine
and ryanodine in our animal model of TdP. A/rt/Wf: Anaesthetized dogs with chronic
AV block received </-sotalol or almokalant followed by pacing. A subset of dogs with
reproducible TdP (> 3 times) were selected to receive flunarizine (2 mg/kg/ 2 min) or
ryanodine (10 (ig/kg/10 min). /tow/ft: After </-sotalol, TdP was induced at a mean cycle
length of the idioventricular rhythm (CL-IVR) of 2070 ± 635 ms and a QT(U) time of
535 ± 65 ms. Induction of TdP was prevented by flunarizine in all experiments (8/8),
electrophysiologically this was associated with a decrease in CL-IVR, QT(U) and QT,-
time (390 ± 100 to 320 ± 45, P<0.05). Ryanodine prevented TdP induction in 4/5
experiments, and decreased the CL-IVR, QT(U) and the QT<- time from 385 ± 75 to
320 ± 20 ms (P<().()5). Both drugs also suppressed the almokalant induced EADs and
related ectopic activity. This antiarrhythmic action corresponded with the inability to
rcinduce TdP by pacing. C«wi"/wj/'o;«: Blockade of the Ca~* release channel of the
sarcoplasmic reticulum by ryanodine or the reduction of [Ca-*]j overload by flunarizine
prevents induction of EAD dependent acquired TdP arrhythmias, suggesting a role for
|Ca-*|j overload in acquired Torsade de Pointes.
INTRODUCTION
Over the years, Torsade de Pointes arrhythmias (TdP) have attracted the interest of
many investigators. However, several questions are still unresolved or a matter of
controversy, including 1) the mechanism(s) responsible for the initiation and perpetua-
tion of TdP, tor which dispersion of repolarization and/or early atterdepolarizations
(IADs) have been suggested (1). 2) The transmembrane currents by which TdP can be
generated. It has been shown that TdP (or EADs) can be evoked under different
circumstances and by several drugs (2-11). all prolonging action potential duration. 3)
The involvement of intracellular Ca~* transients (9,12,13). It was first suggested by
Capogrossi and Lakatta (12), that spontaneous Ca^* oscillations are the common basis
of EADs and delayed afterdepolarizations (DADs). Experimentally this has been con-
firmed in situations of |Ca-*]j overload (9,13.14). Pharmaceutical interventions directed
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to reduce the [Ca-*]j-overload will suppress DADs and perhaps EADs and their
arrhythmias.
Ryanodine, a blocker of the Ca~* release channel or the sarcoplasmic reticulum (SR) is
known to suppress DAD dependent tachyarrhythmias both in vivo (15.16,17) and in
vitro (18). Its effects on EADs is somewhat controversial: in vitro no effect was seen in
cesium induced EADs (18) whereas it suppressed isoprotcrenol induced EADs (9).
Similar results have been documented for the (Ca-*]j overload blocker tlun.iri/inc.
Flunarizine prevented the development of DADs caused by ouabain and/or
cathecholamines in vitro (19) and stopped and prevented ouabain induced tachycardia
in the intact dog heart (17). Flunarizine has been reported not to influence cesium
induced EADs in Purkinje fibers (19).
No studies are available on the antiarrhythmic effect of ryanodine and Hunari/inc on
EADs and EAD dependent arrhythmias in the intact heart. Therefore we tested these
drugs in our animal model of acquired EAD dependent Torsade de Pointes arrhythmias
(20). Secondly, because the exact mechanism of action of flunari/ine is still unknown,
this study also allowed a comparison between the mode of action of flunari/inc and
ryanodine.
METHODS
All experiments were performed according to the principles of the American Physiologi-
cal Society and approved by the Committee for Experiments on Animals of the
University of Limburg, Maastricht, the Netherlands.
The experiments (n=17) were performed on 11 anaesthetized adult mongrel dogs with
chronic AV block (9 ± 6 weeks) of either sex with a body weight between 1 8 and 32 kg.
In between the AV block operation and the experiment, dogs were daily checked whether
their idioventricular rate was sufficient to obtain adequate cardiac output.
Each dog had two epicardial electrodes (Bakken Research Center, Medtronic,
Maastricht, The Netherlands) implanted at the apex of the left ventricle and at the base
of the right ventricle, when a right sided thoracotomy was performed to produce a
chronic AV block (21).
Pacing was done with a programmable stimulator capable of pacing synchronously to
the QRS complexes. Unipolar stimuli were given using a pulse width of 2 ms and a
stimulus strength of twice diastolic threshold. As indifferent electrode a needle was
placed through the skin. Six surface electrocardiographic leads were registered and stored
on optical disc. All drugs were administered through a canula in the cephalic vein.
Anaesthesia was induced by 1) premedication i.m. (1 ml/5 kg: 10 mg oxycodon, 1 mg
acepromazine and 0.5 mg atropine) and 2) sodium pentobarbital (20 mg/kg i.v.) The
dogs were artificially ventilated through a cuffed endotracheal tube using a mixture of
oxygen, nitrous oxide and halothane (vapor concentration 0.5%) by a respirator.
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Ventilation was controlled by continuous reading of the carbon dioxide concentration
in the expired air. A thermal mattress was used to maintain adequate body temperature.
Proper care was taken before and after the experiments, including antibiotics (1000 mg
ampicillin) and analgesics (0.1 mg i.m. buprenorfine). A temporary ventricular
pacemaker (maximum of 24 hours) was given after the AV block operation and after
the experiments.
A detailed description of the Torsade de Pointes protocol is given elsewhere (20). In
short, anesthetized animals with chronic AV block received two defibrillation patches
that were attached to both sides of the chest and connected with a defibrillator. Half an
hour after onset of anaesthesia, pacing was done from the epicardial electrode and
consisted of three different pacing modes: 1) short long short sequences and 2) 8 basic
stimuli followed by an extrastimulus and 3) 3 basic stimuli. The intersrimulus interval
was 400, 600 or I 200 ms, the extrastimulus interval shortened from 500 ms in steps of
40 nis until the ventricular effective refractory period was reached. After completing the
pacing protocol, </-sotalol (2 mg/kg/5 min) or almokalant (0.12 mg/kg/10 min) was
administered, facing was resumed 10 minutes after the start of the injection. A Torsade
de Pointes arrhythmia was defined as a polymorphic ventricular tachycardia consisting
of > 5 beats, which twisted around its baseline in the presence of a prolonged QT(U)
duration. When TdP did not stop spontaneously within 10 seconds or deteriorated into
ventricular fibrillation, cardioversion (60-70 J) was performed.
liulucibility was defined as the initiation of TdP 3 or more times using the same pacing
mode, l.arlier experiments have proven that the electrophysiological and pro-arrhythmic
effects of a single intravenous bolus of </-sotalol and almokalant last for at least 60
minutes (20,22). In 3 experiments (flunari/ine n=2, ryanodine n=l) a second bolus of
^/-sotalol or rtV-sotalol was needed to provide reproducible inducible TdP. In subsequent
experiments, in two of these three dogs induction was repeated consistently after the
second bolus to also test this reproducibility in time.
Reproducible inducible TdP experiments were selected to test the preventive effect of
flunari/ine (2 mg/kg/2 min) and ryanodine (10 Ug/kg/10 min). Both drugs were
administered within 45 minutes after the last bolus of r/-sotalol, and within 20 minutes
after almokalant. Five minutes (flunarizine) and 10 minutes (ryanodine) after the start
of the injection the pacing train(s) which initiated the TdP was (were) repeated.
Both flunari/ine and ryanodinc are known to decrease blood pressure (16,23,24), due
to their vasodilator)' effects and/or negative inotropic effects. This blood pressure drop
may lead to a reflex tachycardia. Because an increased ventricular rate may protect against
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TdP induction (20), we performed for both drugs experiments in which the basic heart
rate was kept constant by pacing. In case of ryanodine, TdP induction was attempted
with the use of a basic ventricular paced rhythm of 2000 ms during two entire
experiments (</-sotalol and almokalant), because the Cl.-IVR of the dogs was very slow
( ± 2200 ms). With flunarizine, TdP induction was attempted for «/-sotalol both at 1VR
(1320 ms) and at the "expected" CL after flunarizine (1100 ms), and at a basic ventricular
rhythm of 2000 ms for almokalant. In one experiment TdP was induced by administra-
tion of <//-sotalol instead of «/-sotalol, so that the acceleration of ventricular rate by
flunarizine would be prevented by (J blockade.
In 8 of these animals electrolyte levels were measured after complete anesthesia was
installed. To exclude changes in electrolytes by drugs, or due to cardiovcrsion, we
measured electrolytes in 2/8 dogs at two other time points: namely after induction of
TdP (with and without the necessity to cardiovert) and after administration of
flunarizine or ryanodine.
Electrophysiological measurements of cycle length of the idioventricular rhythm (CL-
IVR) and QT(U) time were performed before and after the administration of <Y-sotalol,
almokalant and the two drugs. The QT^ time was calculated using the formula of Bazett
(25).
To review the direct effects of ryanodine and flunarizine on the presence of EADs, a
monophasic action potential catheter (MAP) was placed in the right ventricle to visualize
action potential duration (APD) and EADs in 5 experiments after ^-sotalol. The MAP
(Franz combination catheter, EPT # 1650) was placed under fluoroscopy through the
jugular vein. The MAP was amplified by a DC-coupled differential amplifier, which is
provided with a 20 mV calibration pulse. The MAP signals were sampled at a rate of 1
KHz. The recording sites were chosen based on stability, quality of the signal and an
amplitude which had to exceed 15 mV (20).
In the first experiments (n=3), we had difficulties to maintain a stable MAP throughout
the duration of the experiment (± 1 20 minutes). Although this problem is now resolved,
it is often difficult to visualize clearly distinguishable EADs after «/-sotalol in the right
ventricle (see also ref #20). Therefore we used a second class III drug: almokalant of
which the prevalence of endocardial EADs is higher than after ^-sotalol (22).
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Statistical significant differences (P<0.05), were calculated with the use of a paired
student /-test. All values are given as mean ± SD.
RESULTS
In our animal model of 1 dP, the combination of bradycardia, ^-sotalol and pacing
results in reproducible TdP in about 50% of the experiments (20). A second bolus of
d'-sotalol increases this figure to almost 90%. Administration of almokalant results in ±
80% of the animals in reproducible TdP (22).
Fifteen induciblc experiments (n= 13 with </-sotalol) in 11 dogs were selected to test the
preventive antiarrhythmic activity of ryanodine (n=6) and flunarizine (n=9). Animals
tested twice had I) different pacing modes tested in the subsequent experiments (n=2),
or 2) dl-sotalol instead of //-sotalol to provide P blockade (n=l). Identical responses to
fV-sotalol were observed in these dogs indicating a high reproducibiliry of this animal
model.
e/-Sotalol prolonged the CL-IVR from 1830 ± 510 to 2070 ± 635 ms (P<0.01) and the
QT(U) time from 445 ± 60 to 535 ± 65 ms (P<().()1). </-Sotalol administration was
often accompanied by a change in the TU wave configuration. In one experiment next
to pacing induced TdP, some episodes of spontaneous TdP were seen. In figure 1, a
representative example of pacing induced TdP is presented.
Administration of almokalant (n=2) resulted in the presence of stable EADs (figure 2,
panel 2). Moreover, spontaneous and pacing induced TdP were seen. TdP induction by
almokalant is alike /^-sotalol characterized by an increased CL-IVR, Q T time and change
in Q T morphology (22).
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Application of cardioversion in order to terminate the TdP did not influence the
reproducible induction of the TdP. Also after a second bolus ofV-sotalol, TdP induction
remained reproducible until 60 minutes after administration.
Administration of flunarizine did not alter COi values of the capnograph indicative that
no major hemodynamic changes occurred by flunarizine. In table 1, the time dependent
effects of </-sotalol and flunarizine (n=7) are summarized. Following the bolus of
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Figure 1. Induction of a Torsade de Pointes arrhythmia by «/-sotalol and pacing.
A six lead ECG at a paper speed of 25 mm/s is shown. In the upper panel two QRS morphologies can be
seen, one before and one complex after pacing. In control conditions (panel 1) pacing (400/800 and an
extra of 340) ms does not result in ectopic activity (stimulated beats are indicated by an S). In this animal
the stimuli were given via a bipolar endocardially located catheter in the right ventricle and not by the
epicardial electrode as done in all other experiments. rf-Sotalol (panel 2) increases the Cl.-IVR and the QT
time. The same pacing train results in a self terminating TdP.
«a'-sotalol, its electrophysiologic effects diminished over time. Therefore we added a
second 'control' measurement (C2), just before the start of flunarizine (29 ± 12 min
after ^/-sotalol). There were no differences in the electrophysiological values at 10
minutes after */-sotalol compared to C2. Flunarizine decreased the CL-IVR (18%) and
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Table 1.
CL-IVR
QT
Effects of ^-sotalol
Cl
1715
435
345
±
±
±
595
60
70
and flunarizine on
dS
2030
540
395
±
±
±
780'
50'
55'
elect rophysiological
C2
1940
525
390
± 580
± 75
± 100
parameters (n=7)
F2
1760
440
340
±
±
±
485
65
55
F10
1595
395
320
±
±
±
380"
55"
45"
P<0.05 vs C l , P<0.05 vj C2; Cl : control values before administration of d'-sotalol. C2: value before
the administration of flunarizine (29±12 minutes after «/-soiaiol), dS: values at 10 minutes after the start
of V-«>i.ilol .id ministration, F2: values at the end of the bolus flunarizine, F10: 10 minutes after flunarizine
administration.
QT(U) time (25%). The latter was more pronounced than could be expected from the
decrease in CI.-IVR, as expressed by the decrease in QT<- from 390 ± 100 to 320 ± 45
(P<().05). Width of the QRS complex did not change after flunarizine.
Administration ol flunari/.inc after almokalant had similar effects: shortening of the
QT(U) time, normalization of the TU wave and furthermore suppression of the EADs
(figure 2). All parameters at 5 minutes were again comparable with the control situation
before almokalant (figure 2). llunari/ine prevented pacing induced episodes of Torsade
de Pointes in all experiments (9/9, </-sotalol and almokalant), as can be seen in figure 3.
Hiinarizinc also suppressed runs of ectopic beats in the two animals with spontaneous
TdP (n=l (7-sotalol, n=1 almokalant, data not shown).
The preventive effect of tlunarizinc was independent of the decrease in CL-IVR. This
could be seen in the experiments where a paced basic rhythm was used, and further when
we analyzed the individual data: 2 experiments did not show rate acceleration after
flun.iii/me. In one of these two experiments this was due to P blockade by dl-sotalol.
The amiarrhythmic effect of flunari/ine lasted at least 30 minutes. ThereafterTdP could
be reinduced in 2 experiments. Besides these elcctrophysiological effects, flunarizine had
also distinct effects on the configuration of the TU wave in all experiments; after
flunarizine administration the U wave disappeared or the T wave became more peaked
suggesting a more homogeneous repolari/.ation of the ventricles. This was also present
in a dog that showed repolarization disturbances already during and directly after pacing
under control conditions (figures 4-5).
Ryanodine had no effect on the CO-> values of the capnograph. Ryanodine was
administered at 3(> ± 19 minutes after «/-sotalol (C2). Again there was no difference in
electrophysiologic parameters between C2 and 10 minutes after </-sotalol. Ryanodine
decreased the QT(U) time and did not significantly affect the CL-IVR at the end of the
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Figure 2. Development of EADs after almokalant and suppression ot F.ADs by
flunarizine.
Lead II of the normal surface ECG and a monophasic action potential recording
(MAP) at a paper speed of 25 mm/s are shown. In panel I, the control situation is
depicted: a ventricular paced rhythm of 2010 ms and a QT time of 455 ms can be
seen. Just before the administration of flunarizine (2 mg/kg/2), almokalant (0.12
mg/kg) has increased the QT time and APD, has changed the QT morphology and
has led to EADs (arrows, panel 2). At the end of the bolus flunarizinc (panel 3), the
QT and the APD has been shortened to 505 ms and 540 ms but an EAD is still
present. At 5 minutes after flunarizine the EAD has completely disappeared and the
QT and the APD have been further reduced (panel 4).
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Figure J. Induction of TdP after almolulam and prevention by flunarizinc.
Same experiment and abbreviations as figure 2. A three lead ECCi is depicted with a MAP recording. There
>'.> .»•.'•'J iwu.,..»m |MIVU' .muiiui 'di II'IH/IIII i r t i w ins. rtiiuoiUl'aiu ru.s ltd u> a prolonged >.j 1 time ot 0U0
ms .ind appearance of F'.APs (indicated by arrow). Pacing (a short cycle of 600, followed by .1 pause of 1200
and .in extrastimulus S00 ms) results in the induction of a TdP (panel 1). Note that the last extrastimulus
docs not capture and that an ectopic beat initiates the TdP. Administration of flunarizinc shortens the QT,
normalizes TU morphology and causes disappearance of the KADs. Repetition of the same pacing train
now docs not lead to induction ol TdP.
infusion (10 minutes). At 15 minutes both QT(U) time (23%) and CL-IVR (20%) were
however significantly reduced (table 2).
Ryanodine prevented pacing dependent TdP successfully in 4/5 dogs after </-sotalol. In
the one experiment with almokalant ryanodine prevented spontaneous TdP by a
decrease in APD and a suppression of EADs, starting from the 8th minute after start of
the infusion.
The effect of ryanodine cannot only be attributed to the acceleration in rhythm, as seen
from the Q'1\. and in the experiments with a constant paced rhythm in which it was also
effective. The effect of both ryanodine and flunarizine seems therefore to be dependent
on the (more pronounced) decrease in QT(<-) time. No reoccurrences of the TdP were
observed after the preventive effect of ryanodine.
In one dog ryanodine administration after //-sotalol did not prevent TdP. In that
experiment even a spontaneous TdP occurred during administration of ryanodine
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Figure 4. Occurrence of pacing induced negative T waves under baseline conditions.
One ECG lead at a paper speed of 25 mm/s is shown. Pacing under control conditions reveals repolarization
disturbances as seen by: 1) the development of a deep TU wave during and after pacing; and 2) the
occurrence of two spontaneous ectopic beats in the pacing train. The altered TU wave morphology
postpacing is disappearing in time (continuous tracing).
(figure 6). During /^-sotalol the use of a pacing train was always necessary to initiate the
TdP. The spontaneous TdP at 7 minutes after the start of the bolus points to a possible
agonistic effect of ryanodine at low concentrations. Repetition of the pacing protocol
after 10, 30 and 40 minutes however still resulted in the induction of TdP. With the
exception of a longer Cl-IVR, there were no electrophysiological differences found in
this animal in comparison with the other animals.
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Figure 5. Honiogcni/ation of rcpolarization under baseline conditions by flunarizine.
Administration of tlunari/ine (panel 1) in the experiment of figure 4 prevents the development of the deep
TU wave during anil after pacing, liirtherniore no spontaneous activity arises during the pacing train. At
6S minutes atlei Iliinari/ine (panel 2) the eflcct of tlunarizine is diminished. The pacing train again leads
to the development of negative TU waves post pacing, although they are present tor a shorter time post
pacing as at control (see figure 4). No ectopic activity is seen.
All tested animals had normal electrolyte levels, mean potassium and magnesium level
were 4.2 ± 0.54 mmol/l. and 0.81 ± 0.05 mmol/L respectively. Administration of
«/-sotalol/ almokalant, tlunarizine/ryanodine or cardioversion did not change the level
ofanv of'the electrolytes.
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Table 2. Effects of </-sotalol and ryanodine on elccirophvsiological parameters ln«5)
CL-IVR
QT
Cl
1965
320
±
±
±
400
65
30
dS
2175
530
365
±
±
±
485'
80*
50"
C2
2015
540
385
±
±
±
345
90
75
R10
19.M)
490
360
±
±
±
430
S5
60
R15
1620
415
320
±
±
±
220"
20"
20"
" P<0.05 vs C l , P<0.05 vs C2; Cl : control values before administration of </-sotalol. C2: v»luc before
the administration of ryanodine (36 1 19 min after </-sotalol). dS: values at 10 minutes liter the start of
l administration, R10: values at the end of the bolus ryanodine. R15: IS minutes after ry.inodine.
Figure 6. Development ot a spontaneous TdP ahcr ryanodine.
Three ECG leads at a paper speed of l()mm/s are shown. Just before administration of ryanodine a slow
rhythm (CL-IVR: 2345 ms) with a prolonged QT interval of 635 ms and very deep T waves during//-sotalol
(panel I).
Ryanodine (lO(ig/kg) is administered in 10 minutes. At 7 minutes after the start of ryanodine infusion
(panel 2) the CL-IVR increases to 2510 ms, the T wave becomes less negative although the Q I' time is not
altered. Interruption of the IVR by a spontaneous beat initiates a TdP. This episode ot TdP requires
cardioversion because it did not stop spontaneously within 10 seconds. After this episode ot TdP
spontaneous ectopic activity remains present in the form of single ectopic beats or short runs (panels 3 and
4). Note that the T wave changes after ryanodine and is completely positive at 9 minutes.
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DISCUSSION
Induction of EAD dependent acquired Torsade de Pointes arrhythmias was prevented
by administration of ryanodine and flunarizine. The prevention of TdP was associated
with a normalization of repolarization as evidenced by a decrease in QT(U)(,~) time
following both drugs. Because both drugs decrease intracellular Ca~*. their inhibition
of EADs and preventive action against TdP points to the involvement of [Ca~*];
overload and/or intracellular Ca^* dyshandling in the initiating mechanism of TdP.
Our animal model of acquired pacing dependent Torsade de Pointes arrhythmias has a
high and reproducible incidence of TdP (20). In half or the experiments /^-sotalol
administration gives rise to spontaneous ectopic beats, whereas "spontaneous" TdP
occurs in approximately 10% of the experiments. Abrupt frequency changes induced by
pacing, result in about 50% of the experiments in reproducible TdP. The incidence can
be increased to 90% with a second dose. Dogs which show spontaneous TdP always had
inducible TdP by pacing (20). The ability to induce TdP reproducibly is present for
aboui 60 minutes (20,22), which allows testing of (pharmaceutical) interventions aimed
to prevent ihe arrhythmia. Turther proof for this observation comes from the reinduc-
tion of TdP in two experiments after flunarizine.
The TdP periods are related to bradycardia, a prolonged QT(U) time and the presence
of EADs (figures 4-5, 20). These EADs are accentuated by pacing and their ectopic beats
often interrupt the pacing train.
Our experience with </-sotalol to record EADs using the MAP at the time of these
experiments prohibited visualization of the effects of flunarizine and ryanodine on
EADs. Because we know that .ilmokalant, also a 1^ blocker, leads to more pro
arrhythmogenic responses and shows (at random placement of the MAP) more
(pronounced) EADs than </-sotalol (22), we added this drug. Unfortunately we could
not establish in these experiments a direct link between the EAD and the start of the
TdP (figure 3) as we have done before. The ability to record triggering EADs depends
on the good fortune to place the MAP catheter (already during control) close to the site
of origin of the (later developing) EADs (as e.g. in the observations during the
development of this model, figure 4 of ref # 20). Replacing the catheter is time
consuming and was not judged to fall within the scope of this investigation. New
experiments are currently performed in which we study the site specificity of EADs in
the right and also in the left ventricle.
None of the interventions performed during the study led to a change in electrolyte
levels. Also there were no major hemodynamic changes during the experiment place as
evidenced by the stable CO i values registered by the capnograph. Although we are aware
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that this is a crude measurement. Therefore we do not consider it likely that electrolyte
or hemodynamic changes contribute to the prevention of TdP.
Ryanodine inhibits the Ca^* release channel of the sarcoplasmic reticulum (26,27). A
dose of 10 |ig/kg was effective to suppress ouabain induced tachycardias without
reaching toxic levels (15,16). Toxicity or ryanodine is dependent on the dose and the
infusion rate, that has to be slow enough to prevent death of the animals (15). During
a slow rate or infusion their will be a relatively long time with a low plasma concentration,
that may exert an agonistic effect on the Ca-* release (28) instead ot an antagonistic
effect. A low dose of ryanodine have been reported to enhance cesium induced ei. topic
activity (29). Therefore possible proarrhythmic responses can be anticipated during the
infusion time.
Flunarizine has proven to be effective both in vitro (19,30.31) and in vivo (17) against
DAD dependent arrhythmias caused by ouabain intoxication, llunari/ine is a very
specific drug to suppress triggered arrhythmias without affecting arrhythmias based on
abnormal automaticity or reentry (19,23,32).
The mechanism of flunarizine is not clear. A broad scala of mechanisms have been
proposed, which all involve regulation of intracellularCa . A possible mechanism could
be blockade of sodium entry (30), although flunarizine does not interfere with the TTX
sensitive Na* channels. The effect on sarcolcmmal Ca^* channels is low (33), and only
detected at high concentrations. Under physiologic conditions, ECG parameters repre-
senting different electrophysiological parameters did not show any changes after
flunarizine (23). Another possible mechanism of action is a direct effect on the SR, e.g.
the ryanodine sensitive Ca^* release channel or SR Ca^+ ATPase.
EADs can be caused by several interventions that prolong the action potential duration.
These include clinical drugs such as class la and class HI drugs (2-5,11,20) and
experimental drugs such as cesium (6,7,19,34), anthopleurine (8), and Bay K 8644 (10).
More recently isoprenaline has been found to induce EADs (9). The exact mechanism
of the EAD is unclear and can be different for the different substances.
EADs can be differentiated in early (phase 2) EADs and late (phase 3) EADs (6). Early
EADs are probably based on the Ca^+ entry trough the L-type Ca^+ channel (10,18),
because they are suppressed by the Ca^+ antagonist nitrendipine and potentiated by the
Ca^+ agonist Bay K 8644 (18). On the other hand late EADs, seem to depend on an
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increased intracellular Ca^* overload (9,13,14). That can be suppressed by ryanodine,
bcnzamil and low extra cellular Na* (9,34).
(Ca^*)j overload is an established cause of triggered arrhythmias based on DADs. It has
been suggested that spontaneous Ca~* oscillations are the common basis of both DADs
and specific (phase 3) EADs (9,12-14). The Ca^-overload related afterdepolarizations
could be induced by an inward Na* current e.g. via the Na*/Ca-* exchange (9,34),
and/or non inactivated Na* channels (3,7,35). Recent computer simulation confirmed
the possible role of both Na* current and Na*/Ca~* exchange (36) in the formation of
EADs. Therefore we used two drugs known to suppress DADs, to evaluate an effect of
diminished Ca'* overload in TdP.
The normalization of the repolarization, and the preventive effect of flunarizine and
ryanodine was independent of the increase in heart rate. The larter can be associated
with a reflex mechanism due to the negative hemodynamic or inotropic eftect of these
drugs (16,23,24). When we corrected the increase by the use of a paced rhythm (n=4),
or by P blockade using e//-sotalol (n=l), we saw similar preventive effects. Therefore it
seems th.it these drugs exert their antiarrhythmic effect by a direct effect on EADs and
APD. This is in contrast with the observation of others who describe that ryanodine
(18) and flunarizine (19) had no effect against cesium induced EADs in vitro. From
these findings Marban et al. draw the conclusion that involvement of [Ca-*]j overload
was less likely, and he emphasized the involvement of the Ca-* L type channel in the
genesis of EADs (18). However recent data with isoprenaline induced EADs and DADs
showed that they are caused by complex Ca"* transients which can be abolished by the
use of ryanodine (13). Therefore, it seems logic that the different ways to initiate EADs
also require different treatments. 'The EADs observed in our animal model (figures 2-3,
20) occur most frequently during phase 3 of the action potential similar to isoproterenol
induced EADs. 'These EADs were diminished and/or suppressed by flunarizine and
ryanodine, explaining the preventive action of flunarizine and ryanodine on pacing
induced TdP.
'The occurrence of a spontaneous 'TdP during the bolus of ryanodine may point to the
enhancement of the SR Ca-* channel by a low concentration of ryanodine (29). This is
an extra argument for a role of [Ca-*|j overload and or Ca~* dyshandling in the
mechanism of TdP.
A way to assess the mechanism of a drug is to compare it with drugs of known action.
Prevention of Torsade de Pointes arrhythmias, either induced by d-sotalol or al-
mokalant, was achieved by both drugs. Electrophysiologically the effects were similar.
/7S | Chapter 6
although flunarizine decreased the QT,. time more than ryanodinc. The fact that
flunarizine was effective in all dogs within 2 minutes, whereas ryanodinc took longer to
be effective and was ineffective in one experiment might point to an important
difference. This difference can be related to the possible agonistic effect of ryanodinc at
low concentrations (28) as seen in these experiments and by others (29). Another
confirmative observation was made recently in dogs, ryanodine caused an acceleration
ofouabain ventricular tachycardia before termination occurred (17). Although the data
of the present study gave a similar result of ryanodine and flunari/inc in suppressing
EADs and prevention of TdP, this does not imply that flunari/inc blocks the ryanodine
sensitive Ca~* release of the SR.
Zv'jw/Mft'o/M ö/V/v x/Wy
In this study we report that [Ca-*]j overload could play an important role in the
mechanism of acquired EAD dependent Tdl \ We come to this conclusion based on the
indirect effects of ryanodinc and flunari/inc. And although these drugs are very specific
to prevent [Ca-*]j overload and restore a normal Ca-* condition in the cell (19,26,27),
we did not measure Ca^* transients to prove [Ca^*)j overload in the generation of TdP.
The results of these animal experiments point to [Ca-*]| overload as playing a role in
the development of acquired TdP. This is suggested by the preventive effect of ryanodine
and flunarizine as well as by the occurrence of a spontaneous TdP after ryanodine.
We thank Prof, dr M. Borgers of Janssen Pharmaceutics, Beerse, Belgium for supplying
flunarizine, Mr H. Wiering and Mr C. Ketelaars, ASTRA, Rijswijk, the Netherlands for
providing almokalant and Mr J Verschuuren, Bristol Meyers Squibb, Brussels, Belgium
for providing </-sota!ol, and Bakken Research Center (Medtronic), Maastricht, the
Netherlands in providing the epicardial electrodes. This study was supported by a grant
from the Netherlands Heart Foundation (#91.104).
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ABSTRACT
We have reported that the combination of 2 mg/kg /^-sotalol (dS) and pacing results in
the reproducible induction of early afterdepolarization (EAD) dependent Torsade de
Pointes arrhythmias in 50% of anesthetized dogs with chronic complete AV block. The
AV block induced bradycardia accompanied by a volume overload causes biventricular
hypertrophy: left ventricle/body weight (LV/BW) increases from 4.3 ± 0.9 to 58 ± 0.9
g/kg and the RV/BW from 1.4 ± 0.4 to 2.6 ± 0.9 g/kg (P<0.05). Ventricular hypertrophy
is associated with prolongation of the action potential duration (APD) and sudden
death. What the contribution of the changes due to AV block are for the occurrence of
acquired 'f'dP is not known. In this model the effect of pacing and dS was therefore
tested twice: at the moment of AV block (n=9) and after 5 weeks of complete AV block
(n= 10). Five dogs were tested at both time points. Cycle length (CL) was kept constant
in both experiments. Monophasic actionpotcntial catheters were placed in the right (RV)
and the left ventricle (I.V) to record KADs, to measure actionpotcntial duration (APD),
dispersion of repolarization (AAPD: LV APD-RV APD), and the incidence of TdP.
/ W t t : At baseline: CL (1600 ± 280 ms), both the LV APD (295 ± 20 vs 390 ± 60 ms)
.nul UV AIM) (260 ± 20 vs 315 ± 10 ms) significantly increased after 5 weeks of AV
block (P<().()5). KADs were not seen and TdP was not induciblc at baseline. dS
administration increased APD significantly in both groups, but to a different degree.
There was a more pronounced increase in AAPD (40 ± 35 to 45 ± 30 vs 70 ± 30 to 125
± 65 ms) and more KADs at 5 weeks. No TdP could be induced after dS at 0 weeks,
whereas TdP occurred in 6/10 dogs at 5 weeks AV block.
C»Mf/««V;/«.' The changes occurring after chronic complete AV block increase the
arrhythmogenic effects of dS resulting in a higher incidence of TdP. This study also
emphasizes again the role of AAPD and KADs in the genesis of TdP.
INTRODUCTION
Left ventricular hypertrophy is a well known risk factor for sudden (arrhythmic) death
(1-4). This higher incidence of ventricular arrhythmias is independent of other factors
like coexisting coronary disease and/or heart failure (4,5). Cardiac hypertrophy can have
different etiologies, like pressure or volume overload (6,7) and may involve the left, the
right or both ventricles. Many studies have described the mechanical, structural and
biochemical alterations occurring in ventricular hypertrophy (e.g. 6-10). Much less
attention has been given, to the electrophysiological changes that occur in the hyper-
trophied myocardium (11). Independent of its cause, ventricular hypertrophy is as-
sociated with a lengthening of the transmembrane action potential duration (8). It has
been suggested that due to this lengthening of repolarization, early afterdepolarizations
(EADs) and triggered activity may occur in hypertrophy (2,11), and one may assume
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that EAD related Torsade de Pointes arrhythmias with the possibility of deterioration
into ventricular fibrillation could be a possible cause for sudden death (12). Other
pathological conditions such as fibrosis or ischemia, could also lead to arrhythmogenic
death based on other mechanisms like reentry or abnormal impulse formation.
In our animal model of acquired Torsade de Pointes arrhythmias (TdP), we have
reported the reproducible development of pacing induced TdP in 50% of the dogs after
administering a class III agent, d-sotalol (2 mg/kg, 13). These dogs were tested minimally
2 weeks after creation or complete atriovcntricular (AV) block. Other investigators using
a similar or higher dosage of (d)-sotalol (14,15) did not report the occurrence of
spontaneous TdP in dogs, when the experiments were carried out in the acute phase of
AV block.
Similar to clinical TdP (16), induction of TdP in our canine model depends on
bradycardia, prolonged API") and the development of EADs (13). Furthermore, we have
described that interventricular dispersion plays an essential role in the induction of TdP
(17).
Our first goal was to assess the structural and electrophysiologic processes, which take
place after the creation of complete AV block. Comparing dogs with normally conducted
sinus rhythm (SR) with chronic AV block (see results), we noticed that the AV block
dogs had 1) biventricular hypertrophy, and 2) prolonged repolari/ation parameters. The
role of these in the development of acquired TdP in our animal model is unknown and
was the subject of this study.
METHODS
The study protocol was approved by the Committee for Experiments on Animals of the
University of Limburg, Maastricht, the Netherlands and conducted in accordance with
the guidelines of the American Physiological Society.
The experiments were performed on 15 anesthetized adult mongrel dogs of cither sex
with a mean body weight of 25 ± 4 kg (range 20-41 kg). Anesthesia was induced by 1)
premedication i.m. (1 ml/5 kg: 10 mg oxycodon, 1 mg acepromazine and 0.5 mg
atropine) and 2) sodium pentobarbital (20 mg/kg i.v.). The dogs were artificially
ventilated through a cuffed endotracheal tube using a mixture of oxygen, nitrous oxide
and halothane (vapor concentration 0.5%-1%) by a respirator. Ventilation was control-
led by continuous reading of the carbon dioxide concentration in the expired air. A
thermal mattress was used to maintain adequate body temperature.
A right sided thoracotomy was performed 1) to implant an epicardial electrode (Bakken
Research Center, Medtronic, Maastricht, The Netherlands) at the apex of the left
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ventricle, and 2) to create complete AV block by injection of formaldehyde (37%) in
the AV node (18). Proper care was taken after the experiments, including antibiotics
(1000 mg ampicillin, pre and post operatively) and analgesics (0.1 cc/7 kg i.m.
buprenorfine).
All electrical stimulation was done from the left epicardial electrode with a custom build
programmable stimulator (University of Limburg), that delivers unipolar stimuli
synchronous to the QRS complexes, with a pulse of 2 ms and a stimulus strength of
twice the diastolic threshold. As indifferent electrode a needle was placed through the
skin.
Retrospective analysis consisted of a comparison between electrophysiological studies
obtained in dogs with normal conducted SR (n=18, 18-20) and in dogs with chronic
AV block (n- 'J, 13). In these experiments the ventricular effective refractory period
(VF.RP) was determined using the extrastimulus technique, after a basic train of 8 paced
stimuli with an interstimulus interval ranging between 250 and 600 ms. The coupling
interval of the- extrastimulus was shortened with 10 ms steps till refractoriness was
reached. The VI.RP was defined as the longest interval that did not capture. QT time
was measured in lead II of the ECG from the last five ventricular paced beats after 30
seconds of continuous pacing at a cycle length of 300 and 400 ms.
To assess the amount of hypertrophy due to the volume overload, the heart weight was
determined in twenty of the dogs used for the above described electrophysiologic studies
(SR: n= 1 1. AV block: n=9). After a final experiment the hearts were excised, rinsed with
water and stored in a formaldehyde solution for at least 2 weeks. The weight of the total
heart, right and left ventricle (including septum) was assessed and related to the body
weight. In addition, the heart weight was assessed in five dogs used in the prospective
limb of this study.
Animals were instrumented to investigate the response to «/-sotalol during spontaneous
idioventricuLu rhythm (1VR) at both time points: acute AV block and at 5 weeks of
chronic complete AV block. Directly after closure of the chest following creation of AV
block, MAP catheters were placed in both ventricles of 7 dogs. Thereafter the TdP
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induction protocol was performed (see farther). To avoid possible influences of the
preceding thoracotomy. four dogs received a ventricular (VV1) pacemaker immediately
after AV block. The pacemaker was programmed at a rate comparable to the former SR
and the dogs were scheduled to be tested three days later. Kach day an electrocardiogram
was registered to check pacemaker function. These dogs were again anesthetized, three
days after creation of AV' block and the endocardial MAP catheters were placed and the
W I pacemaker was switched off. In the presence of a stable 1VR (> S minutes), the TdP
protocol (see further) was performed. Unfortunately one ot these four dogs died before
the experiment could be carried out, and in another dog the AV node conduction
partially returned (2:1 AV block). These dogs were excluded, so that ') dogs were
evaluated for I dP induction in the acute phase of AV block.
In these experiments 7 dogs met the standards in respect to the quality of both MAPs
to ensure appropriate data sampling (7 x 2= 14 MAPs). These dogs were planned to be
retested 4-6 weeks later. Unfortunately one of them died, and in one dog we could not
record adequate MAP signals during the second experiment, i.e. five dogs could be
analyzed at both time points (table 3). To increase the number of dogs with chronic AV
block, we added 4 consecutive dogs that were only tested at 5 weeks of AV block. So
during chronic AV block 10 dogs were given <-/-sotalol, of which ') had adequate MAPs
for electrophysiological analysis (9 x 2=18 MAPs).
A detailed description of the TdP induction protocol is described elsewhere (13). In
short, anesthetized animals received two defibrillation patches that were attached to both
sides of the chest and connected with a defibrillator. Two different pacing modes were
used 1) short long short sequence, A) an interstimulus interval of 400 ms followed by
one of 800 ms and by an extrastimulus or B) four intervals of 600, followed by one of
1200 ms and an extra stimulus and 2) An 8+1 protocol with an interstimulus interval
of 600 ms followed by one extra stimulus (13). During both pacing modes the coupling
interval ot the extrastimulus was shortened from 500 to 300 ms in 50 ms steps. After
completing the pacing protocol, d-sotalol (2 mg/kg/5 min i.v.) was administered. The
pacing protocol was resumed 10 minutes after the start of the drug injection. A Torsade
de Pointes arrhythmia was defined as a polymorphic ventricular tachycardia consisting
of > 5 beats, which twisted around the baseline and occurring in the presence of a
prolonged QT(U) duration. A dog was called inducible when TdP could be induced >
3 times with the same pacing mode. When TdP did not terminate spontaneously within
10 seconds or when it deteriorated into ventricular fibrillation, cardioversion (60-70 J)
was performed.
Because pacing is necessary to induce TdP, we also paid careful attention in those dogs
tested twice to the development of EADs and ectopic beats within the pacing mode.
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Variables of ventricular rcpolarization are heart rate dependent and it was previously
reported thar inducible dogs have a longer cycle length of the 1VR than the non inducible
ones (13). Therefore, in those dogs studied both during acute and chronic AV block,
we performed when necessary the TdP induction protocol after d'-sotalol during AV
block at two basic cycle lengths: during spontaneous IVR and at a paced cycle length
identical to the cycle length of the first experiment. Continuous pacing was started 20
minutes after d'-sotalol.
MAPs were recorded to observe the occurrence of EADs and to measure the duration
of the action potential (API)) of the left and right ventricular endocardium at 100% of
repolari/ation. Quadripolar contact electrodes (Franz combination catheter, EPT #
1650), that provide both pacing and MAP recording capabilities were randomly placed
endocardially in the left and the right ventricle via the carotid artery and the external
jugular vein. MAP phases were defined according to the definitions used for trans-
membrane potentials (21). Amplitude was defined as the voltage difference between
phase 4 and 2 of the signal. Besides a minimal MAP amplitude of 15 mV, a stable
configuration and a smooth shape had to be present under control circumstances.
EADs were defined as an interruption of the smooth contour of phase 2 and/or 3 of the
action potential (22), and were examined in both MAPs.
Six surface elcctrocardiographic leads and 2 MAP signals were simultaneously registered
and stored on hard disc during the experiment. Both MAPs and ECG leads were sampled
with at rate of 1 kHz. Applying a custom made computer program (ECG View;
University of Limburg, Maastricht, the Netherlands) with a resolution of 2 ms and
adjustable gain and time scale, the following parameters were measured: CL-1VR, QT
time (lead II) and LV and RV APDjoo at baseline and at 10 minutes after </-sotalol. In
the 5 dogs tested twice we also measured these parameters at 20 minutes after */-sotalol
when the cycle length was corrected. All electrophysiological data reported are the mean
of 5 consecutive beats, liiterventricular dispersion (AAPD) was defined as the difference
between the left and right ventricular APD at a certain time point.
Paired and unpaired Student's r-test, were applied to compare data obtained in pre drug
condition and after d-sotalol and between 0 and 5 weeks of AV block. The X~ test was
used when the data were presented as a proportion. P values <0.05 were considered
significant. All data are presented as mean ± standard deviation (SD).
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RESULTS
Assessment of the heart weight in dogs with chronic AV block (20 ± 11 weeks) revealed
a significant increase in mass when compared to the hearts of dogs in SR with comparable
body weight (table 1). This increase is present in the left and right ventricle (table 1).
leading to biventricular hypertrophy.
Anesthetized dogs with chronic AV block (CL-IVR: ± 1670ms) had significantly longer
repolarization parameters than dogs in SR (SR-CI.: ±520 ms). This remained present
after 30 seconds or continuous ventricular pacing at 300 ms: the QT time amounted
205 ± 15 ms in dogs with SR, vs 275 ± 20 ms in the chronic AV block dogs (IM).OS).
A similar pattern was found with 400 ms pacing (225 ± 15 vs 300 ± 20 ms). At these
cycle lengths the VI'RP was also significantly increased when chronic AV block dogs
were compared with dogs in sinus rhythm (figure 1).
Prospective study
The amount of biventricular hypertrophy in the subgroup or 5 dogs studied prospec-
tively was: LV/BW of 5.9 ± 0.8 and a RV/BW of 2.6 ± 0.3 g/kg. The dogs had chronic
Table 1. Heart weights of dogs in sinus rhythm (SR) compared with dogs with chronic complete A V block
(20 weeks, range 10-34)
SR(n=ll) AV(n=9)
Heart weight (g) 225 ± 34 280 ± 64'
H/BW(g/kg) 7.7 ± 1.2 11.2 ± 1.9'
LV(g) 125 ± 26 145 ± 32
RV(g) 40 ± 8 65 ± 22'
LV/BW (g/kg) 4.3 ± 0.9 5.8 + 0.9'
RV/BW (g/kg) 1.4 ± 0.4 2.6 ± 0.9'
BW(kg) 29.6 ± 5.6 25.1 ± 5.6
H/BW: Hcart/bodyweight (g/kg), LV: left ventricle weight (g), RV: right ventricle weight (g), LV/BW:
left ventricle/body weight (g/kg), RV/BW: righr vcntricle/bodywcight; P<0.05 vs SR
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Figure I. Increase in vi-iuricul.tr effective refractory period after chronic AV block.
lir.ipli showing the results ot a retrospective study performed in anesthetized dogs in which we compare
lite ventricular cfrcctivc refractory period (VERP)in sinus rhythm (•, n=18) with dogs in chronic AV block
(± ') weeks, Q n=9). The VF.RP was determined by one single extrastimulus following 8 basic stimuli at
different basic cycle lengths. The ventricular cycle length during sinus rhythm (SR) and the mean cycle
length of the idioventricular rhythm K'l.-IVR) are indicated on the horizontal axis. The AV blocked dogs
show a significantly longer VI\RI' than the dogs in SR at those cycle lengths that can be compared (400
-300 ms).
AV block for 9 weeks and the data were comparable with the retrospective data shown
in table I.
/nrKAfr A/I/"/) rf/ /IT
Arter creation ot complete block or arter switching off the pacemaker a stable
idioventricular rhythm evolved with a cycle length of ± 1600 ms. No differences were
found in the electrophysiological parameters of the dogs in which the experiment was
performed tight after closure of the chest or with a delay of three days. Therefore we
combined the results of the two groups (table 2). At baseline all dogs had smooth MAP
signals: no EADs were present. At this time point TdP could not be induced by pacing
(n=9).
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ACUTE AV BLOCK 2 CHRONIC AV BLOCK
Figure 2. Differences in baseline rcpolarization values in acute and chronii AV blink.
Two panels with a lead II ECG and a recording «I the led and right ventricular (l.V and RV) monnphatic
action potential (MAP) are shown at a paper speed of 25 ms. Panel 1 shows the baseline situation, directly
after creation of AV block. The cycle length of the idioventricular rhythm (CL-IVR) is 1840 mswitha QT
time of 360 ms. The action potential duration (APD) of the LV is 330 ms whereas the RV APD is 280 ms
resulting in an interventricular dispersion of repolarization (AAPD) of 50 ms. In this dog, 6 weeks of chronic
complete AV block led to a prolonged QT time (panel 2) while the CL-IVR and QRS duration are similar.
The LV APD and RV APD are also prolonged. Because this prolongation is more pronounced for the LV,
the AAPD has increased to 80 ms.
Five weeks of chronic AV block led to a significant increase in all repolarization
parameters (table 2) while the cycle length of IVR was similar. The number of F.ADs
was not increased, but the interventricular AAPD augmented from 40 ± 35 to 70 ± 30
ms due to the absolute and relative larger increase of the LV APD compared with the
RV APD. A representative example of the differences in QT, LV and RV APD measured
in the acute and chronic phase of complete AV block is shown in figure 2. In one dog
very outspoken repolarization disorders were present in the form of EADs in the left
ventricle, resulting in a larger AAPD (130 ms). TdP could be induced by pacing.
In the acute phase of complete AV block (after ± 30 minutes), */-sotalol increased the
CL-IVR, the Q T time and APD in both ventricles (table 2), to an extent that was less
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Table 2. Elcctrophysiologk effects of chronic complete AV block and effect of (/-sotalol
CL-IVR
QT
IV APD
RVAI'I)
AAPD
EAD*
TdP
baseline
0 wks
1600 ±280
315 ±25
295 ± 20
260 ± 20
40 ± 35
0/14
0/9
5wks
16151280
390 1 65'
390 ± 60'
315140"
70 1 30
1/18
1/10
</-sotalol
Owks'
1720 1 465
385 1 40*
340 1 40*
295 1 20'
45 1 30
4/14
0/9
• 22%
+ 15%
• 15%
• 12%
5 wks
19351425
485185'*
495 195'*
370 1 55'*
125 ± 6 5 *
9/18*
6/10*
•25%
+28%
• 18%
•80%
Mean ± SI) and percent increase afler rt'-sotjlol; *: 5 dogs with a paced rhythm. P<0.05 vs 0 wks, * P<0.05
baseline vs c/-sotalol. ("1.-1VR: cycle length of the idiovcntricular rhythm. APD: action potential duration.
l.V: left ventricle, RV: right ventricle. AAPD:I V APD - RV APD.
Table 3. I IK idem e of early .iltcrdipolari/ation* (KAD). amount of intcrvcntricular dispersion of repolari-
/.nion (AAI'I)) .nul incidence ol Torsadc de Pointes arrhythmias ( IdP) at 0 and 5 weeks alter d-sotalol
( d S ) i n i l u i . i i i i i ' i i c > c
I.V7KV IAD (I AAI'I) TdlM) £AD 5 M P D IdP 5
1
2
3
4
5
Total
l.V +
RV •
IV
RV
l.V
RV
l.V
RV
I V •
RV +
•t/10
75
35
80
25
40
501 25 0/5 8/10
180
70
ISO
80
125 +
120 ±45' 4/5
': IV0.01 0 w S weeks. 1 V: left ventricle. RV: richt ventricle.
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Figure 3. Difference in arrhythmogenic response after d-sotalol.
This figure (for abbreviations see figure 2) consists of three LCX; leads and two MAP recordings, one in
the RV and one in the LV at a paper speed of 10 mm/s. After d-sotalol, during a paced rhythm of 1730
ms the LV APD is 380 and the RV APD 300 ms resulting in a AAPD of 80 ms. Both MAP's are smooth:
no early afterdepolarizations (EADs) are present. Performance of a pacing protocol consisting of 4 beats
with a cycle length of 600 followed by beat after 1200 ms and an extra stimulus after 350 ms does not
result in an arrhythmia. Six weeks later (panel 2), administration of 2 mg/kg d-sotalol results in a LV APD
of 500 and a RV APD of 350 ms causing a AAPD of 150 ms. Note that both MAPs now show EADs
(arrows). Performance of the same pacing mode results in a self terminating IdP.
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in comparison to the effect of the chronic adaptations present after AV block. The latter
occurred uniformly so that no effect on interventricular AAPD was seen. In five dogs,
the prolongation of the CL-IVR by d-sotalol, led to hyperventilation as evidenced by a
fall in CO2 values. We choose to temporarily (20 min) pace these dogs at a CL
comparable with baseline IVR, which resulted in restoration of the functional status.
The value found after at 10 minutes d-sotalol is therefore an underestimation of the
CL-IVR prolonging effect of d-sotalol. After 20 minutes of «/-sotalol, the dogs could
tolerate the slow rate and back up pacing was stopped, at spontaneous IVR the TdP
induction protocol was repeated for a second time.
The effect of d-sotalol on repolarization was much more pronounced in the dogs with
chronic AV block. This was the case using a group comparison (table 2) as well as when
the dogs were studied twice (table 3). Especially the prolongation of the LV APD (+28%
vs 15%) was larger in the hypertrophicd group. EADs also developed more frequently
after d-sotalol during chronic AV block (4/14 vs 9/18). All these changes led to an
increased AAPD.
At 20 minutes the CL was similar at both groups (due to the rate correction) the
difference in Q'I, LV APÜ, RV APD and AAPD remained significantly higher after
chronic AV block.
hollowing acute AV block, pacing after administration of ^-sotalol never resulted in
induction of TdP (0/9, figure 3. panel 1). Repetition of PES at spontaneous IVR after
r/sotalol also did not induce TdP. In contrast, TdP was induced in 6/10 dogs with
chronic AV block (table 2, figure 3, panel 2).
When using the dog as its own control, TdP induction was associated with a longer
APD. an increased AAPD and more frequent development of EADs after </-sotalol
during spontaneous IVR (table 3). The non inducible dog had the smallest AAPD and
no EADs (table 3). PES was repeatedly interrupted by ectopic beats in 3/5 dogs after
chronic AV block while in acute AV block this was never the case. After correcting for
the slower heart rate in the inducible animals, pacing did not lead to a different response.
They remained inducible.
DISCUSSION
Chronic complete AY block is not a frequently used method to induce cardiac hyper-
trophy, although such a model was already described in the beginning of the century
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(23). The increase in heart weight is due to the adaptations that take place to compensate
for the volume overload that occurs when the heart rate slows (24). Hypertrophy has
been described to appear in both the right as well as in the left ventricle (24,25). These
authors also describe the occurrence ot cardiac failure in a number of dogs (7/11) when
the animals are regularly exercised (25). Later reports in a larger scries of dogs, showed
compensated hypertrophy on as evidenced by the findings of normal l.V hemodynamics
(26). It is also our experience that compensated biventricular hypertrophy occurs when
the dogs are kept in their cages without regular exercise. In our series of approximately
150 dogs with complete AV block, the incidence of overt heart failure is low ( ± 10%).
None or the dogs used in the present study showed any signs of cardiac failure as assessed
by body weight measurements, overall impression (ascites). and auscultation of the
lungs.
In our model the LV mass to body weight ratio has increased from 4.3 g/kg during sinus
rhythm to 5.8 g/kg during chronic AV block. Other canine studies using volume
overload due to mitral valve regurgitation or arteriovenous fistula (6,7) or pressure
overload by clamping the renal artery (27,28) show similar values of left ventricular
hypertrophy. In contrast, aortic banding of puppies results in higher values: from 6.9 to
8.8 g/kg (7,9). In this model, the authors have suggested to differentiate in two
subgroups of hypertrophy: mild or severe depending on percent increase of the l.V mass
and diminished subendocardial blood flow (9).
As far as the degree of RV hypertrophy is concerned, the increase in RV to body weight
ratio is more pronounced than that of the left ventricle. In dogs with arteriovenous shunt
(6) and pulmonary banding (10) a similar amount of RV hypertrophy ( ± 2.6 g/kg) has
been found.
Ventricular hypertrophy results in lengthening of the repolarization parameters, like Q T
time and APD. It has been suggested that this prolongation predisposes the heart for
EADs and triggered arrhythmias (11).
Mild hypertrophy caused by pressure overload in dogs has been shown to prolong LV
APD by 14% both in situ (28), and in vitro (29). The present study shows that chronic
AV block leads to a prolongation of LV APD with 32%. This different increase in LV
APD, despite a similar amount of LV hypertrophy, could be due to differences in cycle
length between the two groups: 800 ms in the pressure vs 1600 ms in our dogs (28).
APD is frequency dependent and when our dogs are paced at comparable rates the
prolongation is less pronounced (30).
Surprisingly, the increase in RV APD is less severe (+21%) than that of the LV APD,
despite a similar absolute increase in heart weight and an even higher percentual increase
of the right ventricular mass. This could indicate that the changes in the
electrophysiological parameters are not only related to hypertrophy and/or bradycardia.
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A comparison with other models is not possible because to our knowledge no report has
been published describing the electrophysiologic effects in dogs with RV hypertrophy.
An explanation for this difference could be the different hemodynamics in the right and
left ventricle. Functionally the left ventricle is completely adapted to the volume overload
as measured by pressure volume loops (SHM de Groot, personal communication) and
also other studies indicate compensation (24,26). The functional status of the right
ventricle has not been determined yet, but it is conceivable that a similar volume overload
leads to different wall strains in the right compared with the left ventricle. Stretch has
the capability to shorten APD (31). and this opposing effect may influence the amount
of prolongation.
Also for the comparison of the APD at the two time points, this stretch induced
shortening may be a confounding parameter. The measured APD at control could be
shorter as expected on the basis of the bradycardia alone.
A second but less likely reason for the difference between the LV and RV APD response,
could be a different rate response in M cells of the right and left ventricle. At longer
cycle lengths the prolongation of the IV is much longer than the RV (32). Studies in
dogs and humans have shown the presence of M cells (32,33).
The consequence of the relative smaller increase in the RV APD compared with the LV
APD is an increase in the interventricular dispersion under baseline conditions in the
chronic AV block phase. Interventricular dispersion is bradycardia dependent, the slower
the heart rate the longer the difference between the LV and RV APD (17). In this study,
we have controlled for the cycle length, so that the observed increase in dispersion is not
based on the frequency. This increased amount of dispersion could have important pro
arrhythmic consequences as we have recently described (17), because it is one of the
components necessary to induce TdP in our animal model. The occurrence of TdP after
administration of class 111 agents (13) is associated with bradycardia, QT/APD prolon-
gation and the development of HADs (17). Suppression of EADs and a diminished
interventricular AAPD by magnesium prevents TdP (17), whereas the class III agent
almokalant, which results in more EADs and a larger AAPD as «/-sotalol, has a higher
incidence of (spontaneous) TdP occurrence (34).
Similar findings were obtained in this study, both in the serial testing as in the group
comparison. TdP induction was related to the presence of EADs and an impressive
amount of interventricular dispersion. Following acute AV block no EADs were present
under baseline situation and interventricular AAPD amounted to 40 ms. Administration
of7/-sotalol led to a lengthening of the repolari/ation parameters, appearance of EADs,
but not to an increase in AAPD, and no TdP could be induced. After 5 weeks of AV
block, interventricular AAPD was increased under baseline situation, while EADs were
still not present, with one exception. In that dog l d P could be induced during baseline.
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</-Sotalol increased interventricular AAPD runher because of to its more pronounced
eftect on the LV' APD and led to a higher incidence of F.ADs, and to TdP induction in
60% of the dogs. This means that not only the baseline values are higher in hypertrophy
but that also the increase in APD and AAPD after </-sotalol is larger. The dogs with a
low interventricular AAPD after «/-sotalol did not develop TdP (see e.g. table 3).
/?o/r o/T^rrrrw^/ry^r r/v /Wurr/on o/
Hypertrophy and its concomitant increase in the dispersion of intra- and/or inter-
ventricular rcpolari/jtion is also associated with a higher vulnerability to other
ventricular arrhythmias in other studies (2,11,27,28,35.36). Moreover, regression of
hypertrophy concomitant with a decrease of the electrophysiological parameters results
in a marked reduced incidence of arrhythmias to baseline (36).
It would also be interesting to see whether the changes in electrophysiologic parameters
in our dogs can be influenced by the prevention or regression of hypertrophy. In this
context it is important to mention the study of Kreher et al. (37) suggesting that the
adaptations leading to hypertrophy and electrophysiologic changes could be two dif-
ferent processes which can operate independently (37).
Occurrence of TdP in dogs in the acute phase of AV block is not impossible. Two studies
have shown the occurrence of spontaneous TdP and polymorphic ventricular arrhyth-
mias after administration of class III agents (38,39). However addition of an a-agonist
(39) or a three times higher dose of almokalant was required (34,38). This could imply
that the processes which takes places in the weeks following creation of complete AV
block are more a facilitating than an absolute requirement for the induction of TdP,
especially in regard to the increased APD and dispersion. In this regard it is of interest
that in the human heart with complete AV block, TdP is rarely seen during acute
ischemic AV block in myocardial infarction, but much more in chronic fibrotic AV
block. It is likely that in the latter patient group ventricular hypertrophy is present.
Prolonged repolarization facilitates the development of EADs (11). The ionic
mechanism of these EADs and of the increase in APD are not completely understood.
Several reports show diminishment in outward K* currents (2,40). ^/-Sotalol, like most
class III agents, blocks the outward K* current. Blockade of an already diminished
current may explain the higher sensitivity to ^/-sotalol of the hypertrophied muscle in
AV block dogs.
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In this study, we did not assess the time dependent behavior of the anatomical and
clectrophysiological changes. Because we measured only at two time points, it is possible
that the adaptations were not fully completed. Earlier studies, however, showed that
there is no relation with duration of AV block and total heart weight when assessed after
two weeks (24,25). We had similar findings comparing the obtained heart weights at
20 weeks with 9 weeks AV block. In relation to the electrophysiological effects, the
response to «/-sotalol does not change in time, when we compare the experiments that
have been started after 2 weeks AV block (13). This suggests that the alteration
responsible for the facilitated TdP induction is already present at two weeks. The time
period between 0 and 2 weeks will be the subject of further investigations.
A second limitation could be the random placement of the endocardial MAPs during
these experiments. This method ignores possible intravcntrictilar differences in APD.
However we have shown that the intravcntricular difference is always much smaller (only
20%) than the interventricular dispersion (17).
Finally, we have the difficulty that we are not yet able to measure the changes that occur
during the pacing train leading to induction of TdP. We know that changes in frequency
lead to augmentation of KADs, and to occurrence of triggered ectopic beats. The
dynamicity of the changes in interventricular AAPD can however not been assessed at
this time.
Extrapolation from data derived from experimental animals to the human setting should
always be done with great caurion. It is known that many different arrhythmic
mechanisms may be generated in the hypertrophied myocardium resulted in
symptomatic arrhythmias and death (2,3). We can hypothesize that patients with
ventricular hypertrophy are more prone to the proarrhythmic effects of the TdP type
during treatment with rcpolari/ation prolonging agents than patients without hyper-
trophy. A first step to be better informed about that possibility could be to stratify
patients with TdP not only to Q T interval, Q T dispersion and heart rate but also to
their degree amount and/or kind of ventricular hypertrophy.
Chronic complete AV block causes volume overload induced biventricular hypertrophy.
Changes after creation of complete AV block do not only results in an increase in APD,
they also lead to an increase in EADs and AAPD after </-sotalol. This change is
accompanied by the occurrence of TdP arrhythmias, once again confirming the impor-
tance of both I.ADs and AAPD in the genesis of TdP.
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Chapter 8
General discussion
Since the beginning of this decade, there has been an increase in the use of class 111 agents
instead of class 1 antiarrhvthmic drugs. Class I drugs primarily delay conduction, while
class III drugs act by lengthening of rcpolari/ation. This change is the result of multi
center trials pointing to a higher complication rate when class 1 drugs are used. 1) The
CAST trials (1,2), in which administration or class 1 drugs (flccuinide, encainide, and
morizicine) after myocardial infarction led to increased mortality. This adverse effect is
observed in patients who had shown a decrease in ventricular arrhythmias on Holier
recordings while using these drugs. 2) The ESVEM trial (3). in which various class I
agents were found to be less effective than sotalol in treating patients with symptomatic
ventricular tachycardia (VT) or those surviving cardiac arrest. In these patients antiar-
rhythmic treatment was guided by cither Programmed Electrical Stimulation (PES) or
Holter. 3) The CASCADE trial (4), in which empiric amiodarone therapy was proven
to be more effective than class 1 agents. Again in this study, treatment was guided by
PES or Holter.
These findings provided the major motive for the development of new class 111 agents
(5,6). Also, because the existing class III agents (sotalol and amiodarone) 1) had other
effects next to their prolongation of the action potential duration, and 2) lacked specific
K+ channel blocking properties, new "pure" class III agents were the targets to develop.
Class III agents in general do have the potential to induce proarrhythmic reactions. The
best known is the occurrence of Torsade de Pointes arrhythmias (TdP). An increasing
clinical use of class III drugs makes it likely that there will be a proportionate increase
in TdP. Fear of this problem has already resulted in the discontinuation of the
development of a number of pure class III agents (7), as is the case with ^/-sotalol where
an increased mortality rate with this drug was reported in the SWORD trial (8), but
also in case of almokalant (9) and sematilide.
To develop a safe class III antiarrhythmic drug, it is necessary to define exactly the precise
electrophysiologic mechanisms of TdP, the clinical circumstances favoring its occur-
rence and how these are effected by the antiarrhythmic drug. For that purpose, it
becomes mandatory to have an animal model of TdP in which TdP can be reproducibly
induced under "clinical" circumstances. Moreover, such a model would allow systematic
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investigation of the different parameters involved and would enable comparison of
different proarrhythmic and antiarrhythmic effects of drugs.
In our opinion, our recently developed TdP model, which is described in this thesis,
meets those requirements. We performed a total of 115 experiments (88 </-sotalol, 27
almokalant) to study the different aspects of TdP. We were not only able to reproducibly
induce TdP during a single experiment but this TdP induction was maintained over
weeks (figure 1).
Like clinical acquired TdP (10), the /'«/V/Vrr/'ow «ƒ 7V/* in our animal model is related to
the following parameters 1) heart rate (bradycardia), 2) prolonged Q T time, 3) presence
of early aftcrdepolarizations (F.ADs), and 4) abrupt frequency changes (short long short
sequence). I n addition, we have confirmed the presumed relevance of another parameter:
5) intervcntricular dispersion of rcpolarization (AAPD) in the genesis of TdP. In the
following paragraphs each of these parameters will be discussed in relation to the results
presented in this thesis and compared to data from the literature.
//«*rf raft*
The importance of a slow heart rate or long cycle length of the idioventricular rhythm
(CL-IVR) is based on the following observations: 1) In the clinical situation TdP often
occurs during bradycardia because of sinoatrial or atrioventricular block. In patients with
.IIII.I! fibrillation I'dP typically develops after conversion to (a slower) sinus rhvrhm; 2)
In our own model, non inducible dogs have a taster rhythm; 3) However when the
CL-IVR of these non induciblc dogs is prolonged with a second bolus of //-sotalol, half
of them become inducible (chapter 2); 4) Both in the clinical situation and in our dog
model, acceleration of the CI.-I VR by isoproterenol or ventricular pacing prevents/sup-
presses TdP induction (chapter 2); 5) CL-IVR is a major determinant of all repolariza-
tion parameters: Q T time, F.ADs and intcrventricular AAPD.
Although we consider bradycardia to be an important requisite, it has also been shown
that other factors need to be concomitantly present like an additional prolonged
repolari/ation time. For example, we demonstrated in inducible dogs that a similar
increase in CL-IVR after the P Mocker atenolol did not lead to TdP induction (chapter
2). Secondly, a further prolongation of the CL-IVR after magnesium administration
was not accompanied by persistence of TdP because the reduction in repolarization
prevented occurrence of TdP (chapters 2 and 3).
In the literature Q T values have been mentioned which could possibly predict the risk
for the development of TdP (11.12). Therefore we plotted the Q T and CL-IVR at
baseline, 10 minutes after //-sntalol and after prevention by MgSO^, verapamil,
flunari/ine. ryanodine or levcromakalim (13) to relate these parameters to the induction
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Figure 1. Reproducibility of the (in)ability IO induce Torsadc de Pointes arrhythmias (7'dP) after «/-«HaJo/
over weeks.
The response ot the dogs which were tested more than once for the TdP experiments after 2 mg/kg */-sotalol
is shown: induction of TdP ( I ) or no induction of TdP (O). On the horizontal axis the number of weeks
after the creation of chronic complete atrioventricular block is depicted. Only 4/62 cases showed a different
response, leading to a reproducibility of 94% over weeks. Two of these changes could be explained by the
use of a diuretic.
of TdP. From figure 2 it is clear that most inducible points fall in the north east quarter
of this graph, but no discriminatory line can be established with a sufficient sensitivity
and/or specificity to predict TdP occurrence. However, the transition to inducible
(</-sotalol) or non inducible events (after preventive medication) is always associated
with a change in QT. These data confirm clinical findings that the absolute value of QT
prolongation is not of great value. In this regard it is of interest to mention that
amiodarone while causing a similar or even longer QT time as other class III or class la
agents, does not result in TdP (14,1 5).
Lately, articles have appeared that indicate that Q T dispersion, that is the difference
between the longest and the shortest QT time on the ECG, may be used as a possible
predictor for TdP in acquired (16-18) and congenital TdP (19). This work has many
limitations, like reproducibility, variation in the number of leads which are measured,
differences in methodology of Q T time measurements, how to account for T wave-
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Figure 2. Importance of the QT time and the cycle length of the idioventricular rhythm for the (in)abiliry
to induce TdP.
In tliis figure, data from 80 experiments with (/-sotalol are combined. Open circles (O) indicate time points
in the experiment in which no Tdl' could be induced: I) during baseline, 2) first bolus //-sotalol not leading
to Tdl' (non induiible animals) and 3) after anti arrhythmic treatment using MgSO4 (100 mg/kg),
ryanodiiu (10ug/kg), vcrapamil (0.04 mg/kg), flunarizinc (2 mg/kg) or levcromakalim (0.01 mg/kg). The
closed squares (•) are the time points at which TdP could reproducibly be induced after PES (first and
second bolus ol r/-sotalol). The specificity and/or sensitivity arc low. For example a QT time of 500 ms has
.1 specificity of 0.88, but only a sensitivity of 0.66. When the QT time is lowered to 450 ms, the specificity
decreases to 0.61, while the sensitivity increases to 0.8. Therefore no discriminating line can be found using
either Cl.-IVR or QT to predict occurrence of TdP.
morphology, the importance or normal and abnormal spread of ventricular activation,
and what to do with the U wave (20). Also these series are small, and follow up time
often to short to get an idea about the true value of this approach.
Regional differences in the length of rcpolarization can be subdivided in inter-, intra-
ventricular or transmural dispersion, including dispersion between Purkinje and
mvocardi.il tissues. Since the introduction of the MAP catheter, many studies have been
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performed that measured APD at different sites. Most of them are limited to intra-
ventricular AAPD. In the normal human heart (see table 5 in chapter 1), the in-
traventricular difference in MAP duration ranges from 0 to "3 milliseconds (21-23). In
patients with congenital long Q T values around 125 ms (23) have been described, while
there has been found an interventricular AAPD of over 250 ms (24) in a patient with
acquired TdP. Transmural and interventricular dispersion have also been the subject of
investigation in vitro. In figure 3, the reaction of 3 different canine ventricular cell types
to changes in cycle length of both ventricles are depicted. At longer IX. the AIM) of the
epicardial and endocardial cells are shorter than that of the midmyocardial (M) cell. In
addition the APDs of LV endocardial and IV' epicardial cells, but especially the M cells
are significantly longer than that of the right ventricular cells (25) (compare right and
left panels of figure 3).
In the dog heart with chronic complete AV block, baseline values of about 60 ms for
interventricular AAPD are encountered. Interventricular dispersion was shown to be
bradycardia dependent (chapter 3), even without the presence of LADs. At a short cycle
length (500 ms), there is already an interventricular difference in the APD of around
10-30 ms (chapter 3 and figure 4). The increase in inrcrventricular AAPD with an
increase in CL can be explained by the difference in response of the right versus left
ventricular cells.
Administration of «/-sotalol or almokalant results in a more pronounced interventricular
AAPD. In our dog.s the intraventricular difference is only 20 to 30% compared with the
interventricular AAPD (table 1 of chapter 3) after class III drugs. This can not only be
explained by the different sensitivity of the LV compared to the RV in regard to changes
in frequency or class III drugs, but is in part also related to the development of EADs
(see below).
Dispersion of repolarization is not only related to differences in APD but can also be
attributed to differences in local activation time (AT) with the beginning of the QRS
complex as a reference. It will change when the normal sequence of activation as
occurring during conducted sinus rhythm changes to a paced or idiovcntricular rhythm.
In the normal heart there exists an inverse relationship between AT and APD resulting
in a relatively homogeneous (endpoint) of repolarization (26). A long repolarization
time can therefore to a certain extent be compensated by differences in AT. Although
we did not determine AT yet (due to the different activation patterns during the
CL-IVR) we do not believe that this is a major contributor to interventricular AAPD in
our experiments.
Early afterdepolarizations are defined as an interruption or retardation of the repolariza-
tion (27) that prolong the APD. In vitro, not all cells are equally sensitive to develop
EADs (28,29). Also in situ, there are findings which suggest a preferential site of EAD
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Figure 3. Interventricular and transmural differences in canine ventricular action potential duration (APD)
in vitro.
The action potential of the left and right ventricle is shown at different cycle lengths for the individual
ventricular cell types: endocardial (A), epicardial (o) and M cells (•). Besides larger transmural differences
in APO at the longer cycle lengths there is also an appreciable difference in the APD when the left (right
part) and right ventricle (lelt part) are compared. This results in a large interventricular AAPD of
approximately 100 ms at a C'.L of" 2000 ms. Figure adapted from reference 25, published with permission
of the American Heart Association and the authors.
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development: 1) Endocardial MAP recordings in humans do not show EADs on every
site (23,24). 2) Experimental studies in dogs have indicated that a) EADs are more prone
to develop on the endocardial than on the epicardial site (2')) and b) there exists a
differential response of the left and right ventricular EAD amplitude after cesium and
left stellate ganglion stimulation (30). We have shown (chapters 2,3 and S) that after
</-sotalol the EADs occur more frequently in the left ventricle, whereas with .ilmok.tl.tm
EADs developed in both ventricles (chapter 4).
The manifestation of EAD dependent triggered activity needs some prerequisites: 1)
critical prolongation of the APD by reducing outward current (as after class 111 agents),
or increasing inward current, 2) a net depolarizing current to create the EAD, and 3)
propagation of the EAD to other regions of the heart resulting in an cxtrasystolc. The
net depolarizing current, causing the EAD, may be secondary to a disbalance in the
intracellular calcium, because both ryanodine and flunari/.ine prevented the I'.AD and
related triggered beats (chapter 6). In our experiments we have found that the coupling
interval of such an extrasystole or cctopic beat (EB) is not always within the APD or QT
time. This can be explained by the fact that 1) the EB was originating from a cell with
a very long APD (e.g. Purkinje or M cell), that is not represented on the MAP or the
ECG due to the small mass, or 2) a long conduction time between the triggering cells
and the ventricular muscle (29) or both. An alternative explanation that is more
controversial, could be the simultaneous presence of EADs and delayed afterdepolari/.a-
tions (31). When the latter are responsible for the EBs the coupling interval will be
beyond the APD.
In patients a short long short sequence of the rhythm is observed at the start of most
episodes of TdP (12,32,33). A recent analysis of Holter recordings in patients with TdP
showed that before the development of TdP there was a significant increase in heart rate
with the occurrence of short long short sequences in the last minutes preceding the TdP
(34).
Frequency changes, either spontaneously occurring (almokalant) or induced by PES (our
(^ -sotalol experiments) form the basis for the initiation of the TdP. Without a first ectopic
beat no TdP will start. With PES induced TdP, one frequency change can already be
sufficient to start EBs and TdP (chapter 2). In the other 50%, more frequency changes
are necessary. On the other hand, the occurrence of spontaneous EBs is not always
sufficient to start a spontaneous TdP (35) and has no meaning for the inducibility of
TdP with PES. The difference could be that 1) the coupling interval of the EB is not
appropriately timed, and/or 2) the number of beats is insufficient. The observation that
class III agents (chapters 2 and 3) favor the occurrence of (or pronunciation of) the EADs
after a rate acceleration was recently confirmed in in vitro studies (36). Rate acceleration
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can also affect the intervcntricular AAPD due to different dynamic responses of the right
and left ventricle to adaptation of the APD.
The relation between EADs and AAPD is not entirely clear. Often the EAD is observed
in the MAP with the longest API) (23,24), thereby contributing to the AAPD. On the
other hand, presence of EADs in both ventricles, as with almokalant, is not associated
with a smaller interventricular AAPD (chapter 4, see below). From the behavior after
spontaneous termination of TdP and the increase in AAPD after the development of
EADs at a stable paced rhythm we concluded that EADs do contribute to inter-
vcntricular AAPD (chapter 5). While it is difficult to quantify their exact contribution,
we have hypothesized it to be around 25 to 30%. Furthermore the electrophysiological
adaptations that occur after chronic complete AV block seem to facilitate the occurrence
of both EADs and intervcntricular AAPD (chapter 7).
That both parameters in combination are necessary for TdP induction can be derived
from observations like: Al) the significant difference in incidence/magnitude of EADs
and interventricular AAPD between indueiblc and non inducible dogs. There existed
however a significant difference in CL between the two groups (chapter 3); A2) When
corrected for this parameter (similar CL), it was noticed that almokalant is associated
«vrfjf fit«»rv &A£>.i dfiJ .1 i'.ii^vi i'iitii>ciuii'iu/ui LA, \ /Y> .JIICV .1 /iig/ic'i milVJciliC o f
(spontaneous) TdP compared to r/-sotalol (chapter 4); A3) the significant difference in
interventricular AAPD between acute and chronic AV block experiments with </-sotalol
and their relevance to the induction of TdP (chapter 7). Bl) Independent of the effect
on the Cl.-IVR, suppression/prevention of TdP by magnesium (chapter 3), flunari/ine,
ryanodine (chapter 6), levcromakalim (13), isoprenaline or ventricular pacing,
diminishes both the EADs and interventricular AAPD, at the last beat of the TdP no
EADs arc present and interventricular AAPD is small and C) Reinduction of TdP is
only possible when F.ADs and intervcntricular AAPD have returned to their original
prepacing values, which changed directly after termination of TdP (chapter 5).
In figure 4, we have hypothesized how EADs occurring in both ventricles can lead to a
(temporarily present) arrhythmogenic window. Either the EADs occur at different time
points in the two ventricles or they have different contribution to the APD or both.
When the IV is considered the most sensitive for the development of EADs, both
possibilities will lead to a maximum intervcntricular dispersion. Over time this disper-
sion will be maintained or reduced, as the RV APD increases.
A limitation of our data is that all measurements concerning interventricular AAPD
where performed during a relative steady state (CL-IVR or paced rhythm) without
dynamic changes in (T . However, the alterations during PFS in EADs and inter-
ventricular AAPD suggest that a non homogeneous response of the ventricles to an
acceleration, may be very important in the continuation of the TdP (37.38).
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Graph illustrating the possible way in which administration of «/-sotalol leads to a larger interventricular
AAPD. The solid lines indicate the frequency behavior of the API) and interventricular AAPD during
baseline at paced frequencies. Interventricular AAPD is bradycardi.i dependent: from 30 ins at 500 ms
(comparable with SR) to 70 ms at idioventricular rhythm (IVR). Administration of </-sotalol (interrupted
line) prolongs APD homogeneously. Therefore there is no increase in interventricular AAPD. The second
effect of (/-sotalol, namely the lengthening of the cycle length of the idioventricular rhythm (IVR-CL d-sot)
does lead to an increased interventricular AAPD. Finally, administration of «/-sotalol may lead to I'ADs.
This may further contribute to interventricular AAPD. As shown by the dotted line 1) the increase in the
RV APD lags behind the LV APD due to a slower development of the EAD and/or 2) the RV EADs develop
later in time. Both changes will increase the interventricular AAPD, to arrhythmogenic levels.
In table 1, the individual role of interventricular AAPD, EB and EADs in the genesis of
TdP is summarized as evidenced from the results obtained in our animal model. Without
EADs and interventricular AAPD (baseline or after preventive measures) no TdP can
be generated, not even by PES. This suggests that the presence of (triggered) EADs is
no guarantee for TdP. PES in the setting of a sufficient interventricular AAPD may start
TdP because PES may mimic and reinforce the occurrence of EADs. Only the combina-
tion of EADs, EBs and interventricular AAPD lead to the spontaneous occurrence of
TdP. The occurrence of each of these parameters is favored by bradycardia, administra-
tion class III agents and chronic complete AV block (biventricular hypertrophy).
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Table 1. Factors related to induction of Torsade de pointes arrhythmias (TdP)
EADi EBs AAPD => spom TdP PES TdP
• - - = » -
• • - ^ -
— - • ^ - +
• - • ^ - +
• • • ^ • •
Abbreviations: EADs: early afterdcpolarizations, EBs: Ectopic beats, AAPD: interventricular dispersion;
spont TdP: spontaneous TdP, PES TdP: programmed electrical stimulation induced TdP, +: presence of
the parameter, -: absence of the parameter.
It has been suggested that the electrophysiologic mechanism responsible for the initiat-
ing beat is triggered activity due to EADs (possibly arising from Purkinje fibers or M
cells). In addition the data in this thesis support the hypothesis that a sufficiently long
interventricular AAPI) should be present for the initiation of TdP. The
electrophysiologic mechanism of the subsequent beats leading to the actual polymorphic
oscillatory pattern of TdP is less certain. Preliminary results show that continuation
could be due to triggered activity arising from several endocardial sites (39-41), or local
reentry (41,42). A reentrant tachycardia requires adjacent zones in which large differen-
ces in APD exist. The large difference in APD seems to be the case in our dogs. However,
the distance between the left and right ventricle could cause some problems to picture
a reentrant circuit between these two ventricles. On the other hand, a possible transmural
difference could form the base of the reentrant tachycardia. Another argument against
a reentrant circuit is the finding that the first beat of subsequent spontaneous TdP
episodes often arises from different places, suggesting different sites of occurrence in the
maintenance of TdP.
So far, the mechanism of TdP continuation, being triggered activity, reentrant tachycar-
dia and/or a combination has not been unraveled and will need further study.
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Summary
Disturbances in cardiac rhythm are a common phenomena in humans. These may vary
from a single innocent ectopic beat to lite threatening arrhythmias. Medical treatment
ot these arrhythmias is sometimes associated with a worsening or the exisit ing arrhythmia
and/or development of a new arrhythmia (proarrhythmic event). In this thesis the
mechanism and possible treatments ot one ot these proarrhythmic events. Torsade de
Pointes (TdP) arrhythmias, is studied. TdP is a polymorphic tachycardia, occurring in
the setting ot an (abnormally) prolonged repolarizarion in which the QRS complexes
twist around the isoelectric axis. TdP can be caused by several antiarrhythmic drugs, but
also by other medicamention which prolong the rcpolarization.
Chapter 1 is a literature review ot the different causes of TdP. with a central role for
acquired TdP by antiarrhythmic drugs. Examples arc the class la drugs: quinidinc,
procainamide and drugs with a class III effect like (</)-sotalol, amiodaronc and al-
mokalant. In addition the different experimental models dealing with TdP that were
published before 1992 are reviewed. The majority of these models used substances that
(in the used dose) are not (or cannot be) used in patients.
In dogs with chronic complete atrioventricular (AV) block, TdP can be reproducibly
induced by administration of antiarrhythmic drugs in a clinical relevant dose (chapter
2). In this model the conduction between atria and ventricles is interrupted permanently.
This offers the possibility to study ventricular arrhythmias, without interference by
normal activation and impulse formation of the atria through the AV node. In addition
there is a slow heart rate (a substantial part of acquired TdP).
During the AV block operation an electrode is placed on the heart. Combined with a
pacemaker this electrode can be used to change (accelerate) the heart rate. After at least
two weeks of AV block, dogs are anesthetized again and monophasic action potential
(MAP) catheters are advanced in both heart chambers. The MAP can determine
regionally the action potential duration and morphology. The action potential exists of
an activation (depolarization) and a deactivation (rcpolarization) phase.
After this, the TdP induction protocol is performed: a specific pacing protocol after
administration of 2 mg/kg ^-sotalol. With this treatment TdP develops reproducibly in
half of the dogs. Acceleration of the basal rhythm with continuous pacing or with
isoprenaline prevents TdP, alike the patient situation.
Chapter 3 describes a group comparison in animals with and without TdP. TdP depends
on 1) a prolonged repolarization (QT time, APD), 2) presence of early afterdepolariza-
tions (EADs) and 3) a sufficient difference between the APD of the left and right
ventricle; the so called interventricular dispersion (AAPD). EADs arc depolarizing
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currents that occur before the repolarization is finished. EADs may result in triggered
ecropic beats. Both EADs and interventricular AAPD are increased at a slow heart rate.
Magnesium prevents and suppresses TdP, because both the EADs and the AAPD are
diminished.
The response to <-/-sotalol remains similar in the same animal at different experiments.
Therefore a comparison can be made to the effect of several interventions, with the
animal as its own control like described in chapter 4. In 14 animals a'-sotalol and
almokalant (0.12 mg/kg) were given in consecutive experiments. A higher incidence in
the same animal of EADs and AAPD after almokalant resulted in a higher incidence of
(spontaneous) TdP (5/14 vs 12/14). Which confirmed the importance of EADs and
AAPD in the initiation of TdP.
Most episodes of I'dP end spontaneously. This fact combined with possibility of
reproducible induction of the TdP, allowed study of the behavior of the EADs and
interventricular AAPD. This provides insight in the mechanism of termination and so
by thus in the mechanisms of continuation (chapter 5). In the last beat of the TdP,
EADs are absent and the difference in APD between the ventricles is minimal. Reoc-
currence of EADs coincided with an increase in interventricular AAPD. Reinduction of
TdP is only possible when both the EADs and the interventricular AAPD are back to
their previous level.
Although interventricular AAPD is an independent parameter, showing a clear frequen-
cy dependence, EADs contribute to the interventricular AAPD. This is supported by
the fact that EADs and interventricular AAPD simultaneously disappear and reappear
after spontaneous termination of TdP episodes, and appearance of EADs at a constantly
paced (!l. after sotalol increases the AAPD (chapter 5).
c/-Sot.ilol .nul .ilmok.il.int prolong the APD, induce EADs and lead to TdP. This is
prevented by administration of flunari/.ine and ryanodine (chapter 6). These two drugs
affect the |Ca)j. A shortening of the repolarization and a suppression of the EADs. Their
prevention points to a disturbed intracellular Ca-* in the genesis of EADs and thereby
TdP.
I lie role of AV block for the 1 dP model is studied in chapter 7. Dogs (n=9) were studied
.it the moment of the creation of AV block and 4 to 6 weeks after AV block (n=10) had
evolved. In five of these dogs both time points could be studied. The APD of both
ventricles was significantly longer when measured at chronic AV block. In addition the
dogs with chronic AV block showed a more pronounced response to </-sotalol. this was
especially the case for the left ventricle resulting in a significantly larger AAPD. I dP
uuild never be induced directly after creation of AV block whereas at chronic AV block
0/11) dogs showed reproducible induction of TdP after rt'-sotalol and PES. This was not
only the case for the group comparison but also when individual animals were compared.
The thesis is concluded by a general discussion which summarizes the results obtained
in this model and points to their consequences for the mechanism of TdP.
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In short, this animal model of acquired TdP allows 1) reproducible induction of TdP
(spontaneous and PES induced). 2) investigation into preventive and suppressive
interventions and 3) comparisons between the proarrhythmic efrect ot different medica-
ments. The initiating mechanisms of TdP in this animal minlel depend on the presence
of EADs in combination with interventricular AAPD. Both parameters are hradycardia
dependent. Furthermore, EADs contribute to interventricular AAPD. The mechanism
responsible for the continuation of TdP is not completely clear. Further investigation
should be performed to clarify this continuation.
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Samenvatting
Verstoringen van het hartritme zijn een normaal verschijnsel in elk mensenleven. Deze
kunnen variëren van een onschuldige extra slag tot levensbedreigende ritmestoornissen.
Behandeling van de/e aritmieën met medicijnen gaat soms (3-5%) gepaard met een
verslechtering van een bestaande en/ot het ontstaan van een nieuwe ritmestoorim (een
proaritmogenc reactie). In dit proefschrift wordt het mechanisme en de mogelijke
behandeling van een van de proaritmogene responsen de zogenaamde Torsade de
Pointes ritmestoornissen (TdP) bestudeerd. TdP is gedefinieerd als een polymorfe
kamerritmestoornis waarbij de QRS complexen een mtatie om de iso-elektrischc as
vertonen op het ECCI (vandaar de franse naam Torsade de Pointes). TdP komt voor bij
een (abnormaal) verlengde repolarisatie dat onder meer het gevolg kan zijn van het
gebruik van bepaalde anti-aritmica, maar ook kan worden veroorzaakt door andere
medicamenten die in de geneeskunde worden toegepast.
In hoofdstuk 1 is een overzicht gegeven van de literatuur met betrekking tot de
verschillende oorzaken van TdP, waarbij de door anti-aritmica veroorzaakte TdP
("acquired" TdP) centraal staat. Voorbeelden van deze medicijnen zijn klasse I anti-.irii
mica als: quinidine, procainamide en disopyramide en stoffen met klasse ill effecten als
«/-sotalol, amiodarone, en almokalant. Tevens zijn de verschillende (dicr)experimcnrcle
modellen besproken die zijn gepubliceerd voor 1992. Het merendeel van deze modellen
werkte met stoffen die (in die dosering) niet bij patiënten gebruikt (kunnen) worden.
In honden met een chronisch compleet atrioventriculair (AV) blok kan TdP op een
reproduceerbare wijze worden geïnduceerd door toediening van anti-aritmica in klinisch
relevante doseringen (hoofdstuk 2). Bij dit AV blok model, waarbij een onderbreking
in de geleiding tussen de boezem en de kamer wordt geïnduceerd, is het mogelijk
kamerritmestoornissen te bestuderen zonder de invloed van de normale kameractivatie
door impuls geleiding van de boezem over de AV knoop. Tevens ontstaat er een traag
kamerritme (een essentieel onderdeel van "acquired" TdP). Tijdens de AV blok operatie
wordt er een elektrode op het hart aangebracht. Die in samenspraak met een pacemaker
kan worden gebruikt om het hart een andere (snellere) frequentie op te leggen. Nadat
dit complete AV blok minstens 2 weken heeft bestaan worden de honden opnieuw onder
narcose gebracht en worden er tijdelijk monofasische actiepotcntiaal catheters (MAI's)
ingebracht in beide hartkamers. Met deze MAPs kan lokaal de vorm en de duur van de
actiepotentiaal van het hart worden bepaald. Deze actiepotentiaal is opgebouwd uit een
activatie- (depolarisatie) en een herstel fase (repolarisatie).
Het TdP inductie protocol dat hierna wordt uitgevoerd bestaat uit een specifiek
paceprotocol na toediening van 2 mg/kg ^-sotalol. In de helft van de honden kan op
deze manier reproduceerbaar TdP worden geïnduceerd. De TdP episoden zijn net als
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bij de humane patiënt te voorkomen door een versnelling van het basale hartritme, met
behulp van isoprenaline (($ agonist) of elektrisch pacen.
Een groepsvergclijking tussen dieren met en zonder TdP laat zien dat TdP initiatie
afhankelijk is van 1) een verlengde repolarisatie (QT tijd en/of actie potentiaal duur
(APD) 2) vroege nadcpolarisaties (EADs) en 3) een voldoende groot verschil in ac-
tiepotcntiaal duur tussen de linker en de rechterkamer: de zogenaamde interventriculaire
dispersie (AAPD, hoofdstuk 3). EADs zijn elektrische ontladingen die optreden voordat
de repolarisatie fase beëindigd is. EADs kunnen resulteren in het optreden van extra
slagen. Zowel het optreden van EADs als interventriculaire AAPD wordt versterkt door
een trager hartritme. Magnesium voorkomt TdP, doordat het zowel de vroege
nadepolarisaties onderdrukt als de interventriculaire AAPD vermindert.
De reactie op «/-sotalol (dat wil zeggen het wel of niet optreden van TdP) is reproduceer-
baar bij hetzelfde- dier tijdens verschillende experimenten. Daarom kunnen vergelijkin-
gen gemaakt worden naar het effect van verschillende interventies met het dier als zijn
eigen controle zoals beschreven in hoofdstuk 4. In totaal 14 honden kregen zowel
«/-sotalol als alniok.il.itu. Almokalant geeft meer EADs en een groter verschil in
repolarisatie duur tussen de linker en rechter kamer dan //-sotalol. Dit gaat gepaard met
cen significante toename in incidentie van (spontane) TdP. Dit bevestigt de noodzaak
van EADs en interventriculaire dispersie voor het initiëren van TdP.
Omdat TdP in de meeste gevallen spontaan eindigt en reproduceerbaar is op te wekken,
kan het gedrag van de actiepotentiaal duur en de EADs na afloop van een TdP worden
bestudeerd. Dit is gebruikt om meer inzicht kunnen krijgen in de terminatie en dus de
mechanismen verantwoordelijk voor de continuatie van de aritmie (hoofdstuk 5). De
laatste slag van de TdP heeft geen EADs en het verschil in APD van de linker en
reclucrkanur is miniem. Het opnieuw optreden van de EAD na afloop van de TdP ging
samen met een toename van de interventriculaire dispersie. Het opnieuw induceren van
TdP is alleen mogelijk als zowel de EAD als de interventriculaire AAPD weer terug zijn
op hun oude niveau. Interventriculaire dispersie is een zelfstandig fenomeen dat onaf-
hankelijk van de aanwezigheid van de EADs toeneemt bij een afname van de hart
frequentie. De ontwikkeling van EADs na «/-sotalol bij een gepacede gelijkblijvende
hartfrequentie leidt ook tot een toename van de interventriculaire AAPD. Dit betekent
dat de EAD een wezenlijke bijdrage levert aan de interventriculaire dispersie.
Verlenging van de APD door /^-sotalol en almokalant leidt tot EADs en TdP. Dit kan
voorkomen worden door toedienen van ryanodine en tlunarizine. Deze twee stoffen
beïnvloeden de calcium huishouding in de cel. Hunarizine corrigeert ook repolarisatie
stoornissen aanwezig in controle omstandigheden. De preventie van TdP door deze twee
stoffen duidt op een belangrijke rol van (intracellulair) calcium in het ontstaan van de
ritmestoornis (hoofdstuk 6).
Het chronische complete AV blok vertraagt de kamerfrequentie, waardoor er een volume
overbelasting optreedt (hoofdstuk 7). Het hart moet een zelfde hoeveelheid bloed in
minder slagen uitpompen. Het hart past zich hieraan aan met een toename van de
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spiermassa in beide kamers (biventriculairc hypertrofie). (Gecorrigeerd naar het
lichaamsgewicht van de hond neemt de rechterkamer meer UK (toename 80%) dan de
linkerkamer (toename 40%). Honden met een chronisch compleet AV blok hebben dus
niet alleen bradycardie maar ook biventriculaire hypertrofie. De elektrofysiologische
gevolgen van chronisch compleet AV blok is bestudeerd in IS honden. Daartoe werden
op twee tijdstippen metingen verricht: 1) direct na en 2) 4-6 weken na het maken van
AV blok. Na 4-6 weken AV blok is de kamerrepolarisatieduur verlengd en ook het
interventriculaire verschil in repolarisatie i.s toegenomen ten op/ichtc van metingen
direct na het maken van AV blok. Bovendien is bij een /.elfde hartfrequentie hei effect
van </-sotalol op de repolarisatieduur en dispersie veel meer uitgesproken, lir ontstaan
dan ook meer vroege nadepolarisaties en een grotere intervcntriculaire AAPD. In dieren
met een chronisch AV blok was TdP aanwezig in 60% van de dieren na 2 mg/kg s/-sotalol
terwijl na acuut AV blok in geen enkel dier TdP kon worden opgewekt met de/e dosering
</-sotalol. Dit maakt duidelijk dat de aanpassingen als gevolg van hei chronische
compleet AV blok het ontstaan van TdP ritme-stoornissen na ^/-sotalol vergemakkelijken
of de omstandigheden tijdens acuut AV blok TdP voorkomen.
Samenvattend kan worden gesteld dat in dit diermodel van "acquired" TdP het mogelijk
is om 1) reproduceerbaar TdP op te wekken (spontaan en PHS-induced), 2) diverse
preventieve en suppressieve interventies te onderzoeken en 3) vergelijkingen te maken
tussen het proaritmogene effect van verschillende medicamenten. Hel initiërend
mechanisme van TdP in dit diermodel is afhankelijk van de aanwezigheid van LADs in
combinatie met een voldoende grote interventriculaire AAPD. Beide factoren nemen
toe met een vertraging van het hart ritme. Los daarvan dragen de EADs bij aan de
interventriculaire AAPD. Het mechanisme dat verantwoordelijk is voor continuatie van
de TdP is nog niet geheel duidelijk. Verder onderzoek zal dit moeten aantonen.
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Het "onderzoeksvirus", met als primaire uiting promotie onder/ock. was de afgelopen
jaren een zeer besmettelijk fenomeen, terug te vinden in groot deel van mijn studie-
vrienden. Hoewel het "onderzoeksvirus" bij mijzelf gelukkig nog lang niet is gene/cn,
wordt met dit promotieboekje toch een periode afgesloten. Aan het einde van dit
proefschrift is dan de gelegenheid om iedereen te bedanken voor zijn of haar bijdragen.
Prof dr. Hein Wellens, wil ik bedanken voor het kritisch doornemen van de manuscripten.
Het aandragen van klinische relevante voorbeelden was en is een extra inspiratie bij het doen
van onderzoek.
Dr. Mare Vos, beste Mare, zonder jou ideeën, geen onderzoek naar Torsadc de Pointes
ritmestoornissen (TdP). Je altijd aanwezige enthousiasme voor onderzoek en dagelijkse
begeleiding werken aanstekelijk. Zonder jou steun in "deadline" momenten, had de
realisatie van dit boekje veel langer in beslaggenomen, bedankt. Ik hoop ook de komende
tijd nog veel van je te leren.
Jet Leunissen en Jolanda van der Zande, zonder jullie hulp zou geen enkel experiment
tot een goed einde zijn gebracht. Mede door jullie zorgvuldigheid bij de lay out van EC Cl
plaatjes en grafieken ziet dit proefschrift er zo mooi uit. Jolanda, ik ben blij, dat je
ondanks je verhuizing naar Utrecht, mijn paranimf wilt zijn om zo samen het "TdP
avontuur" af te sluiten.
Dierexperimenteel onderzoek, kan alleen plaats vinden dankzij de goede verzorging van
de honden door de medewerkers van het C.P.V. met name Ton van de Boogaard, Huub
Simons, Frans Slangen, bedankt. Voor de uitvoering en verwerking van experimenten
wordt veel apparatuur gebruikt, goed onderhoud door de instrumentele dienst is hierbij
essentieel. Het telefoonnummer van Leon Dohmen ken ik inmiddels uit mijn hoofd,
bedankt voor al je hulp bij het "redden" van mijn data.
Cardiologie zelf is een prima afdeling om kennis te maken met een zeer uitgebreide
selectie Limburgse vlaaien, die bijna continu aanwezig zijn, behalve het suikergehalte
wordt zo ook op een leuke manier de kennis met de restvan de vakgroep op peil gebracht.
De directe collega's van een experimentele cardiologie: Marieke de (jroot, Henny
Leerssen, Paul Volders, Attila Kulscar, Erik van der Veen en Jo Habets. Marieke, Henny,
Paul en Attilla wil ik ook bedanken voor de vele discussies over onder/.oek, het
meedenken over protocollen, correcties etcetera die behalve het werk sterk veraan-
Nawoord | / 65
genamen ook verantwoordelijk zijn voor het ontstaan van nieuwe ideeën en experimen-
ten.
Jurrcn van Opstal vanaf 1994 ben je bijna continu bezig geweest met het helpen
analyseren van Torsade de Pointes, bedankt. Tijdens moeizame schrijfuren werd ik
opgefleurd door de mensen van kantoortuin 3: Jacqueline, Lidwien, Willie, bedankt
voor de vele kopjes thee.
De leden van de beoordelingscommissie: Prof dr. M.A. Allessie (voorzitter), Dr
H.J.G.M. Grijns, Prof dr R.S. Reneman, Prof dr J.F.M. Smits wil ik bedanken voor de
beoordeling van dit proefschrift. I also like to thank Dr C. Antzelevitch for his
willingness to be a member of the review committee, and to be present at my defense.
Writing in cnglish, also a word of thanks to the foreign guests who were involved in this
project, Kat ja and Dr. Tamas Fa/.ckas. Hamas, you make analyzing TdP a wonderful
imaginary world. Thanks for reviewing the hypertrophy manuscript.
Experimentele cardiologie zit verscholen aan het einde van de gang van fysiologie. Dat
veroorzaakt lange loop afstanden, maar ook een aantal "gedag zeggende" Fysiologie
collega's op die daardoor de wandeltocht veraangenamen. Naast de OK's ligt een
koffiekamer, waar als je er niet voor de koffie komt (heren, waar blijft de thee ?) voor
cen altijd vriendelijk "goedemorgen" terecht kunt, Ruud, Theo, Ferenc en Bas bedankt.
En Fercnc, welkom bij Cardiologie en veel succes bij jouw 1'dP onderzoek.
Ook een woord van dank aan de mensen in de diverse laboratoria voor het lenen van
stikstofemmertjes, weegschalen, etcetera, en de goede raad bij het oplossen van
medicamenten.
Use, bedankt voor het realiseren van het Cardiac Ballet aan de voorkant van dit
proefschrift.
Hans en Peter, het is fijn om zulke broers te hebben, die je op vreemde momenten altijd
kunt lastig vallen. Hans, ik ben blij dat je mijn paranimf wilt zijn.
Als laatste wil ik mijn ouders bedanken, voor hun altijd openstaan voor dat vreemde
universitaire wereldje.
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